WO2015066669A1 - Proteases in corn processing - Google Patents
Proteases in corn processing Download PDFInfo
- Publication number
- WO2015066669A1 WO2015066669A1 PCT/US2014/063798 US2014063798W WO2015066669A1 WO 2015066669 A1 WO2015066669 A1 WO 2015066669A1 US 2014063798 W US2014063798 W US 2014063798W WO 2015066669 A1 WO2015066669 A1 WO 2015066669A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- slurry
- protease
- corn
- enzyme
- starch
- Prior art date
Links
- 108091005804 Peptidases Proteins 0.000 title claims description 106
- 239000004365 Protease Substances 0.000 title claims description 100
- 102000035195 Peptidases Human genes 0.000 title description 84
- 240000008042 Zea mays Species 0.000 title description 38
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 title description 38
- 235000002017 Zea mays subsp mays Nutrition 0.000 title description 38
- 235000005822 corn Nutrition 0.000 title description 38
- 238000012545 processing Methods 0.000 title description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 152
- 239000002002 slurry Substances 0.000 claims abstract description 110
- 238000000855 fermentation Methods 0.000 claims abstract description 100
- 230000004151 fermentation Effects 0.000 claims abstract description 100
- 230000001965 increasing effect Effects 0.000 claims abstract description 13
- 108090000790 Enzymes Proteins 0.000 claims description 193
- 102000004190 Enzymes Human genes 0.000 claims description 192
- 229940088598 enzyme Drugs 0.000 claims description 191
- 238000000034 method Methods 0.000 claims description 142
- 229920002472 Starch Polymers 0.000 claims description 121
- 235000019698 starch Nutrition 0.000 claims description 118
- 239000008107 starch Substances 0.000 claims description 117
- 235000019419 proteases Nutrition 0.000 claims description 73
- 230000008569 process Effects 0.000 claims description 63
- 102100022624 Glucoamylase Human genes 0.000 claims description 59
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 claims description 46
- 238000004519 manufacturing process Methods 0.000 claims description 37
- 108010056534 proteinase T Proteins 0.000 claims description 37
- 108090000637 alpha-Amylases Proteins 0.000 claims description 34
- 230000002829 reductive effect Effects 0.000 claims description 31
- 102000004139 alpha-Amylases Human genes 0.000 claims description 27
- 229940024171 alpha-amylase Drugs 0.000 claims description 25
- 101710130006 Beta-glucanase Proteins 0.000 claims description 16
- 150000001413 amino acids Chemical class 0.000 claims description 13
- 235000000346 sugar Nutrition 0.000 claims description 11
- 150000007524 organic acids Chemical class 0.000 claims description 9
- 239000006260 foam Substances 0.000 claims description 7
- 239000003242 anti bacterial agent Substances 0.000 claims description 3
- 230000003115 biocidal effect Effects 0.000 claims description 3
- 229940088597 hormone Drugs 0.000 claims description 3
- 239000005556 hormone Substances 0.000 claims description 3
- 229940088594 vitamin Drugs 0.000 claims description 3
- 235000013343 vitamin Nutrition 0.000 claims description 3
- 239000011782 vitamin Substances 0.000 claims description 3
- 229930003231 vitamin Natural products 0.000 claims description 3
- 125000003158 alcohol group Chemical group 0.000 claims description 2
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 22
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract description 39
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract description 15
- 239000004310 lactic acid Substances 0.000 abstract description 8
- 235000014655 lactic acid Nutrition 0.000 abstract description 8
- 210000004027 cell Anatomy 0.000 description 90
- 108090000623 proteins and genes Proteins 0.000 description 61
- 108090000765 processed proteins & peptides Proteins 0.000 description 51
- 239000004382 Amylase Substances 0.000 description 50
- 102000004196 processed proteins & peptides Human genes 0.000 description 48
- 150000007523 nucleic acids Chemical class 0.000 description 45
- 229920001184 polypeptide Polymers 0.000 description 45
- 102000013142 Amylases Human genes 0.000 description 44
- 108010065511 Amylases Proteins 0.000 description 44
- 235000019418 amylase Nutrition 0.000 description 43
- 230000000694 effects Effects 0.000 description 40
- 102000004169 proteins and genes Human genes 0.000 description 39
- 102000039446 nucleic acids Human genes 0.000 description 38
- 108020004707 nucleic acids Proteins 0.000 description 38
- 235000018102 proteins Nutrition 0.000 description 37
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 35
- 229910001868 water Inorganic materials 0.000 description 32
- 239000000463 material Substances 0.000 description 30
- 230000014509 gene expression Effects 0.000 description 29
- 239000013598 vector Substances 0.000 description 28
- 239000000758 substrate Substances 0.000 description 27
- 238000007792 addition Methods 0.000 description 26
- 239000000047 product Substances 0.000 description 26
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 25
- 235000013339 cereals Nutrition 0.000 description 24
- 108020004414 DNA Proteins 0.000 description 22
- 102000053602 DNA Human genes 0.000 description 22
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 21
- 125000003275 alpha amino acid group Chemical group 0.000 description 21
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 20
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 20
- 230000002538 fungal effect Effects 0.000 description 20
- 102000040430 polynucleotide Human genes 0.000 description 20
- 108091033319 polynucleotide Proteins 0.000 description 20
- 239000002157 polynucleotide Substances 0.000 description 20
- 239000000243 solution Substances 0.000 description 20
- 239000008103 glucose Substances 0.000 description 19
- -1 etc. Substances 0.000 description 17
- 239000002609 medium Substances 0.000 description 17
- 239000000203 mixture Substances 0.000 description 17
- 239000007787 solid Substances 0.000 description 17
- 235000020357 syrup Nutrition 0.000 description 17
- 239000006188 syrup Substances 0.000 description 17
- 235000001014 amino acid Nutrition 0.000 description 16
- 230000001580 bacterial effect Effects 0.000 description 16
- 238000006467 substitution reaction Methods 0.000 description 16
- 240000005979 Hordeum vulgare Species 0.000 description 14
- 235000007340 Hordeum vulgare Nutrition 0.000 description 14
- 108091028043 Nucleic acid sequence Proteins 0.000 description 14
- 108010076504 Protein Sorting Signals Proteins 0.000 description 14
- 108090001109 Thermolysin Proteins 0.000 description 13
- 229940024606 amino acid Drugs 0.000 description 13
- 239000013604 expression vector Substances 0.000 description 13
- 244000005700 microbiome Species 0.000 description 13
- 241000894007 species Species 0.000 description 13
- 229920002245 Dextrose equivalent Polymers 0.000 description 12
- 229940025131 amylases Drugs 0.000 description 12
- 150000001720 carbohydrates Chemical class 0.000 description 12
- 235000015165 citric acid Nutrition 0.000 description 12
- 108050008938 Glucoamylases Proteins 0.000 description 11
- 125000000539 amino acid group Chemical group 0.000 description 11
- 238000003556 assay Methods 0.000 description 11
- 108010019077 beta-Amylase Proteins 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 11
- 241000228245 Aspergillus niger Species 0.000 description 10
- 241000196324 Embryophyta Species 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 10
- 238000001914 filtration Methods 0.000 description 10
- 230000009466 transformation Effects 0.000 description 10
- 241000209140 Triticum Species 0.000 description 9
- 235000021307 Triticum Nutrition 0.000 description 9
- 235000006085 Vigna mungo var mungo Nutrition 0.000 description 9
- 240000005616 Vigna mungo var. mungo Species 0.000 description 9
- 239000008186 active pharmaceutical agent Substances 0.000 description 9
- 238000012217 deletion Methods 0.000 description 9
- 230000037430 deletion Effects 0.000 description 9
- 239000000706 filtrate Substances 0.000 description 9
- 235000013312 flour Nutrition 0.000 description 9
- 210000001938 protoplast Anatomy 0.000 description 9
- 238000013518 transcription Methods 0.000 description 9
- 230000035897 transcription Effects 0.000 description 9
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 8
- 241000499912 Trichoderma reesei Species 0.000 description 8
- 239000000872 buffer Substances 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 239000008187 granular material Substances 0.000 description 8
- 238000006460 hydrolysis reaction Methods 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- 240000006439 Aspergillus oryzae Species 0.000 description 7
- 241000194108 Bacillus licheniformis Species 0.000 description 7
- 235000014469 Bacillus subtilis Nutrition 0.000 description 7
- 241000233866 Fungi Species 0.000 description 7
- 240000003183 Manihot esculenta Species 0.000 description 7
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 7
- 208000037855 acute anterior uveitis Diseases 0.000 description 7
- 230000007062 hydrolysis Effects 0.000 description 7
- 238000000746 purification Methods 0.000 description 7
- 241000228212 Aspergillus Species 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 6
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 6
- 229920002261 Corn starch Polymers 0.000 description 6
- 102000005741 Metalloproteases Human genes 0.000 description 6
- 108010006035 Metalloproteases Proteins 0.000 description 6
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 6
- 241001557886 Trichoderma sp. Species 0.000 description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 239000011575 calcium Substances 0.000 description 6
- 229910052791 calcium Inorganic materials 0.000 description 6
- 229960005069 calcium Drugs 0.000 description 6
- 229910001424 calcium ion Inorganic materials 0.000 description 6
- 239000008120 corn starch Substances 0.000 description 6
- 230000002255 enzymatic effect Effects 0.000 description 6
- 239000001963 growth medium Substances 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- 239000011159 matrix material Substances 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 238000001238 wet grinding Methods 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 108091026890 Coding region Proteins 0.000 description 5
- 241000605056 Cytophaga Species 0.000 description 5
- 108010028688 Isoamylase Proteins 0.000 description 5
- 240000006394 Sorghum bicolor Species 0.000 description 5
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 230000000295 complement effect Effects 0.000 description 5
- 238000009837 dry grinding Methods 0.000 description 5
- 235000019534 high fructose corn syrup Nutrition 0.000 description 5
- 238000009396 hybridization Methods 0.000 description 5
- 238000003780 insertion Methods 0.000 description 5
- 230000037431 insertion Effects 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 230000010076 replication Effects 0.000 description 5
- 230000028327 secretion Effects 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000193749 Bacillus coagulans Species 0.000 description 4
- 244000063299 Bacillus subtilis Species 0.000 description 4
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 4
- 229920001503 Glucan Polymers 0.000 description 4
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 4
- 240000007594 Oryza sativa Species 0.000 description 4
- 235000007164 Oryza sativa Nutrition 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- 241000187747 Streptomyces Species 0.000 description 4
- 229940054340 bacillus coagulans Drugs 0.000 description 4
- 235000013405 beer Nutrition 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 210000000349 chromosome Anatomy 0.000 description 4
- 210000004748 cultured cell Anatomy 0.000 description 4
- 239000004744 fabric Substances 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 239000002773 nucleotide Substances 0.000 description 4
- 125000003729 nucleotide group Chemical group 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000000123 paper Substances 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 235000019833 protease Nutrition 0.000 description 4
- 230000002797 proteolythic effect Effects 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 235000009566 rice Nutrition 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 238000000108 ultra-filtration Methods 0.000 description 4
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- 229920000856 Amylose Polymers 0.000 description 3
- 241000193389 Bacillus thermoproteolyticus Species 0.000 description 3
- 108010059892 Cellulase Proteins 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
- 102100033448 Lysosomal alpha-glucosidase Human genes 0.000 description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 241000959173 Rasamsonia emersonii Species 0.000 description 3
- 241000235403 Rhizomucor miehei Species 0.000 description 3
- 241000209056 Secale Species 0.000 description 3
- 235000007238 Secale cereale Nutrition 0.000 description 3
- 244000061456 Solanum tuberosum Species 0.000 description 3
- 235000002595 Solanum tuberosum Nutrition 0.000 description 3
- 244000062793 Sorghum vulgare Species 0.000 description 3
- 241000223259 Trichoderma Species 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 239000005018 casein Substances 0.000 description 3
- 235000021240 caseins Nutrition 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000000446 fuel Substances 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 238000000227 grinding Methods 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 239000011630 iodine Substances 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 235000019713 millet Nutrition 0.000 description 3
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 3
- 229920001542 oligosaccharide Polymers 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 235000010356 sorbitol Nutrition 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000001890 transfection Methods 0.000 description 3
- 230000014616 translation Effects 0.000 description 3
- 229940100445 wheat starch Drugs 0.000 description 3
- 235000020985 whole grains Nutrition 0.000 description 3
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 108010011619 6-Phytase Proteins 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- 229920000945 Amylopectin Polymers 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241001513093 Aspergillus awamori Species 0.000 description 2
- 241000351920 Aspergillus nidulans Species 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 239000002028 Biomass Substances 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- 108020004635 Complementary DNA Proteins 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 2
- 108090000371 Esterases Proteins 0.000 description 2
- 108050001049 Extracellular proteins Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 244000017020 Ipomoea batatas Species 0.000 description 2
- 235000002678 Ipomoea batatas Nutrition 0.000 description 2
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 2
- 241000235058 Komagataella pastoris Species 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241000579835 Merops Species 0.000 description 2
- 241000235395 Mucor Species 0.000 description 2
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 2
- 102100026367 Pancreatic alpha-amylase Human genes 0.000 description 2
- 241000235648 Pichia Species 0.000 description 2
- 108010059820 Polygalacturonase Proteins 0.000 description 2
- 241000235346 Schizosaccharomyces Species 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000228341 Talaromyces Species 0.000 description 2
- BGRWYDHXPHLNKA-UHFFFAOYSA-N Tetraacetylethylenediamine Chemical compound CC(=O)N(C(C)=O)CCN(C(C)=O)C(C)=O BGRWYDHXPHLNKA-UHFFFAOYSA-N 0.000 description 2
- 241000223257 Thermomyces Species 0.000 description 2
- 235000009430 Thespesia populnea Nutrition 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- 102100028709 Thyroxine-binding globulin Human genes 0.000 description 2
- 102000004357 Transferases Human genes 0.000 description 2
- 108090000992 Transferases Proteins 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 238000001042 affinity chromatography Methods 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 150000008051 alkyl sulfates Chemical class 0.000 description 2
- 108010028144 alpha-Glucosidases Proteins 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 230000003625 amylolytic effect Effects 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000010804 cDNA synthesis Methods 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 2
- 239000000920 calcium hydroxide Substances 0.000 description 2
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 229940106157 cellulase Drugs 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 239000004464 cereal grain Substances 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 229960005091 chloramphenicol Drugs 0.000 description 2
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 231100000673 dose–response relationship Toxicity 0.000 description 2
- 108010093305 exopolygalacturonase Proteins 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 235000019985 fermented beverage Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 108010061330 glucan 1,4-alpha-maltohydrolase Proteins 0.000 description 2
- 239000000174 gluconic acid Substances 0.000 description 2
- 235000012208 gluconic acid Nutrition 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 230000013595 glycosylation Effects 0.000 description 2
- 238000006206 glycosylation reaction Methods 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 108010002430 hemicellulase Proteins 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 238000004255 ion exchange chromatography Methods 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 235000018977 lysine Nutrition 0.000 description 2
- ZDGGJQMSELMHLK-UHFFFAOYSA-N m-Trifluoromethylhippuric acid Chemical compound OC(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 ZDGGJQMSELMHLK-UHFFFAOYSA-N 0.000 description 2
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 238000001471 micro-filtration Methods 0.000 description 2
- 238000003801 milling Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000012038 nucleophile Substances 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 229960003330 pentetic acid Drugs 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 229940085127 phytase Drugs 0.000 description 2
- 230000008488 polyadenylation Effects 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 239000001965 potato dextrose agar Substances 0.000 description 2
- 229920001592 potato starch Polymers 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000011218 seed culture Methods 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 238000010361 transduction Methods 0.000 description 2
- 230000026683 transduction Effects 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 238000010977 unit operation Methods 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- FYGDTMLNYKFZSV-WFYNLLPOSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,3s,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-WFYNLLPOSA-N 0.000 description 1
- AEQDJSLRWYMAQI-UHFFFAOYSA-N 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- VBUYCZFBVCCYFD-NUNKFHFFSA-N 2-dehydro-L-idonic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)C(=O)C(O)=O VBUYCZFBVCCYFD-NUNKFHFFSA-N 0.000 description 1
- MHKLKWCYGIBEQF-UHFFFAOYSA-N 4-(1,3-benzothiazol-2-ylsulfanyl)morpholine Chemical compound C1COCCN1SC1=NC2=CC=CC=C2S1 MHKLKWCYGIBEQF-UHFFFAOYSA-N 0.000 description 1
- LKDMKWNDBAVNQZ-WJNSRDFLSA-N 4-[[(2s)-1-[[(2s)-1-[(2s)-2-[[(2s)-1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NC=1C=CC(=CC=1)[N+]([O-])=O)CC1=CC=CC=C1 LKDMKWNDBAVNQZ-WJNSRDFLSA-N 0.000 description 1
- ZMZGIVVRBMFZSG-UHFFFAOYSA-N 4-hydroxybenzohydrazide Chemical compound NNC(=O)C1=CC=C(O)C=C1 ZMZGIVVRBMFZSG-UHFFFAOYSA-N 0.000 description 1
- TYMLOMAKGOJONV-UHFFFAOYSA-N 4-nitroaniline Chemical compound NC1=CC=C([N+]([O-])=O)C=C1 TYMLOMAKGOJONV-UHFFFAOYSA-N 0.000 description 1
- IZSRJDGCGRAUAR-MROZADKFSA-M 5-dehydro-D-gluconate Chemical compound OCC(=O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IZSRJDGCGRAUAR-MROZADKFSA-M 0.000 description 1
- 238000010269 ABTS assay Methods 0.000 description 1
- 101150006240 AOX2 gene Proteins 0.000 description 1
- 108091005508 Acid proteases Proteins 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 102000016912 Aldehyde Reductase Human genes 0.000 description 1
- 108010053754 Aldehyde reductase Proteins 0.000 description 1
- 108010017640 Aspartic Acid Proteases Proteins 0.000 description 1
- 102000004580 Aspartic Acid Proteases Human genes 0.000 description 1
- 241001225321 Aspergillus fumigatus Species 0.000 description 1
- 241000122821 Aspergillus kawachii Species 0.000 description 1
- 101000757144 Aspergillus niger Glucoamylase Proteins 0.000 description 1
- 241000228232 Aspergillus tubingensis Species 0.000 description 1
- 241000222400 Athelia Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 241001112741 Bacillaceae Species 0.000 description 1
- 108090000145 Bacillolysin Proteins 0.000 description 1
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 1
- 101000775727 Bacillus amyloliquefaciens Alpha-amylase Proteins 0.000 description 1
- 241000193422 Bacillus lentus Species 0.000 description 1
- 241000194107 Bacillus megaterium Species 0.000 description 1
- 241000193388 Bacillus thuringiensis Species 0.000 description 1
- 108091005658 Basic proteases Proteins 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- 101000851056 Bos taurus Elastin Proteins 0.000 description 1
- 241000193764 Brevibacillus brevis Species 0.000 description 1
- 238000009631 Broth culture Methods 0.000 description 1
- 101000898643 Candida albicans Vacuolar aspartic protease Proteins 0.000 description 1
- 101000898783 Candida tropicalis Candidapepsin Proteins 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 108010008885 Cellulose 1,4-beta-Cellobiosidase Proteins 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 241001509321 Clostridium thermoamylolyticum Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 101000898784 Cryphonectria parasitica Endothiapepsin Proteins 0.000 description 1
- 108010005843 Cysteine Proteases Proteins 0.000 description 1
- 102000005927 Cysteine Proteases Human genes 0.000 description 1
- 102100027364 Cysteine-rich protein 3 Human genes 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- VBUYCZFBVCCYFD-UHFFFAOYSA-N D-arabino-2-Hexulosonic acid Natural products OCC(O)C(O)C(O)C(=O)C(O)=O VBUYCZFBVCCYFD-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 1
- 125000002353 D-glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- ZAQJHHRNXZUBTE-WUJLRWPWSA-N D-xylulose Chemical compound OC[C@@H](O)[C@H](O)C(=O)CO ZAQJHHRNXZUBTE-WUJLRWPWSA-N 0.000 description 1
- 108010058076 D-xylulose reductase Proteins 0.000 description 1
- 108010087427 Endo-1,3(4)-beta-Glucanase Proteins 0.000 description 1
- 241000588921 Enterobacteriaceae Species 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- 241000223221 Fusarium oxysporum Species 0.000 description 1
- 108010001498 Galectin 1 Proteins 0.000 description 1
- 102100021736 Galectin-1 Human genes 0.000 description 1
- 102100024637 Galectin-10 Human genes 0.000 description 1
- 101001011019 Gallus gallus Gallinacin-10 Proteins 0.000 description 1
- 101001011021 Gallus gallus Gallinacin-12 Proteins 0.000 description 1
- 241000626621 Geobacillus Species 0.000 description 1
- 101001124321 Geobacillus stearothermophilus Thermostable neutral protease NprT Proteins 0.000 description 1
- 101100001650 Geobacillus stearothermophilus amyM gene Proteins 0.000 description 1
- 108091005503 Glutamic proteases Proteins 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 101100295959 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) arcB gene Proteins 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 241000223198 Humicola Species 0.000 description 1
- 241000223199 Humicola grisea Species 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 241000235649 Kluyveromyces Species 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 241000186604 Lactobacillus reuteri Species 0.000 description 1
- 241000186610 Lactobacillus sp. Species 0.000 description 1
- 241000178948 Lactococcus sp. Species 0.000 description 1
- 241001627205 Leuconostoc sp. Species 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 239000007993 MOPS buffer Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 108090000131 Metalloendopeptidases Proteins 0.000 description 1
- 102000003843 Metalloendopeptidases Human genes 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 229910017974 NH40H Inorganic materials 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241000194109 Paenibacillus lautus Species 0.000 description 1
- 241000604136 Pediococcus sp. Species 0.000 description 1
- 241001326562 Pezizomycotina Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 241000235061 Pichia sp. Species 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 1
- HLCFGWHYROZGBI-JJKGCWMISA-M Potassium gluconate Chemical compound [K+].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O HLCFGWHYROZGBI-JJKGCWMISA-M 0.000 description 1
- 101710180316 Protease 2 Proteins 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 241000947836 Pseudomonadaceae Species 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 108010011939 Pyruvate Decarboxylase Proteins 0.000 description 1
- 238000010240 RT-PCR analysis Methods 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 241000235402 Rhizomucor Species 0.000 description 1
- 101000968489 Rhizomucor miehei Lipase Proteins 0.000 description 1
- 241000235527 Rhizopus Species 0.000 description 1
- 101000933133 Rhizopus niveus Rhizopuspepsin-1 Proteins 0.000 description 1
- 101000910082 Rhizopus niveus Rhizopuspepsin-2 Proteins 0.000 description 1
- 101000910079 Rhizopus niveus Rhizopuspepsin-3 Proteins 0.000 description 1
- 101000910086 Rhizopus niveus Rhizopuspepsin-4 Proteins 0.000 description 1
- 101000910088 Rhizopus niveus Rhizopuspepsin-5 Proteins 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 101000898773 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Saccharopepsin Proteins 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 108010022999 Serine Proteases Proteins 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- HIWPGCMGAMJNRG-ACCAVRKYSA-N Sophorose Natural products O([C@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HIWPGCMGAMJNRG-ACCAVRKYSA-N 0.000 description 1
- 102100026974 Sorbitol dehydrogenase Human genes 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 244000057717 Streptococcus lactis Species 0.000 description 1
- 235000014897 Streptococcus lactis Nutrition 0.000 description 1
- 241000194022 Streptococcus sp. Species 0.000 description 1
- 241000187432 Streptomyces coelicolor Species 0.000 description 1
- 241001468239 Streptomyces murinus Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241001484137 Talaromyces leycettanus Species 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 241000193447 Thermoanaerobacter thermohydrosulfuricus Species 0.000 description 1
- 101100157012 Thermoanaerobacterium saccharolyticum (strain DSM 8691 / JW/SL-YS485) xynB gene Proteins 0.000 description 1
- 241001136490 Thermomyces dupontii Species 0.000 description 1
- 241001494489 Thielavia Species 0.000 description 1
- 108091005501 Threonine proteases Proteins 0.000 description 1
- 102000035100 Threonine proteases Human genes 0.000 description 1
- 241000222354 Trametes Species 0.000 description 1
- 108700029229 Transcriptional Regulatory Elements Proteins 0.000 description 1
- 102000005924 Triose-Phosphate Isomerase Human genes 0.000 description 1
- 108700015934 Triose-phosphate isomerases Proteins 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 235000019714 Triticale Nutrition 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 241000588901 Zymomonas Species 0.000 description 1
- 238000011481 absorbance measurement Methods 0.000 description 1
- 108010048241 acetamidase Proteins 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 108010045649 agarase Proteins 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 101150069003 amdS gene Proteins 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000013011 aqueous formulation Substances 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 101150008194 argB gene Proteins 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 229940091771 aspergillus fumigatus Drugs 0.000 description 1
- 235000020054 awamori Nutrition 0.000 description 1
- 229940097012 bacillus thuringiensis Drugs 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 102000006995 beta-Glucosidase Human genes 0.000 description 1
- 108010047754 beta-Glucosidase Proteins 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- HIWPGCMGAMJNRG-UHFFFAOYSA-N beta-sophorose Natural products OC1C(O)C(CO)OC(O)C1OC1C(O)C(O)C(O)C(CO)O1 HIWPGCMGAMJNRG-UHFFFAOYSA-N 0.000 description 1
- 238000010364 biochemical engineering Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000004227 calcium gluconate Substances 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- 229960004494 calcium gluconate Drugs 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- RKFLKNFLAJISPF-OGXRZFKVSA-L calcium;(3s,4s)-3,4,6-trihydroxy-2,5-dioxohexanoate Chemical compound [Ca+2].OCC(=O)[C@@H](O)[C@H](O)C(=O)C([O-])=O.OCC(=O)[C@@H](O)[C@H](O)C(=O)C([O-])=O RKFLKNFLAJISPF-OGXRZFKVSA-L 0.000 description 1
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 1
- KLOIYEQEVSIOOO-UHFFFAOYSA-N carbocromen Chemical compound CC1=C(CCN(CC)CC)C(=O)OC2=CC(OCC(=O)OCC)=CC=C21 KLOIYEQEVSIOOO-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- HJMZMZRCABDKKV-UHFFFAOYSA-N carbonocyanidic acid Chemical compound OC(=O)C#N HJMZMZRCABDKKV-UHFFFAOYSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 101150114858 cbh2 gene Proteins 0.000 description 1
- 230000006727 cell loss Effects 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 210000004671 cell-free system Anatomy 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000007398 colorimetric assay Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000003636 conditioned culture medium Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 238000012364 cultivation method Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 108010005400 cutinase Proteins 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- YXVFQADLFFNVDS-UHFFFAOYSA-N diammonium citrate Chemical compound [NH4+].[NH4+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O YXVFQADLFFNVDS-UHFFFAOYSA-N 0.000 description 1
- GSPKZYJPUDYKPI-UHFFFAOYSA-N diethoxy sulfate Chemical compound CCOOS(=O)(=O)OOCC GSPKZYJPUDYKPI-UHFFFAOYSA-N 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 101150003727 egl2 gene Proteins 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 108010091371 endoglucanase 1 Proteins 0.000 description 1
- 108010091384 endoglucanase 2 Proteins 0.000 description 1
- 108010092450 endoglucanase Z Proteins 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 239000002803 fossil fuel Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000012224 gene deletion Methods 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 229950006191 gluconic acid Drugs 0.000 description 1
- 235000012209 glucono delta-lactone Nutrition 0.000 description 1
- 239000000182 glucono-delta-lactone Substances 0.000 description 1
- 229960003681 gluconolactone Drugs 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 235000013882 gravy Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000000976 ink Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- ODBLHEXUDAPZAU-UHFFFAOYSA-N isocitric acid Chemical compound OC(=O)C(O)C(C(O)=O)CC(O)=O ODBLHEXUDAPZAU-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- 108010032581 isopullulanase Proteins 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 229940001882 lactobacillus reuteri Drugs 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 238000001638 lipofection Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 101150039489 lysZ gene Proteins 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000005360 mashing Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012092 media component Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- 108010009355 microbial metalloproteinases Proteins 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 229940057059 monascus purpureus Drugs 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 1
- 239000004223 monosodium glutamate Substances 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 101150095344 niaD gene Proteins 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 101150105920 npr gene Proteins 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229940012843 omega-3 fatty acid Drugs 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 210000002824 peroxisome Anatomy 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229960002816 potassium chloride Drugs 0.000 description 1
- 239000004224 potassium gluconate Substances 0.000 description 1
- 235000013926 potassium gluconate Nutrition 0.000 description 1
- 229960003189 potassium gluconate Drugs 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 210000001995 reticulocyte Anatomy 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 230000001523 saccharolytic effect Effects 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 239000013605 shuttle vector Substances 0.000 description 1
- 235000020374 simple syrup Nutrition 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000010352 sodium erythorbate Nutrition 0.000 description 1
- 239000004320 sodium erythorbate Substances 0.000 description 1
- 239000000176 sodium gluconate Substances 0.000 description 1
- 235000012207 sodium gluconate Nutrition 0.000 description 1
- 229940005574 sodium gluconate Drugs 0.000 description 1
- RBWSWDPRDBEWCR-RKJRWTFHSA-N sodium;(2r)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethanolate Chemical compound [Na+].[O-]C[C@@H](O)[C@H]1OC(=O)C(O)=C1O RBWSWDPRDBEWCR-RKJRWTFHSA-N 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000002910 solid waste Substances 0.000 description 1
- 238000010563 solid-state fermentation Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- PZDOWFGHCNHPQD-VNNZMYODSA-N sophorose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](C=O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PZDOWFGHCNHPQD-VNNZMYODSA-N 0.000 description 1
- 239000004458 spent grain Substances 0.000 description 1
- 229940063673 spermidine Drugs 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 108010082371 succinyl-alanyl-alanyl-prolyl-phenylalanine-4-nitroanilide Proteins 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000005469 synchrotron radiation Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000012209 synthetic fiber Substances 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000014621 translational initiation Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 238000003828 vacuum filtration Methods 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002912 waste gas Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
- 241000228158 x Triticosecale Species 0.000 description 1
- 101150110790 xylB gene Proteins 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/56—Lactic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/02—Monosaccharides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/14—Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
- C12P7/06—Ethanol, i.e. non-beverage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/44—Polycarboxylic acids
- C12P7/48—Tricarboxylic acids, e.g. citric acid
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/10—Biofuels, e.g. bio-diesel
Definitions
- biochemicals for example, alcohols - ethanol, butanol, etc., acids - lactic acid, citric acid, etc.
- feedstock One major cost of the bioproduction is the feedstock.
- the fermentation feedstock is usually high quality glucose or liquefact from refined starch.
- Some producers are using cruder materials like whole ground corn, cassava chips, etc., in the fermentations, for examples, citric acid, other organic acids, and butanol fermentation.
- the key issue of this kind of process is that there is one filtration process to remove the fiber, fat, protein, unsolubolized starch and other impurities before pumping the syrup to fermentor.
- Alcohol fermentation production processes and particularly ethanol production processes are generally characterized as wet milling or dry milling processes. Reference is made to Bothast et al., 2005,Appl. Microbiol. Biotechnol. 67: 19-25 and THE ALCOHOL TEXTBOOK, 5th Ed, W.M. Ingledew et al. Eds, 2009, Nottingham University Press, UK for a review of these processes.
- Wet milling process involves a series of soaking (steeping) steps to soften the cereal grain wherein soluble starch is removed followed by recovery of the germ, fiber (bran) and gluten (protein). The remaining starch is further processed by drying, chemical and/or enzyme treatments. The starch may then be used for alcohol production, high fructose corn syrup or commercial pure grade starch or other fermentration products.
- Dry grain milling involves a number of basic steps, which include: grinding, cooking, liquefaction, saccharification, fermentation and separation of liquid and solids to produce alcohol and other co-products. Generally, whole cereal, such as corn cereal, is ground to a fine particle size and then mixed with liquid in a slurry tank.
- the slurry is subjected to high temperatures in a jet cooker along with liquefying enzymes (e.g. alpha-amylases) to solubilize and hydrolyze the starch in the cereal to dextrins.
- liquefying enzymes e.g. alpha-amylases
- saccharifying enzymes e.g. glucoamylases
- the mash containing glucose is then fermented for approximately 24 to 120 hours in the presence of ethanol producing microorganisms.
- the solids in the mash are separated from the liquid phase and ethanol and useful co-products such as distillers' grains are obtained.
- Increased ethanol production may result by use of the simultaneous saccharification and fermentation processes.
- the corn kernel has two kinds of endosperm portion: hard and soft endosperm.
- the soft endosperm contains spherical starch granule in protein matrix.
- the hard endosperm contains polygonal starch granules packed in a highly complex protein matrix.
- starch granules which themselves change shapes from nice spherical shapes to polygonal shapes due to stretching during drying.
- Adding a protease to break the protein structure may result in release of more starch to be available for enzymes and yeast.
- Viscosity of corn slurry increase rapidly when milled corn, corn flour, corn starch, or other starch granular substrates are heated above 60°C at various dry solids level in water.
- alpha amylase is added to minimize the initial rise in the slurry viscosity (aka peak viscosity) as well as the viscosity of the final hot slurry produced (aka final viscosity).
- the present invention develops a new process, using proteases and/or other enzymes before or during the liquefaction process, solubolizing more starch and reducing the viscosity of the syrup, thus reducing the residual starch in the filtered cake.
- the protease produces more Free amino nitrogen (FAN), which is helpful to the fermentation organism, thus improving the fermentation process.
- FAN Free amino nitrogen
- the invention comprises a method for producing a fermentation product from corn or similar grain, comprising: liquifying the corn-like grain slurry at a pH of about 4.0 to about 7.0 at a temperature in the range from about 25°C to about 65°C using: an alpha amylase, a protease; and optionally a beta-glucanase; saccharifying and fermenting the slurry using enzymes, including a glucoamylase and a fermenting organism to produce the
- the invention comprises a method for increasing the yield and/or rate of ethanol production from corn or similar grain, comprising: liquifying the corn-like grain slurry at a pH of about 4.0 to about 7.0 at a temperature in the range from about 25°C to about 65°C using: an alpha amylase, a protease; and optionally a beta-glucanase; saccharifying and fermenting the slurry using enzymes, including a glucoamylase and a fermenting organism to produce ethanol, wherein the yield and/or rate of ethanol production is greater than the rate observed witout the addition of protease.
- the invention comprises a method for reducing the viscosity of the corn-like grain slurry during a fermentation, comprising: liquifying the corn-like grain slurry at a pH of about 4.0 to about 7.0 at a temperature in the range from about 25°C to about 65°C using: an alpha amylase, a protease; and optionally a beta-glucanase; saccharifying and fermenting the slurry using enzymes, including a glucoamylase and a fermenting organism to produce the fermentation product, wherein the viscosity of the slurry is reduced by at least 20% compared to a slurry not treated with a protease.
- the viscosity is reduced by 30%, 50% or 60%.
- the invention comprises a method for reducing the viscosity of the corn- like grain slurry during a liquefaction process, comprising: liquifying the corn-like gain slurry at a pH of about 4.0 to about 7.0 at a temperature in the range from about 25°C to about 65°C using an alpha amylase, a protease; and optionally a beta-glucanase; wherein the viscosity of the slurry is reduced by at least 20% compared to a slurry not treated with a protease.
- the viscosity is reduced by 30%, 50% or 60%.
- the invention comprises a method for reducing the viscosity of the corn-like grain slurry during a liquefaction process, comprising: liquifying the corn-like gain slurry at a pH of about 4.0 to about 7.0 at a temperature in the range from about 25°C to about 95°C using an alpha amylase, a protease; and optionally a beta-glucanase;
- the viscosity of the slurry is reduced by at least 20% compared to a slurry not treated with a protease. In another aspect, the viscosity is reduced by 30%, 40%, 50% or 60%.
- the invention comprises a method for reducing foam in a corn-like grain slurry during a liquefaction process, comprising: liquifying the corn-like gain slurry at a pH of about 4.0 to about 7.0 at a temperature in the range from about 25°C to about 90°C using an alpha amylase, a protease; and optionally a beta-glucanase; and wherein the foam in the slurry is reduced by at least 20%, 30%, 50% or 60% compared to a slurry not treated with a protease.
- the invention comprises a method for reducing amount of residual starch after a liquefaction process of a corn-like grain slurry, comprising: liquifying the corn-like gain slurry at a pH of about 4.0 to about 7.0 at a temperature in the range from about 25°C to about 90°C using: an alpha amylase, a protease; and optionally a beta- glucanase; andwherein the amount of residual starch of the slurry is reduced by at least 20%, 30%, 50% or 60% compared to a slurry not treated with a protease.
- the protease is a metallopro tease.
- the metalloprotease is a thermolysin or Proteinase T.
- the protease is a variant thermolysin with one or more substitutions.
- the protease is NprE.
- the protease is an NprE varaint with one or more substitutions.
- the protease is Fermgen, an acid fungal protease.
- the fermentation product is an alcohol, an organic acid, an amino acid, a sugar, an antibiotic, an enzyme, a vitamin or a hormone.
- Figure 1 Titration of Proteinase T with 15 ⁇ grams of Cytophaga spp alpha amylase.
- Figure 2 Addition of protease (lmg purified NprE) to 15 ⁇ grams of Cytophaga spp alpha amylase.
- Figure 4 The final ethanol yield at 48 hr for different liquefaction and SSF treatments.
- Figure 5 The final ethanol yield at 48 hr for different liquefaction and SSF treatments.
- Figure 6 The final ethanol yield at 48 hr for both Proteinase T and FAN used in SSF with Fermgen.
- compositions and methods relating to protease enzymes are described in detail, below.
- Exemplary applications for the protease enzymes are for starch liquefaction, to reduce viscosity and increase the yield and/or rate of ethanol production.
- ABTS 2,2-azino-bis-3-ethylbenzothiazoline-6-sulfonic acid
- AE or AEO alcohol ethoxylate
- AES or AEOS alcohol ethoxysulfate
- AkAA Aspergillus kawachii a-amylase
- AnGA Aspergillus niger glucoamylase
- AOS a-olefinsulfonate
- AS alkyl sulfate
- cDNA complementary DNA
- CMC carboxymethylcellulose
- DE dextrose equivalent
- DNA deoxyribonucleic acid
- DPn degree of saccharide polymerization having n subunits
- ds or DS dry solids
- DTMPA diethylenetriaminepentaacetic acid
- EC Enzyme Commission
- EDTA ethylenediaminetetraacetic acid
- GA glucoamylase
- GAU/g ds glucoamylase activity unit/gram dry solids
- HFCS high fructose corn syrup
- HgGA Humicola grisea glucoamylase
- IPTG isopropyl ⁇ -D- thiogalactoside
- IRS insoluble residual starch
- kDa kiloDalton
- LAS linear
- RNA poly(vinylpyrrolidone); RCF: relative centrifugal/centripetal force ⁇ i.e., x gravity); RNA:
- SAS alkanesulfonate
- SDS-PAGE sodium dodecyl sulfate polyacrylamide gel electrophoresis
- SSF simultaneous saccharification and fermentation
- SSU/g solid soluble starch unit/gram dry solids
- TAED tetraacetylethylenediamine
- Tm melting temperature
- TrGA Trichoderma reesei glucoamylase
- w/v weight/volume
- w/w
- Tris-HCl tris(hydroxymethyl)aminomethane hydrochloride
- HEPES 4-(2-hydroxyethyl)-l-piperazineethanesulfonic acid
- mS/cm milli- Siemens/cm
- CV column volumes.
- protease As used herein, the terms “protease” and “proteinase” refer to an enzyme protein that has the ability to break down proteins or peptides.
- a protease has the ability to conduct “proteolysis,” which begins protein catabolism by hydrolysis of peptide bonds that link amino acids together in a peptide or polypeptide chain forming the protein. This activity of a protease as a protein-digesting enzyme is referred to as “proteolytic activity.”
- proteolytic activity This activity of a protease as a protein-digesting enzyme is referred to as "proteolytic activity.”
- Many procedures exist for measuring proteolytic activity ⁇ See e.g., Kalisz, "Microbial Proteinases,” In: Fiechter (ed.), Advances in Biochemical Engineering/Biotechnology. (1988)).
- proteolytic activity may be ascertained by comparative assays which analyze the respective protease' s ability to hydrolyze a commercially available substrate.
- Exemplary substrates useful in the analysis of protease or proteolytic activity include, but are not limited to, di-methyl casein (Sigma C-9801), bovine collagen (Sigma C-9879), bovine elastin (Sigma E-1625), and bovine keratin (ICN Biomedical 902111). Colorimetric assays utilizing these substrates are well known in the art (See e.g., WO 99/34011 and U.S. Pat. No. 6,376,450, both of which are incorporated herein by reference).
- the pNA assay (See e.g., Del Mar et al, Anal. Biochem. 99:316-320 [1979]) also finds use in determining the active enzyme concentration for fractions collected during gradient elution. This assay measures the rate at which p-nitroaniline is released as the enzyme hydrolyzes the soluble synthetic substrate, succinyl-alanine-alanine-proline-phenylalanine-p-nitroanilide (suc-AAPF-pNA). The rate of production of yellow color from the hydrolysis reaction is measured at 410 nm on a spectrophotometer and is proportional to the active enzyme concentration. In addition, absorbance measurements at 280 nanometers (nm) can be used to determine the total protein concentration. The active enzyme/total protein ratio gives the enzyme purity.
- thermolysin refers any member of the M4 protease family as described in MEROPS - The Peptidase Data base (See, Rawlings et al., MEROPS: the peptidase database, Nucl Acids Res, 34 Database issue, D270-272 [2006]), of which thermolysin (TLN; EC 3.4.24.27) is the prototype.
- TNN The amino acid sequence of thermolysin, (EC 3.4.24.27) the neutral metallo endo-peptidase secreted from Bacillus thermoproteolyticus was first reported by Titani et al (Titani et al, (1972), Amino-acid sequence of thermolysin.
- thermolysin stearolysin
- bacillolysin proteinase-T
- PrT Thermolysin-like protease
- TLPs the neutral metalloprotease enzyme of Bacillus thermoproteolyticus
- amylase or "amylolytic enzyme” refer to an enzyme that is, among other things, capable of catalyzing the degradation of starch, a-amylases are hydrolases that cleave the a-D-(l ⁇ 4) O-glycosidic linkages in starch.
- a-amylases (EC 3.2.1.1 ; a-D-(l ⁇ 4)- glucan glucanohydrolase) are defined as endo-acting enzymes cleaving a-D-(l ⁇ 4) O-glycosidic linkages within the starch molecule in a random fashion yielding polysaccharides containing three or more (l-4)-a-linked D-glucose units.
- the exo-acting amylolytic enzymes such as ⁇ -amylases (EC 3.2.1.2; a-D-(l ⁇ 4)-glucan maltohydrolase) and some product- specific amylases like maltogenic a-amylase (EC 3.2.1.133) cleave the polysaccharide molecule from the non-reducing end of the substrate, ⁇ -amylases, a-glucosidases (EC 3.2.1.20; a-D-glucoside glucohydrolase), glucoamylase (EC 3.2.1.3; a-D-(l ⁇ 4)-glucan glucohydrolase), and product- specific amylases like the maltotetraosidases (EC 3.2.1.60) and the maltohexaosidases (EC 3.2.1.98) can produce malto-oligosaccharides of a specific length or enriched syrups of specific maltooligosaccharides.
- Enzyme units herein refer to the amount of product formed per time under the specified conditions of the assay.
- a "glucoamylase activity unit” GAU
- a "soluble starch unit” SSU
- SSU soluble starch unit
- starch refers to any material comprised of the complex polysaccharide carbohydrates of plants, comprised of amylose and amylopectin with the formula (C 6 H 1 oOs) x , wherein X can be any number.
- the term includes plant-based materials such as grains, cereal, grasses, tubers and roots, and more specifically materials obtained from wheat, barley, corn, rye, rice, sorghum, brans, cassava, millet, milo, potato, sweet potato, and tapioca.
- starch includes granular starch.
- granular starch refers to raw, i.e., uncooked starch, e.g., starch that has not been subject to gelatinization.
- wild-type refers to a naturally-occurring polypeptide that does not include a man-made substitution, insertion, or deletion at one or more amino acid positions.
- wild-type refers to a naturally-occurring polynucleotide that does not include a man-made nucleoside change.
- a polynucleotide encoding a wild-type, parental, or reference polypeptide is not limited to a naturally-occurring
- polynucleotide encompasses any polynucleotide encoding the wild- type, parental, or reference polypeptide.
- a "mature" polypeptide or variant, thereof, is one in which a signal sequence is absent, for example, cleaved from an immature form of the polypeptide during or following expression of the polypeptide.
- variant refers to a polypeptide that differs from a specified wild-type, parental, or reference polypeptide in that it includes one or more naturally-occurring or man-made substitutions, insertions, or deletions of an amino acid.
- variant refers to a polynucleotide that differs in nucleotide sequence from a specified wild-type, parental, or reference polynucleotide.
- identity of the wild-type, parental, or reference polypeptide or polynucleotide will be apparent from context.
- activity refers to a-amylase activity, which can be measured as described, herein.
- recombinant when used in reference to a subject cell, nucleic acid, protein or vector, indicates that the subject has been modified from its native state.
- recombinant cells express genes that are not found within the native (non-recombinant) form of the cell, or express native genes at different levels or under different conditions than found in nature.
- Recombinant nucleic acids differ from a native sequence by one or more nucleotides and/or are operably linked to heterologous sequences, e.g. , a heterologous promoter in an expression vector.
- Recombinant proteins may differ from a native sequence by one or more amino acids and/or are fused with heterologous sequences.
- a vector comprising a nucleic acid encoding an amylase is a recombinant vector.
- polypeptides cell, nucleic acid, amino acid, or other specified material or component that is removed from at least one other material or component with which it is naturally associated as found in nature.
- isolated polypeptides includes, but is not limited to, a culture broth containing secreted polypeptide expressed in a heterologous host cell.
- purified refers to material (e.g. , an isolated polypeptide or polynucleotide) that is in a relatively pure state, e.g., at least about 90% pure, at least about 95% pure, at least about 98% pure, or even at least about 99% pure.
- enriched refers to material (e.g., an isolated polypeptide or polynucleotide) that is in about 50% pure, at least about 60% pure, at least about 70% pure, or even at least about 70% pure.
- thermostability refers to the ability of the enzyme to retain activity after exposure to an elevated temperature.
- the thermostability of an enzyme is measured by its half-life (t ⁇ ) given in minutes, hours, or days, during which half the enzyme activity is lost under defined conditions.
- the half-life may be calculated by measuring residual a-amylase activity following exposure to (i.e. , challenge by) an elevated temperature.
- amino acid sequence is synonymous with the terms “polypeptide,” “protein,” and “peptide,” and are used interchangeably. Where such amino acid sequences exhibit activity, they may be referred to as an "enzyme.”
- amino acid sequences exhibit activity, they may be referred to as an "enzyme.”
- the conventional one-letter or three-letter codes for amino acid residues are used, with amino acid sequences being presented in the standard amino- to-carboxy terminal orientation (i.e., N ⁇ C).
- nucleic acid encompasses DNA, RNA, heteroduplexes, and synthetic molecules capable of encoding a polypeptide. Nucleic acids may be single stranded or double stranded, and may be chemical modifications. The terms “nucleic acid” and “polynucleotide” are used interchangeably. Because the genetic code is degenerate, more than one codon may be used to encode a particular amino acid, and the present compositions and methods encompass nucleotide sequences that encode a particular amino acid sequence. Unless otherwise indicated, nucleic acid sequences are presented in 5'-to-3' orientation.
- Hybridization refers to the process by which one strand of nucleic acid forms a duplex with, i.e., base pairs with, a complementary strand, as occurs during blot hybridization techniques and PCR techniques.
- Hybridized, duplex nucleic acids are characterized by a melting temperature (T m ), where one half of the hybridized nucleic acids are unpaired with the complementary strand. Mismatched nucleotides within the duplex lower the T m .
- a "synthetic" molecule is produced by in vitro chemical or enzymatic synthesis rather than by an organism.
- transformed means that the cell contains a non-native (e.g., heterologous) nucleic acid sequence integrated into its genome or carried as an episome that is maintained through multiple generations.
- the non-native sequence may be endogenous seqeunce.
- a "host strain” or "host cell” is an organism into which an expression vector, phage, virus, or other DNA construct, including a polynucleotide encoding a polypeptide of interest (e.g., an amylase) has been introduced.
- exemplary host strains are microorganism cells (e.g., bacteria, filamentous fungi, and yeast) capable of expressing the polypeptide of interest and/or fermenting saccharides.
- the term "host cell” includes protoplasts created from cells.
- heterologous with reference to a polynucleotide or protein refers to a polynucleotide or protein that does not naturally occur in a host cell.
- endogenous with reference to a polynucleotide or protein refers to a polynucleotide or protein that occurs naturally in the host cell.
- expression refers to the process by which a polypeptide is produced based on a nucleic acid sequence.
- the process includes both transcription and translation.
- a "selective marker” or “selectable marker” refers to a gene capable of being expressed in a host to facilitate selection of host cells carrying the gene.
- selectable markers include but are not limited to antimicrobials (e.g. , hygromycin, bleomycin, or chloramphenicol) and/or genes that confer a metabolic advantage, such as a nutritional advantage on the host cell.
- a "vector” refers to a polynucleotide sequence designed to introduce nucleic acids into one or more cell types.
- Vectors include cloning vectors, expression vectors, shuttle vectors, plasmids, phage particles, cassettes and the like.
- An "expression vector” refers to a DNA construct comprising a DNA sequence encoding a polypeptide of interest, which coding sequence is operably linked to a suitable control sequence capable of effecting expression of the DNA in a suitable host.
- control sequences may include a promoter to effect transcription, an optional operator sequence to control transcription, a sequence encoding suitable ribosome binding sites on the mRNA, enhancers and sequences which control termination of transcription and translation.
- operably linked means that specified components are in a relationship (including but not limited to juxtaposition) permitting them to function in an intended manner.
- a regulatory sequence is operably linked to a coding sequence such that expression of the coding sequence is under control of the regulatory sequences.
- a "signal sequence” is a sequence of amino acids attached to the N-terminal portion of a protein, which facilitates the secretion of the protein outside the cell.
- the mature form of an extracellular protein lacks the signal sequence, which is cleaved off during the secretion process.
- Bioly active refer to a sequence having a specified biological activity, such an enzymatic activity.
- specific activity refers to the number of moles of substrate that can be converted to product by an enzyme or enzyme preparation per unit time under specific conditions. Specific activity is generally expressed as units (U)/mg of protein.
- water hardness is a measure of the minerals (e.g. , calcium and magnesium) present in water.
- an "effective amount of amylase,” or similar expressions refers to an amount of amylase sufficient to produce a visible, or otherwise measurable amount of starch hydrolysis in an particular application.
- Starch hydrolysis may result in, e.g. , a visible cleaning of fabrics or dishware, reduced viscosity of a starch slurry or mash, and the like.
- a "swatch" is a piece of material such as a fabric that has a stain applied thereto.
- the material can be, for example, fabrics made of cotton, polyester or mixtures of natural and synthetic fibers.
- the swatch can further be paper, such as filter paper or nitrocellulose, or a piece of a hard material such as ceramic, metal, or glass.
- the stain is starch based, but can include blood, milk, ink, grass, tea, wine, spinach, gravy, chocolate, egg, cheese, clay, pigment, oil, or mixtures of these compounds.
- a "smaller swatch" is a section of the swatch that has been cut with a single hole punch device, or has been cut with a custom manufactured 96-hole punch device, where the pattern of the multi-hole punch is matched to standard 96- well microtiter plates, or the section has been otherwise removed from the swatch.
- the swatch can be of textile, paper, metal, or other suitable material.
- the smaller swatch can have the stain affixed either before or after it is placed into the well of a 24-, 48- or 96-well microtiter plate.
- the smaller swatch can also be made by applying a stain to a small piece of material.
- the smaller swatch can be a stained piece of fabric 5/8" or 0.25" in diameter.
- the custom manufactured punch is designed in such a manner that it delivers 96 swatches simultaneously to all wells of a 96-well plate.
- the device allows delivery of more than one swatch per well by simply loading the same 96-well plate multiple times.
- Multi-hole punch devices can be conceived of to deliver simultaneously swatches to any format plate, including but not limited to 24-well, 48-well, and 96-well plates.
- the soiled test platform can be a bead made of metal, plastic, glass, ceramic, or another suitable material that is coated with the soil substrate. The one or more coated beads are then placed into wells of 96-, 48-, or 24-well plates or larger formats, containing suitable buffer and enzyme.
- a cultured cell material comprising an amylase refers to a cell lysate or supernatant (including media) that includes an amylase as a component.
- the cell material may be from a heterologous host that is grown in culture for the purpose of producing the amylase.
- Percent sequence identity means that a particular sequence has at least a certain percentage of amino acid residues identical to those in a specified reference sequence, when aligned using the CLUSTAL W algorithm with default parameters. See Thompson et al. (1994) Nucleic Acids Res. 22:4673-4680.
- Default parameters for the CLUSTAL W algorithm are: Gap opening penalty: 10.0; Gap extension penalty: 0.05; Protein weight matrix: BLOSUM series; DNA weight matrix: IUB; Delay divergent sequences %:40; Gap separation distance: 8; DNA transitions weight: 0.50; List hydrophilic residues: G, P, S, N, D, Q, E, K, R; Use negative matrix: OFF; Toggle Residue specific penalties: ON; Toggle hydrophilic penalties: ON; Toggle end gap separation penalty OFF.
- Deletions are counted as non-identical residues, compared to a reference sequence. Deletions occurring at either terminus are included. For example, a variant 500-amino acid residue polypeptide with a deletion of five amino acid residues from the C-terminus would have a percent sequence identity of 99% (495/500 identical residues x 100) relative to the parent polypeptide. Such a variant would be encompassed by the language, "a variant having at least 99% sequence identity to the parent.”
- fused polypeptide sequences are connected, i.e., operably linked, via a peptide bond between two subject polypeptide sequences.
- filamentous fungi refers to all filamentous forms of the subdivision
- Eumycotina particulary species within Pezizomycotina subdivision.
- degree of polymerization refers to the number (n) of anhydro- glucopyranose units in a given saccharide.
- DPI the monosaccharides glucose and fructose.
- DP2 the disaccharides maltose and sucrose.
- DE the term "DE"
- Dextrose equivalent is defined as the percentage of reducing sugar, i.e., D-glucose, as a fraction of total carbohydrate in a syrup.
- dry solids content refers to the total solids of a slurry in a dry weight percent basis.
- slurry refers to an aqueous mixture containing insoluble solids.
- SSF saccharification and fermentation
- An "ethanologenic or fermenting microorganism” refers to a microorganism with the ability to convert a sugar or oligosaccharide to ethanol.
- the term "fermented beverage” refers to any beverage produced by a method comprising a fermentation process, such as a microbial fermentation, e.g., a bacterial and/or fungal fermentation.
- a fermentation process such as a microbial fermentation, e.g., a bacterial and/or fungal fermentation.
- "Beer” is an example of such a fermented beverage, and the term “beer” is meant to comprise any fermented wort produced by fermentation/brewing of a starch-containing plant material. Often, beer is produced exclusively from malt or adjunct, or any combination of malt and adjunct.
- malt refers to any malted cereal grain, such as malted barley or wheat.
- adjunct refers to any starch and/or sugar containing plant material that is not malt, such as barley or wheat malt.
- adjuncts include common corn grits, refined corn grits, brewer's milled yeast, rice, sorghum, refined corn starch, barley, barley starch, dehusked barley, wheat, wheat starch, torrified cereal, cereal flakes, rye, oats, potato, tapioca, cassava and syrups, such as corn syrup, sugar cane syrup, inverted sugar syrup, barley and/or wheat syrups, and the like.
- biomass refers to aqueous slurry of any starch and/or sugar containing plant material, such as grist, e.g., comprising crushed barley malt, crushed barley, and/or other adjunct or a combination thereof, mixed with water later to be separated into wort and spent grains.
- wort refers to the unfermented liquor run-off following extracting the grist during mashing.
- Iodine-positive starch or "IPS” refers to (1) amylose that is not hydrolyzed after liquefaction and saccharification, or (2) a retrograded starch polymer.
- IPS a retrograded starch polymer.
- the high DPn amylose or the retrograded starch polymer binds iodine and produces a characteristic blue color.
- the saccharide liquor is thus termed “iodine-positive saccharide,” “blue saccharide,” or “blue sac.”
- starch retro gradation refers to changes that occur spontaneously in a starch paste or gel on ageing.
- Proteases are currently classified into six broad groups: Serine proteases, Threonine proteases, Cysteine proteases, Aspartate proteases, Glutamic proteases, Metallopro teases.
- the mechanism used to cleave a peptide bond involves making an amino acid residue that has the cysteine and threonine (proteases) or a water molecule (aspartic acid, metallo- and glutamic acid proteases) nucleophilic so that it can attack the peptide carboxyl group.
- One way to make a nucleophile is by a catalytic triad, where a histidine residue is used to activate serine, cysteine, or threonine as a nucleophile.
- proteases of the invention may be wild type proteases or a variant thereof. Any suitable protease may be adapted to perform in the methods of the invention.
- the protease is a metallopro tease.
- the metalloprotease is a thermolysin or Proteinase T.
- the protease is a variant thermolysin with one or more substitutions.
- the protease is NprE.
- the protease is an NprE varaint with one or more substitutions.
- the present enzymes have a defined degree of amino acid sequence identity to other enzymes, for example, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or even at least 99%, amino acid sequence identity.
- the present enzymes are derived from a parental enzyme having a defined degree of amino acid sequence identity, for example, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or even at least 99%, amino acid sequence identity.
- the present enzymes comprise conservative substitution of one or several amino acid residues relative to the amino acid sequence of a parent enzyme.
- Exemplary conservative amino acid substitutions are listed in the Table 1. Some conservative mutations can be produced by genetic manpulation, while others are produced by introducing synthetic amino acids into a polypeptide other means. Table 1. Conservative amino acid substitutions
- the present enzymes comprises a deletion, substitution, insertion, or addition of one or a few amino acid residues.
- the present enzymes are derived from the amino acid sequence of the parent enzyme by conservative substitution of one or several amino acid residues.
- the present enzymes are derived from the amino acid sequence of the parent enzyme by deletion, substitution, insertion, or addition of one or a few amino acid residues. In all cases, the expression "one or a few amino acid residues" refers to 10 or less, i.e., 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10, amino acid residues.
- the present enzymes are encoded by a nucleic acid that hybridizes under stringent conditions to a nucleic acid sequence that is complementary to a nucleic acid that encodes the parent enzyme.
- the present enzymes may be "precursor,” “immature,” or “full-length,” in which case they include a signal sequence, or “mature,” in which case they lack a signal sequence. Mature forms of the polypeptides are generally the most useful. Unless otherwise noted, the amino acid residue numbering used herein refers to the mature forms of the respective amylase
- amylase polypeptides may also be truncated to remove the N or C- termini, so long as the resulting polypeptides retain enzyme activity.
- the present enzyme may be a "chimeric" or “hybrid” polypeptide, in that it includes at least a portion of a first enzyme polypeptide, and at least a portion of a second enzyme polypeptide (such chimeric enzymes have recently been “rediscovered” as domain-swap enzymes).
- the present enzymes may further include heterologous signal sequence, an epitope to allow tracking or purification, or the like.
- Exemplary heterologous signal sequences are from B. licheniformis amylase (LAT), B. subtilis (AmyE or AprE), and Streptomyces CelA.
- nucleic acids encoding an enzyme polypeptide may encode the enzyme having the amino acid sequence having a specified degree of amino acid sequence identity.
- the nucleic acid encodes an enzyme having at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or even at least 99%, amino acid sequence identity to a parental enzyme.
- the nucleic acid has at least 80%, at least 85%, at least 90%, at least 95%, or even at least 98% nucleotide sequence identity to parental enzyme.
- the present compositions and methods include nucleic acids that encode an enzyme having deletions, insertions, or substitutions, such as those mentioned, above. It will be appreciated that due to the degeneracy of the genetic code, a plurality of nucleic acids may encode the same polypeptide.
- the nucleic acid hybridizes under stringent or very stringent conditions to a nucleic acid complementary to a nucleic acid encoding an enzyme having at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or even at least 99%, amino acid sequence identity to a parent enzyme.
- the nucleic acid hybridizes under stringent or very stringent conditions to a nucleic acid complementary to a nucleic acid having the sequence of a parent enzyme. Such hybridization conditions are described herein but are also well known in the art.
- Nucleic acids may encode a "full-length" (“fl” or “FL”) amylase, which includes a signal sequence, only the mature form of an enzyme, which lacks the signal sequence, or a truncated form of an enzyme, which lacks the N or C-terminus of the mature form.
- the nucleic acids are of sufficient length to encode an active enzyme.
- a nucleic acid that encodes an enzyme can be operably linked to various promoters and regulators in a vector suitable for expressing the enzyme in host cells.
- exemplary promoters are from B. licheniformis amylase (LAT), B. subtilis (AmyE or AprE), and Streptomyces CelA.
- LAT B. licheniformis amylase
- B. subtilis AmyE or AprE
- Streptomyces CelA e.g., Streptomyces CelA.
- Such a nucleic acid can also be linked to other coding sequences, e.g., to encode a chimeric polypeptide.
- the present enzymes can be produced in host cells, for example, by secretion or intracellular expression.
- a cultured cell material ⁇ e.g., a whole-cell broth) comprising an enzyme can be obtained following secretion of the enzyme into the cell medium.
- the enzyme can be isolated from the host cells, or even isolated from the cell broth, depending on the desired purity of the final enzyme.
- a gene encoding an enzyme can be cloned and expressed according to methods well known in the art.
- Suitable host cells include bacterial, fungal (including yeast and filamentous fungi), and plant cells (including algae). Particularly useful host cells include Aspergillus niger, Aspergillus oryzae or Trichoderma reesei.
- Other host cells include bacterial cells, e.g., Bacillus subtilis or B. licheniformis, as well as Streptomyces.
- the host cell further may express a nucleic acid encoding a homologous or heterologous glucoamylase, i.e., a glucoamylase that is not the same species as the host cell, or one or more other enzymes.
- the glucoamylase may be a variant glucoamylase, such as one of the glucoamylase variants disclosed in U.S. Patent No. 8,058,033 (Danisco US Inc.), for example.
- the host may express one or more accessory enzymes, proteins, peptides. These may benefit liquefaction, saccharification, fermentation, SSF, etc., processes.
- the host cell may produce biochemicals in addition to enzymes used to digest the various feedstock(s). Such host cells may be useful for fermentation or simultaneous saccharification and fermentation processes to reduce or eliminate the need to add enzymes.
- a DNA construct comprising a nucleic acid encoding an enzyme can be constructed to be expressed in a host cell. Because of the well-known degeneracy in the genetic code, different polynucleotides that encode an identical amino acid sequence can be designed and made with routine skill. It is also well-known in the art to optimize codon use for a particular host cell. Nucleic acids encoding enzymes can be incorporated into a vector. Vectors can be transferred to a host cell using well-known transformation techniques, such as those disclosed below.
- the vector may be any vector that can be transformed into and replicated within a host cell.
- a vector comprising a nucleic acid encoding an enzyme can be transformed and replicated in a bacterial host cell as a means of propagating and amplifying the vector.
- the vector also may be transformed into an expression host, so that the encoding nucleic acids can be expressed as a functional enzyme.
- Host cells that serve as expression hosts can include filamentous fungi, for example.
- the Fungal Genetics Stock Center (FGSC) Catalogue of Strains lists suitable vectors for expression in fungal host cells. See FGSC, Catalogue of Strains, University of Missouri, at www.fgsc.net (last modified January 17, 2007).
- pJG153 a promoterless Cre expression vector that can be replicated in a bacterial host. See Harrison et al. (2011) Applied Environ. Microbiol. 77:3916-22.
- pJG153 can be modified with routine skill to comprise and express a nucleic acid encoding an enzyme variant.
- a nucleic acid encoding an enzyme can be operably linked to a suitable promoter, which allows transcription in the host cell.
- the promoter may be any DNA sequence that shows transcriptional activity in the host cell of choice and may be derived from genes encoding proteins either homologous or heterologous to the host cell.
- Exemplary promoters for directing the transcription of the DNA sequence encoding an enzyme, especially in a bacterial host, are the promoter of the lac operon of E.
- the Streptomyces coelicolor agarase gene dag A or celA promoters the promoters of the Bacillus licheniformis a-amylase gene (amyL), the promoters of the Bacillus stearothermophilus maltogenic amylase gene (amyM), the promoters of the Bacillus amyloliquefaciens ⁇ -amylase (amyQ), the promoters of the Bacillus subtilis xylA and xylB genes etc.
- examples of useful promoters are those derived from the gene encoding Aspergillus oryzae TAKA amylase, Rhizomucor miehei aspartic proteinase, Aspergillus niger neutral a-amylase, A. niger acid stable a-amylase, A. niger glucoamylase, Rhizomucor miehei lipase, A. oryzae alkaline protease, A. oryzae triose phosphate isomerase, or A. nidulans acetamidase.
- TAKA amylase Rhizomucor miehei aspartic proteinase
- Aspergillus niger neutral a-amylase A. niger acid stable a-amylase
- A. niger glucoamylase Rhizomucor miehei lipase
- Rhizomucor miehei lipase Rhizomucor miehe
- a suitable promoter can be selected, for example, from a bacteriophage promoter including a T7 promoter and a phage lambda promoter.
- suitable promoters for the expression in a yeast species include but are not limited to the Gal 1 and Gal 10 promoters of Saccharomyces cerevisiae and the Pichia pastoris AOXl or AOX2 promoters
- cbhl is an endogenous, inducible promoter from T. reesei. See Liu et al. (2008) "Improved heterologous gene expression in Trichoderma reesei by cellobiohydrolase I gene (cbhl) promoter optimization," Acta Biochim. Biophys. Sin (Shanghai) 40(2): 158-65.
- the coding sequence can be operably linked to a signal sequence.
- the DNA encoding the signal sequence may be the DNA sequence naturally associated with the enzyme gene to be expressed or from a different Genus or species.
- a signal sequence and a promoter sequence comprising a DNA construct or vector can be introduced into a fungal host cell and can be derived from the same source.
- the signal sequence is the cbhl signal sequence that is operably linked to a cbhl promoter.
- An expression vector may also comprise a suitable transcription terminator and, in eukaryotes, polyadenylation sequences operably linked to the DNA sequence encoding an enzyme. Termination and polyadenylation sequences may suitably be derived from the same sources as the promoter.
- the vector may further comprise a DNA sequence enabling the vector to replicate in the host cell.
- a DNA sequence enabling the vector to replicate in the host cell. Examples of such sequences are the origins of replication of plasmids pUC19, pACYClW, pUBHO, pE194, pAMBl, and pIJ702.
- the vector may also comprise a selectable marker, e.g., a gene the product of which complements a defect in the isolated host cell, such as the dal genes from B. subtilis or B. licheniformis, or a gene that confers antibiotic resistance such as, e.g., ampicillin, kanamycin, chloramphenicol or tetracycline resistance.
- a selectable marker e.g., a gene the product of which complements a defect in the isolated host cell, such as the dal genes from B. subtilis or B. licheniformis, or a gene that confers antibiotic resistance such as, e.g., ampicillin, kanamycin, chloramphenicol or tetracycline resistance.
- the vector may comprise Aspergillus selection markers such as amdS, argB, niaD and xxsC, a marker giving rise to hygromycin resistance, or the selection may be accomplished by co-transformation, such as known in the art.
- Intracellular expression may be advantageous in some respects, e.g., when using certain bacteria or fungi as host cells to produce large amounts of enzyme for subsequent enrichment or purification.
- Extracellular secretion of enzyme into the culture medium can also be used to make a cultured cell material comprising the isolated enzyme.
- the expression vector typically includes the components of a cloning vector, such as, for example, an element that permits autonomous replication of the vector in the selected host organism and one or more phenotypically detectable markers for selection purposes.
- the expression vector normally comprises control nucleotide sequences such as a promoter, operator, ribosome binding site, translation initiation signal and optionally, a repressor gene or one or more activator genes.
- the expression vector may comprise a sequence coding for an amino acid sequence capable of targeting the enzyme to a host cell organelle such as a peroxisome, or to a particular host cell compartment.
- a targeting sequence includes but is not limited to the sequence, SKL.
- the nucleic acid sequence of the enzyme is operably linked to the control sequences in proper manner with respect to expression.
- An isolated cell is advantageously used as a host cell in the recombinant production of an enzyme.
- the cell may be transformed with the DNA construct encoding the enzyme, conveniently by integrating the DNA construct (in one or more copies) in the host chromosome. This integration is generally considered to be an advantage, as the DNA sequence is more likely to be stably maintained in the cell. Integration of the DNA constructs into the host chromosome may be performed according to conventional methods, e.g., by homologous or heterologous recombination. Alternatively, the cell may be transformed with an expression vector as described above in connection with the different types of host cells.
- suitable bacterial host organisms are Gram positive bacterial species such as Bacillaceae including Bacillus subtilis, Bacillus licheniformis, Bacillus lentus, Bacillus brevis, Geobacillus (formerly Bacillus) stearothermophilus, Bacillus alkalophilus, Bacillus amyloliquefaciens, Bacillus coagulans, Bacillus lautus, Bacillus megaterium, and Bacillus thuringiensis; Streptomyces species such as Streptomyces murinus; lactic acid bacterial species including Lactococcus sp. such as Lactococcus lactis; Lactobacillus sp.
- Bacillaceae including Bacillus subtilis, Bacillus licheniformis, Bacillus lentus, Bacillus brevis, Geobacillus (formerly Bacillus) stearothermophilus, Bacillus alkalophilus, Bacillus amyloliquefaciens, Bacillus coagulans,
- strains of a Gram negative bacterial species belonging to Enterobacteriaceae including E. coli, or to Pseudomonadaceae can be selected as the host organism.
- a suitable yeast host organism can be selected from the biotechnologically relevant yeasts species such as but not limited to yeast species such as Pichia sp., Hansenula sp., or Kluyveromyces, Yarrowinia, Schizosaccharomyces species or a species of Saccharomyces, including Saccharomyces cerevisiae or a species belonging to Schizosaccharomyces such as, for example, S. pombe species.
- a strain of the methylotrophic yeast species, Pichia pastoris can be used as the host organism.
- the host organism can be a Hansenula species.
- Suitable host organisms among filamentous fungi include species of Aspergillus, e.g.,
- Aspergillus nidulans strains of a Fusarium species, e.g., Fusarium oxysporum or of a Rhizomucor species such as Rhizomucor miehei can be used as the host organism. Other suitable strains include Thermomyces and Mucor species.
- Trichoderma sp. such as T. reesei can be used as a host.
- a suitable procedure for transformation of Aspergillus host cells includes, for example, that described in EP 238023.
- An enzyme expressed by a fungal host cell can be glycosylated, i.e., will comprise a glycosyl moiety.
- the glycosylation pattern can be the same or different as present in the wild-type enzyme.
- the type and/or degree of glycosylation may impart changes in enzymatic and/or biochemical properties.
- genes from expression hosts where the gene deficiency may be cured by the transformed expression vector.
- Known methods may be used to obtain a fungal host cell having one or more inactivated genes. Gene inactivation may be accomplished by complete or partial deletion, by insertional inactivation or by any other means that renders a gene nonfunctional for its intended purpose, such that the gene is prevented from expression of a functional protein. Any gene from a Trichoderma sp. or other filamentous fungal host that has been cloned can be deleted, for example, cbhl, cbh2, egll, and egl2 genes. Gene deletion may be accomplished by inserting a form of the desired gene to be inactivated into a plasmid by methods known in the art.
- Introduction of a DNA construct or vector into a host cell includes techniques such as transformation; electroporation; nuclear microinjection; transduction; transfection, e.g., lipofection mediated and DEAE-Dextrin mediated transfection; incubation with calcium phosphate DNA precipitate; high velocity bombardment with DNA-coated microprojectiles; and protoplast fusion.
- General transformation techniques are known in the art. See, e.g., Sambrook et al. (2001), supra.
- the expression of heterologous protein in Trichoderma is described, for example, in U.S. Patent No. 6,022,725. Reference is also made to Cao et al. (2000) Science 9:991-1001 for transformation of Aspergillus strains.
- Genetically stable transformants can be constructed with vector systems whereby the nucleic acid encoding an enzyme is stably integrated into a host cell chromosome. Transformants are then selected and purified by known techniques.
- the preparation of Trichoderma sp. for transformation may involve the preparation of protoplasts from fungal mycelia. See Campbell et al. (1989) Curr. Genet. 16: 53-56.
- the mycelia can be obtained from germinated vegetative spores.
- the mycelia are treated with an enzyme that digests the cell wall, resulting in protoplasts.
- the protoplasts are protected by the presence of an osmotic stabilizer in the suspending medium.
- These stabilizers include sorbitol, mannitol, potassium chloride, magnesium sulfate, and the like. Usually the concentration of these stabilizers varies between 0.8 M and 1.2 M, e.g., a 1.2 M solution of sorbitol can be used in the suspension medium.
- Uptake of DNA into the host Trichoderma sp. strain depends upon the calcium ion concentration. Generally, between about 10-50 mM CaCl 2 is used in an uptake solution. Additional suitable compounds include a buffering system, such as TE buffer (10 mM Tris, pH 7.4; 1 mM EDTA) or 10 mM MOPS, pH 6.0 and polyethylene glycol. The polyethylene glycol is believed to fuse the cell membranes, thus permitting the contents of the medium to be delivered into the cytoplasm of the Trichoderma sp. strain. This fusion frequently leaves multiple copies of the plasmid DNA integrated into the host chromosome.
- TE buffer 10 mM Tris, pH 7.4; 1 mM EDTA
- MOPS pH 6.0
- polyethylene glycol polyethylene glycol
- Trichoderma sp. uses protoplasts or cells that have been subjected to a permeability treatment, typically at a density of 10 5 to 107 /mL, particularly 2xl0 6 /mL.
- a volume of 100 of these protoplasts or cells in an appropriate solution ⁇ e.g., 1.2 M sorbitol and 50 mM CaCl 2 ) may be mixed with the desired DNA.
- a high concentration of PEG is added to the uptake solution. From 0.1 to 1 volume of 25% PEG 4000 can be added to the protoplast suspension; however, it is useful to add about 0.25 volumes to the protoplast suspension.
- Additives, such as dimethyl sulfoxide, heparin, spermidine, potassium chloride and the like, may also be added to the uptake solution to facilitate transformation.
- a method of producing an enzyme may comprise cultivating a host cell as described above under conditions conducive to the production of the enzyme and recovering the enzyme from the cells and/or culture medium.
- the medium used to cultivate the cells may be any conventional medium suitable for growing the host cell in question and obtaining expression of an enzyme. Suitable media and media components are available from commercial suppliers or may be prepared according to published recipes (e.g., as described in catalogues of the American Type Culture Collection).
- An enzyme secreted from the host cells can be used in a whole broth preparation.
- the preparation of a spent whole fermentation broth of a recombinant microorganism can be achieved using any cultivation method known in the art resulting in the expression of an enzyme. Fermentation may, therefore, be understood as comprising shake flask cultivation, small- or large-scale fermentation (including continuous, batch, fed-batch, or solid state fermentations) in laboratory or industrial fermenters performed in a suitable medium and under conditions allowing the enzyme to be expressed or isolated.
- the term "spent whole fermentation broth” is defined herein as unfractionated contents of fermentation material that includes culture medium, extracellular proteins (e.g., enzymes), and cellular biomass. It is understood that the term "spent whole fermentation broth” also encompasses cellular biomass that has been lysed or permeabilized using methods well known in the art.
- An enzyme secreted from the host cells may conveniently be recovered from the culture medium by well-known procedures, including separating the cells from the medium by centrifugation or filtration, and precipitating proteinaceous components of the medium by means of a salt such as ammonium sulfate, followed by the use of chromatographic procedures such as ion exchange chromatography, affinity chromatography, or the like.
- the polynucleotide encoding an enzyme in a vector can be operably linked to a control sequence that is capable of providing for the expression of the coding sequence by the host cell, i.e. the vector is an expression vector.
- the control sequences may be modified, for example by the addition of further transcriptional regulatory elements to make the level of transcription directed by the control sequences more responsive to transcriptional modulators.
- the control sequences may in particular comprise promoters.
- Host cells may be cultured under suitable conditions that allow expression of an enzyme. Expression of the enzymes may be constitutive such that they are continually produced, or inducible, requiring a stimulus to initiate expression.
- protein production can be initiated when required by, for example, addition of an inducer substance to the culture medium, for example dexamethasone or IPTG or Sophorose.
- an inducer substance for example dexamethasone or IPTG or Sophorose.
- Polypeptides can also be produced recombinantly in an in vitro cell-free system, such as the TNTTM (Promega) rabbit reticulocyte system.
- An expression host also can be cultured in the appropriate medium for the host, under aerobic conditions. Shaking or a combination of agitation and aeration can be provided, with production occurring at the appropriate temperature for that host, e.g., from about 25°C to about 75°C (e.g., 30°C to 45°C), depending on the needs of the host and production of the desired enzyme. Culturing can occur from about 12 to about 100 hours or greater (and any hour value there between, e.g., from 24 to 72 hours). Typically, the culture broth is at a pH of about 4.0 to about 8.0, again depending on the culture conditions needed for the host relative to production of an enzyme.
- assays can measure the expressed protein, corresponding mRNA, or enzyme activity.
- suitable assays include Northern blotting, reverse transcriptase polymerase chain reaction, and in situ hybridization, using an appropriately labeled hybridizing probe.
- Suitable assays also include measuring enzyme activity in a sample, for example, by assays directly measuring products in the culture media. For example, glucose concentration may be determined using glucose reagent kit No. 15-UV (Sigma Chemical Co.) or an instrument, such as Technicon Autoanalyzer.
- a- Amylase activity also may be measured by any known method, such as the PAHBAH or ABTS assays, described below. Assays are also known in the art to measure other enzyme activities.
- a fermentation broth is obtained, the microbial cells and various suspended solids, including residual raw fermentation materials, are removed by conventional separation techniques in order to obtain an enzyme solution. Filtration, centrifugation, microfiltration, rotary vacuum drum filtration, ultrafiltration, centrifugation followed by ultra-filtration, extraction, or chromatography, or the like, are generally used.
- the enzyme containing solution is concentrated using conventional concentration techniques until the desired enzyme level is obtained. Concentration of the enzyme containing solution may be achieved by any of the techniques discussed herein. Exemplary methods of enrichment and purification include but are not limited to rotary vacuum filtration and/or ultrafiltration.
- the enzyme solution is concentrated into a concentrated enzyme solution until the enzyme activity of the concentrated enzyme polypeptide-containing solution is at a desired level.
- an enzyme polypeptide accumulates in the culture broth.
- the culture broth is centrifuged or filtered to eliminate cells, and the resulting cell-free liquid is used for enzyme enrichment or purification.
- the cell-free broth is subjected to salting out using ammonium sulfate at about 70% saturation; the 70% saturation-precipitation fraction is then dissolved in a buffer and applied to a column such as a Sephadex G-100 column, and eluted to recover the enzyme-active fraction.
- a conventional procedure such as ion exchange or affinity chromatography may be used.
- enzyme polypeptides can be enriched or partially purified as generally described above by removing cells via flocculation with polymers.
- the enzyme can be enriched or purified by microfiltration followed by
- the enzyme does not need to be enriched or purified, and whole broth culture can be lysed and used without further treatment.
- the enzyme can then be processed, for example, into granules.
- proteases are useful for a variety of industrial applications.
- proteases are useful in a starch conversion process, particularly in a saccharification process of a starch that has undergone liquefaction.
- the desired end-product may be any product that may be produced by the enzymatic conversion of the starch substrate.
- the desired product may be a syrup rich in glucose and maltose, which can be used in other processes, such as the preparation of HFCS, or which can be converted into a number of other useful products, such as ascorbic acid intermediates (e.g.
- gluconate gluconate; 2-keto-L-gulonic acid; 5- keto-gluconate; and 2,5-diketogluconate); ethanol, butanol, 1,3-propanediol; aromatic amino acids (e.g. , tyrosine, phenylalanine and tryptophan); organic acids (e.g. , lactate, pyruvate, succinate, citrate, isocitrate, gluconic acid, and oxaloacetate); amino acids (e.g. , serine, lysine, glutamic acid, and glycine); antibiotics; antimicrobials; enzymes; vitamins; and hormones.
- aromatic amino acids e.g. , tyrosine, phenylalanine and tryptophan
- organic acids e.g. , lactate, pyruvate, succinate, citrate, isocitrate, gluconic acid, and oxaloacetate
- amino acids
- the starch conversion process may be a precursor to, or simultaneous with, a fermentation process designed to produce alcohol for fuel or drinking (i.e. , potable alcohol).
- a fermentation process designed to produce alcohol for fuel or drinking (i.e. , potable alcohol).
- One skilled in the art is aware of various fermentation conditions that may be used in the production of these end-products.
- Proteases are also useful in compositions and methods of food preparation. These various uses of proteases are described in more detail below.
- a useful starch substrate may be obtained from tubers, roots, stems, legumes, cereals or whole grain. More specifically, the granular starch may be obtained from corn, cobs, wheat, barley, rye, triticale, milo, sago, millet, cassava, tapioca, sorghum, rice, peas, bean, banana, or potatoes. Corn contains about 60-68% starch; barley contains about 55-65% starch; millet contains about 75-80% starch; wheat contains about 60-65% starch; and polished rice contains 70-72% starch.
- starch substrates are corn starch and wheat starch.
- the starch from a grain may be ground or whole and includes corn solids, such as kernels, bran and/or cobs.
- the starch may also be highly refined raw starch or feedstock from starch refinery processes.
- starches also are commercially available.
- corn starch is available from Cerestar, Sigma, and Katayama Chemical Industry Co. (Japan); wheat starch is available from Sigma; sweet potato starch is available from Wako Pure Chemical Industry Co. (Japan); and potato starch is available from Nakaari Chemical Pharmaceutical Co. (Japan).
- the starch substrate can be a crude starch from milled whole grain, which contains non-starch fractions, e.g., germ residues and fibers.
- Milling may comprise either wet milling or dry milling or grinding.
- wet milling whole grain is soaked in water or dilute acid to separate the grain into its component parts, e.g., starch, protein, germ, oil, kernel fibers.
- Wet milling efficiently separates the germ and meal (i.e., starch granules and protein) and is especially suitable for production of syrups.
- whole kernels are ground into a fine powder and often processed without fractionating the grain into its component parts. In some cases, oils from the kernels are recovered.
- Dry ground grain thus will comprise significant amounts of non-starch carbohydrate compounds, in addition to starch. Dry grinding of the starch substrate can be used for production of ethanol and other biochemicals.
- the starch to be processed may be a highly refined starch quality, for example, at least 90%, at least 95%, at least 97%, or at least 99.5% pure. 4.2. Gelatinization and Liquefaction of Starch
- the term "liquefaction” or “liquefy” means a process by which starch is converted to less viscous and shorter chain dextrins. Generally, this process involves gelatinization of starch simultaneously with or followed by the addition of an a-amylase, although additional liquefaction-inducing enzymes optionally may be added.
- the starch substrate prepared as described above is slurried with water.
- the starch slurry may contain starch as a weight percent of dry solids of about 10-55%, about 20-45%, about 30-45%, about 30-40%, or about 30-35%.
- a-Amylase (EC 3.2.1.1) may be added to the slurry, with a metering pump, for example.
- the a-amylase typically used for this application is a thermally stable, bacterial a-amylase, such as a Geobacillus stearothermophilus a-amylase.
- the ⁇ -amylase is usually supplied, for example, at about 1500 units per kg dry matter of starch.
- the pH of the slurry typically is adjusted to about pH 5.5-6.5 and about 1 mM of calcium (about 40 ppm free calcium ions) can also be added.
- Geobacillus stearothermophilus variants or other cc-amylases may require different conditions.
- Bacterial ⁇ -amylase remaining in the slurry following liquefaction may be deactivated via a number of methods, including lowering the pH in a subsequent reaction step or by removing calcium from the slurry in cases where the enzyme is dependent upon calcium.
- the slurry of starch plus the ⁇ -amylase may be pumped continuously through a jet cooker, which is steam heated to 105°C. Gelatinization occurs rapidly under these conditions, and the enzymatic activity, combined with the significant shear forces, begins the hydrolysis of the starch substrate.
- the residence time in the jet cooker is brief.
- the partly gelatinized starch may be passed into a series of holding tubes maintained at 105-110°C and held for 5-8 min. to complete the gelatinization process ("primary liquefaction").
- Hydrolysis to the required DE is completed in holding tanks at 85-95°C or higher temperatures for about 1 to 2 hours (“secondary liquefaction"). These tanks may contain baffles to discourage back mixing.
- minutes of secondary liquefaction refers to the time that has elapsed from the start of secondary liquefaction to the time that the Dextrose Equivalent (DE) is measured.
- the slurry is then allowed to cool to room temperature. This cooling step can be 30 minutes to 180 minutes, or more.
- the liquefied starch typically is in the form of a slurry having a dry solids content (w/w) of about 10-50%; about 10-45%; about 15-40%; about 20-40%; about 25-40%; or about 25-35%.
- Liquefaction with amylases advantageously can be conducted at low pH, eliminating the requirement to adjust the pH to about pH 5.5-6.5.
- Proteases can be used for liquefaction at a pH range of 2 to 7, e.g., pH 3.0 - 7.5, pH 4.0 - 6.0, or pH 4.5 - 5.8.
- Amylases can maintain liquefying activity at a temperature range of about 85°C - 95°C, e.g., 85°C, 90°C, or 95°C.
- liquefaction can be conducted with an amylase in a solution of 25% DS corn starch for 10 min at pH 5.8 and 85°C, or pH 4.5 and 95°C, for example.
- Liquefying activity can be assayed using any of a number of known viscosity assays in the art.
- starch liquefaction is performed at a temperature range of 90-115°C, for the purpose of producing high-purity glucose syrups, HFCS,
- the liquefied starch can be saccharified into a syrup rich in lower DP (e.g., DPI + DP2) saccharides, using a-amylases, optionally in the presence of other enzyme(s).
- DP e.g., DPI + DP2
- the syrup may contain a weight percent of DP2 of the total oligosaccharides in the saccharified starch exceeding 30%, e.g., 45% - 65% or 55% - 65%.
- the weight percent of (DPI + DP2) in the saccharified starch may exceed about 70%, e.g., 75% - 85% or 80% - 85%.
- the present amylases also produce a relatively high yield of glucose, e.g., DPI > 20%, in the syrup product.
- Saccharification is often conducted as a batch process. Saccharification typically is most effective at temperatures of about 60-65°C and a pH of about 4.0-4.5, e.g., pH 4.3, necessitating cooling and adjusting the pH of the liquefied starch. Saccharification may be performed, for example, at a temperature between about 40°C, about 50°C, or about 55°C to about 60°C or about 65°C. Saccharification is normally conducted in stirred tanks, which may take several hours to fill or empty. Enzymes typically are added either at a fixed ratio to dried solids as the tanks are filled or added as a single dose at the commencement of the filling stage.
- a saccharification reaction to make a syrup typically is run over about 24-72 hours, for example, 24-48 hours. When a maximum or desired DE has been attained, the reaction is stopped by heating to 85°C for 5 min., for example. Further incubation will result in a lower DE, eventually to about 90 DE, as accumulated glucose re-polymerizes to isomaltose and/or other reversion products via an enzymatic reversion reaction and/or with the approach of thermodynamic equilibrium.
- saccharification optimally is conducted at a temperature range of about 30°C to about 75°C, e.g., 45°C - 75°C or 47°C - 74°C.
- the saccharifying may be conducted over a pH range of about pH 3 to about pH 7, e.g., pH 3.0 - pH 7.5, pH 3.5 - pH 5.5, pH 3.5, pH 3.8, or pH 4.5.
- An amylase may be added to the slurry in the form of a composition.
- Amylase can be added to a slurry of a granular starch substrate in an amount of about 0.6 - 10 ppm ds, e.g., 2 ppm ds.
- An amylase can be added as a whole broth, clarified, enriched, partially purified, or purified enzyme.
- the specific activity of the amylase may be about 300 U/mg of enzyme, for example, measured with the PAHBAH assay.
- the amylase also can be added as a whole broth product.
- An amylase may be added to the slurry as an isolated enzyme solution.
- an amylase can be added in the form of a cultured cell material produced by host cells expressing an amylase.
- An amylase may also be secreted by a host cell into the reaction medium during the fermentation or SSF process, such that the enzyme is provided continuously into the reaction.
- the host cell producing and secreting amylase may also express an additional enzyme, such as a glucoamylase.
- U.S. Patent No. 5,422,267 discloses the use of a glucoamylase in yeast for production of alcoholic beverages.
- a host cell e.g., Trichoderma reesei ox Aspergillus niger
- a host cell may be engineered to co-express an amylase and a glucoamylase, e.g., HgGA, TrGA, or a TrGA variant, during saccharification.
- the host cell can be genetically modified so as not to express its endogenous glucoamylase and/or other enzymes, proteins or other materials.
- the host cell can be engineered to express a broad spectrum of various saccharolytic enzymes.
- the recombinant yeast host cell can comprise nucleic acids encoding a glucoamylase, an alpha-glucosidase, an enzyme that utilizes pentose sugar, an a-amylase, a pullulanse, an isoamylase, and/or an isopullulanase. See, e.g., WO 2011/153516 A2. 4.4. Fermentation
- the soluble starch hydrolysate can be fermented by contacting the starch hydrolysate with a fermenting organism typically at a temperature around 32°C, such as from 30°C to 35°C for alcohol-producing yeast.
- a fermenting organism typically at a temperature around 32°C, such as from 30°C to 35°C for alcohol-producing yeast.
- the temperature and pH of the fermentation will depend upon the fermenting organism.
- EOF products include metabolites, such as citric acid, lactic acid, succinic acid, monosodium glutamate, gluconic acid, sodium gluconate, calcium gluconate, potassium gluconate, itaconic acid and other carboxylic acids, glucono delta-lactone, sodium erythorbate, lysine and other amino acids, omega 3 fatty acid, butanol, isoprene, 1,3-propanediol and other biomaterials.
- metabolites such as citric acid, lactic acid, succinic acid, monosodium glutamate, gluconic acid, sodium gluconate, calcium gluconate, potassium gluconate, itaconic acid and other carboxylic acids, glucono delta-lactone, sodium erythorbate, lysine and other amino acids, omega 3 fatty acid, butanol, isoprene, 1,3-propanediol and other biomaterials.
- Ethanologenic microorganisms include yeast, such as Saccharomyces cerevisiae and bacteria, e.g., Zymomonas moblis, expressing alcohol dehydrogenase and pyruvate decarboxylase.
- the ethanologenic microorganism can express xylose reductase and xylitol dehydrogenase, which convert xylose to xylulose. Improved strains of ethanologenic yeast, such as Saccharomyces cerevisiae and bacteria, e.g., Zymomonas moblis, expressing alcohol dehydrogenase and pyruvate decarboxylase.
- the ethanologenic microorganism can express xylose reductase and xylitol dehydrogenase, which convert xylose to xylulose.
- Improved strains of ethanologenic microorganisms include yeast, such as Saccharomyces cerevis
- microorganisms which can withstand higher temperatures, for example, are known in the art and can be used. See Liu et al. (2011) Sheng Wu Gong Cheng Xue Bao 27: 1049-56.
- yeast Commercial sources include ETHANOL RED® (LeSaffre); THERMOSACC®
- Microorganisms that produce other metabolites, such as citric acid and lactic acid, by fermentation are also known in the art. See, e.g., Papagianni (2007) Biotechnol. Adv. 25:244-63; John et al. (2009) Biotechnol. Adv. 27: 145-52.
- the saccharification and fermentation processes may be carried out as an SSF process. Fermentation may comprise subsequent enrichment, purification, and recovery of ethanol, for example.
- the ethanol content of the broth or "beer” may reach about 8-18% v/v, e.g., 14-15% v/v.
- the broth may be distilled to produce enriched, e.g., 96% pure, solutions of ethanol.
- C0 2 generated by fermentation may be collected with a C0 2 scrubber, compressed, and marketed for other uses, e.g., carbonating beverage or dry ice production.
- Solid waste from the fermentation process may be used as protein-rich products, e.g., livestock feed.
- an SSF process can be conducted with fungal cells that express and secrete amylase continuously throughout SSF.
- the fungal cells expressing amylase also can be the fermenting microorganism, e.g., an ethanologenic microorganism. Ethanol production thus can be carried out using a fungal cell that expresses sufficient amylase so that less or no enzyme has to be added exogenously.
- the fungal host cell can be from an
- Fungal host cells that express and secrete other enzymes, in addition to amylase, also can be used. Such cells may express one or more glucoamylase and/or a pullulanase, phytase, ⁇ / ⁇ -glucosidase, isoamylase, beta-amylase cellulase, xylanase, other hemicellulases, protease, beto-glucosidase, pectinase, esterase, redox enzymes, transferase, or other enzyme.
- glucoamylase and/or a pullulanase phytase, ⁇ / ⁇ -glucosidase, isoamylase, beta-amylase cellulase, xylanase, other hemicellulases, protease, beto-glucosidase, pectinase, esterase, redox enzymes, transferase
- a variation on this process is a "fed-batch fermentation" system, where the substrate is added in increments as the fermentation progresses.
- Fed-batch systems are useful when catabolite repression may inhibit the metabolism of the cells and where it is desirable to have limited amounts of substrate in the medium.
- the actual substrate concentration in fed- batch systems is estimated by the changes of measurable factors such as pH, dissolved oxygen and the partial pressure of waste gases, such as C0 2 . Batch and fed-batch fermentations are common and well known in the art.
- Continuous fermentation is an open system where a defined fermentation medium is added continuously to a bioreactor, and an equal amount of conditioned medium is removed simultaneously for processing.
- Continuous fermentation generally maintains the cultures at a constant high density where cells are primarily in log phase growth.
- Continuous fermentation permits modulation of cell growth and/or product concentration. For example, a limiting nutrient such as the carbon source or nitrogen source is maintained at a fixed rate and all other parameters are allowed to moderate. Because growth is maintained at a steady state, cell loss due to medium being drawn off should be balanced against the cell growth rate in the fermentation.
- Proteases may be combined with a glucoamylase (EC 3.2.1.3), e.g., a
- Trichoderma glucoamylase or variant thereof Trichoderma reesei glucoamylase (TrGA) and variants thereof that possess superior specific activity and thermal stability. See U.S. Published Applications Nos. 2006/0094080, 2007/0004018, and 2007/0015266 (Danisco US Inc.).
- TrGA Trichoderma reesei glucoamylase
- Suitable variants of TrGA include those with glucoamylase activity and at least 80%, at least 90%, or at least 95% sequence identity to wild-type TrGA.
- a- amylases advantageously increase the yield of glucose produced in a saccharification process catalyzed by TrGA.
- the glucoamylase may be another glucoamylase derived from plants (including algae), fungi, or bacteria.
- the glucoamylases may be Aspergillus niger Gl or G2 glucoamylase or its variants (e.g., Boel et al. (1984) EMBO J. 3: 1097-1102; WO 92/00381 ; WO 00/04136 (Novo Nordisk A/S)); and A. awamori glucoamylase (e.g. , WO
- Aspergillus glucoamylase include variants with enhanced thermal stability, e.g., G137A and G139A (Chen et al. (1996) Prot. Eng. 9:499-505); D257E and D293E/Q (Chen et al. (1995) Prot. Eng. 8:575-582); N182 (Chen et al. (1994) Biochem. J. 301:275-281); A246C (Fierobe et al. (1996) Biochemistry, 35: 8698-8704); and variants with Pro residues in positions A435 and S436 (Li et al. (1997) Protein Eng.
- G137A and G139A Choen et al. (1996) Prot. Eng. 9:499-505)
- D257E and D293E/Q Choen et al. (1995) Prot. Eng. 8:575-582
- N182 Chen et al. (1994) Biochem. J.
- glucoamylases include Talaromyces glucoamylases, in particular derived from T. emersonii (e.g., WO 99/28448 (Novo Nordisk A/S), T. leycettanus (e.g., U.S. Patent No. RE 32,153 (CPC International, Inc.)), T. duponti, or T. thermophilus (e.g., U.S.
- Contemplated bacterial glucoamylases include glucoamylases from the genus Clostridium, in particular C. thermoamylolyticum ⁇ e.g., EP 135138 (CPC International, Inc.) and C. thermohydrosulfuricum ⁇ e.g., WO 86/01831 (Michigan Biotechnology Institute)).
- Suitable glucoamylases include the glucoamylases derived from Aspergillus oryzae, such as a glucoamylase shown in WO 00/04136 (Novo Nordisk A/S).
- glucoamylases such as AMG 200L; AMG 300 L; SANTM SUPER and AMGTM E (Novozymes); OPTIDEX® 300 and OPTIDEX L-400 (Danisco US Inc.); AMIGASETM and AMIGASETM PLUS (DSM); G-ZYME® G900 (Enzyme Bio-Systems); and G-ZYME® G990 ZR (A. niger glucoamylase with a low protease content). Still other suitable glucoamylases include
- Glucoamylases typically are added in an amount of about 0.1 - 2 glucoamylase units (GAU)/g ds, e.g., about 0.16 GAU/g ds, 0.23 GAU/g ds, or 0.33 GAU/g ds.
- GAU glucoamylase units
- OPTIMASHTM BG may be used which is an enzyme preparation intended for the fuel alcohol industry. This product is capable of reducing viscosity of barley and wheat mashes.
- OPTIMASHTM BG enzyme contains a combination of enzymes, including but not limited to, a beta glucanase and a xylanase, which effectively modify and digest non- starch carbohydrates, the structural material of plant ceils.
- OPTIMASHTM BG is produced by subraergedfermentation of a genetically modified strain of Trichoderma reesei.
- OPTIMASHTM TBG may be used, which is an enzyme blend that is heat stable, food grade preparation of the enzyme cellulase, EC 3.2.1.4.
- the product has been specifically formulated for use in the fermentation ethanol and starch processing industries for the breakdown of the non-starch polysaccharides of barley and wheat. It is produced by the fermentation of a non-genetically modified strain of Geosmithia emersonii, also known as Talaromyces emersonii.
- the major enzyme activity of OPTIMASHTM TBG enzyme is a component, endo- 1,3(4)- B-glucanase (systematic name: (l ,3-l ,3;L4) ⁇ a-D ⁇ glucan 3(4)- glucanohydrolase), which catalyses the endohydrolysis of 1,3- or 1,4-!inkages in ⁇ -D-glucans.
- Suitable enzymes include a phytase, protease, pullulanase, ⁇ -amylase, isoamylase, a different a-amylase, alpha-glucosidase, cellulase, xylanase, other hemicellulases, beta-glucosidase, transferase, pectinase, lipase, cutinase, esterase, redox enzymes, or a combination thereof.
- a debranching enzyme such as an isoamylase (EC 3.2.1.68), may be added in effective amounts well known to the person skilled in the art.
- a pullulanase (EC 3.2.1.41), e.g., PROMOZYME®, is also suitable. Pullulanase typically is added at 100 U/kg ds.
- Further suitable enzymes include proteases, such as fungal and bacterial proteases. Fungal proteases include those obtained from Aspergillus, such as A. niger, A.
- awamori A. oryzae
- Mucor e.g., M. miehei
- Rhizopus Rhizopus
- Trichoderma Trichoderma
- ⁇ -Amylases (EC 3.2.1.2) are exo-acting maltogenic amylases, which catalyze the hydrolysis of 1,4-a-glucosidic linkages into amylopectin and related glucose polymers, thereby releasing maltose.
- ⁇ -Amylases have been isolated from various plants and microorganisms. See Fogarty et al. (1979) in PROGRESS IN INDUSTRIAL MICROBIOLOGY, Vol. 15, pp. 112-115. These ⁇ -Amylases have optimum temperatures in the range from 40°C to 65°C and optimum pH in the range from about 4.5 to about 7.0.
- Contemplated ⁇ -amylases include, but are not limited to, ⁇ -amylases from barley SPEZYME® BBA 1500, SPEZYME® DBA, OPTIMALTTM ME, OPTIMALTTM BBA (Danisco US Inc.); and NOVOZYMTM WBA (Novozymes A/S).
- compositions comprising the present proteases may be aqueous or non-aqueous formulations, granules, powders, gels, slurries, pastes, etc., which may further comprise any one or more of the additional enzymes listed, herein, along with buffers, salts, preservatives, water, co-solvents, surfactants, and the like.
- Such compositions may work in combination with endogenous enzymes or other ingredients already present in a slurry, water bath, washing machine, food or drink product, etc, for example, endogenous plant (including algal) enzymes, residual enzymes from a prior processing step, and the like.
- NprE at 0.05mg/g ds.
- the metal beakers were fitted back into the LABOMAT for liquefaction unit operation at 60°C for 45 min followed by 85°C for 90 min with clockwise and counterclockwise constant mixing at 60rpm.
- the objective of this experiment is to determine effects of protease addition on viscosity changes during corn liquefaction by alpha amylases.
- Enzymes used in liquefaction and/or fermentation are used in liquefaction and/or fermentation.
- the slurry was then brought back to an 85°C (185.0°F) water bath and continuously mixed for the remainder of the experiment (160 minutes total).
- the secondary dosage of SPEZYME CL at 1.0 AAUs/g ds was added at the 45 minute mark. Samples of ⁇ 1 gram were taken for DE determination at 50 and 160 minutes.
- a 20% w/v yeast solution was prepared by adding 5 grams of Ethanol Red yeast in a 50 mL conical centrifuge tube with the addition of DI water up to 25 mL mark. The yeast solution was mixed for 10 minutes at 150 rpm and each fermentation flask was dosed with 500 ⁇ ⁇ of yeast, which yielded a concentration of 0.1% w/w. Each flask was then covered with a rubber stopper with a hole to vent C0 2 . The 12 flasks were incubated at 32°C at 150 rpm for 72 hours. Samples were taken at 5, 18, 24, 42, 48, 66, and 72 hours for ethanol concentrations.
- a sample was measured into a 2.0 mL centrifuge tube and centrifuged for approximately 3 minutes at 13.2k rpm and prepared for HPLC analysis, where 0.5 mL of supernatant was acidified with 50 ⁇ ⁇ of IN sulfuric acid for 5 minutes, diluted with 4.45 mL of RO water, and then filtered through a 3 mL syringe with a 0.45 ⁇ GHP membrane.
- the samples were placed in HPLC vials and went through the organic acid column.
- SPEZYME CL in liquefaction compared to control when only SPEZYME CL was used.
- SPEZYME CL and TRGA+AKAA+ Fermgen reached 16.47% w/w. Ethanol increase was also seen with use of SPEZYME FAN and Fermgen in liquefaction.
- FERMGEN process add FERMGEN at 0.2kg/tds into the slurry and put it in 55°C water bath for 0.5hr to do pretreatment process, then add Supra at 0.7kg/tds and transferred to 95°C water bath for 1.5hr to do liquefaction process.
- For blank group add Supra at 0.7kg/tds and put it into 95°C water bath for 1.5hr to do liquefaction process.
- the slurry was filtrated and collected the cake, which was then dried in 60°C oven overnight. The cake was crashed to fine powder and check residual starch in it.
- Seed media Casein 10.0 g, Beef extract 10.0 g, Yeast extract 5.0 g, Glucose 5.0 g, Sodium acetate 5.0 g, Diammonium citrate 2.0 g, Tween 80 1.0 g, K2HP04 2.0 g,
- Fermentation medium whole ground Corn liquefact, one treated with additional Protease like FERMGEN, another run as control without protease.
- Casein Beef extract, Yeast extract, Glucose, Sodium acetate, diammonium hydrogen citrate, Tween 80, K2HP04, MgS04.7H20, MnS04.H20, Agar powder, NH40H, calcium hydroxide were analytical grade from local supplier.
- Whole ground corn was from Yixin Xielian Citric acid factory.
- FERMGEN, SPEZYME ALPHA, TrGA was from
- Lactic acid fermentation was carried out using Bacillus coagulans strain.
- the inoculums of Bacillus coagulans was transferred to each lOOmL seed culture and cultivated at 50°C, 12 ⁇ 24hrs, 200rpm. The cultivation was controlled based on OD 6 oo value around 0.5.
- 500 mL filtrate was used as fermentation medium, Treesei GlucoAmylase (TrGA) was dosed at 0.75 GAU/g for SSF process, then 50mL seed culture was added to each fermentor to start fermentation.
- Fermentation pH was maintained at pH 6.5 using 15% Ca(OH) 2 and the temperature was set at 55°C, and the agitation was 300rpm. Samples were taken at 18h, 25h, 44h, 50h. Lactic acid concentration of the fermentation broth was given in Table 6.1.
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The present invention relates to reducing the viscosity of a corn-like grain slurry during a liquefaction and/or fermentation. The invention also relates to increasing the rate and/or yield of fermentation products, including, but not limited to ethanol, lactic acid and citric acid from corn-like grains.
Description
PROTEASES IN CORN PROCESSING
CROSS REFERENCE TO RELATED APPLICATIONS
[001] This application claims benefit of priorities from the U. S. Provisional application Serial No. 61/899755 filed 04 November 2013 and International application Serial No.
PCT/CN2014/089754, filed 29 October, 2014 and both of which are incorporated by reference herewith in their entirety.
BACKGROUND OF THE INVENTION
[002] More and more biochemicals (for example, alcohols - ethanol, butanol, etc., acids - lactic acid, citric acid, etc.), are being produced from fermentation processes using renewable feedstocks to replace the traditional processes using limited fossil fuel. One major cost of the bioproduction is the feedstock. The fermentation feedstock is usually high quality glucose or liquefact from refined starch. Some producers are using cruder materials like whole ground corn, cassava chips, etc., in the fermentations, for examples, citric acid, other organic acids, and butanol fermentation. The key issue of this kind of process is that there is one filtration process to remove the fiber, fat, protein, unsolubolized starch and other impurities before pumping the syrup to fermentor. Otherwise, these impurities will affect the functions of bacteria, yeast or other fermentation organism.The disadvantages of the current process is that the filtration is needed to be done at high temperature, with high viscosity of the syrup, which leads to high residual starch in the filtered cake and loss of sugars.
[003] The commercial viability of producing ethanol as a fuel source from agricultural crops has generated renewed worldwide interest due to a variety of reasons that include continued and increased dependence on limited oil supplies and the fact that ethanol production is a renewable energy source.
[004] Alcohol fermentation production processes and particularly ethanol production processes are generally characterized as wet milling or dry milling processes. Reference is made to Bothast et al., 2005,Appl. Microbiol. Biotechnol. 67: 19-25 and THE ALCOHOL TEXTBOOK, 5th Ed, W.M. Ingledew et al. Eds, 2009, Nottingham University Press, UK for a review of these processes.
[005] Wet milling process involves a series of soaking (steeping) steps to soften the cereal grain wherein soluble starch is removed followed by recovery of the germ, fiber (bran) and gluten (protein). The remaining starch is further processed by drying, chemical and/or enzyme treatments. The starch may then be used for alcohol production, high fructose corn syrup or commercial pure grade starch or other fermentration products.
[006] Dry grain milling involves a number of basic steps, which include: grinding, cooking, liquefaction, saccharification, fermentation and separation of liquid and solids to produce alcohol and other co-products. Generally, whole cereal, such as corn cereal, is ground to a fine particle size and then mixed with liquid in a slurry tank. The slurry is subjected to high temperatures in a jet cooker along with liquefying enzymes (e.g. alpha-amylases) to solubilize and hydrolyze the starch in the cereal to dextrins. The mixture is cooled down and further treated with saccharifying enzymes (e.g. glucoamylases) to produce fermentable glucose. The mash containing glucose is then fermented for approximately 24 to 120 hours in the presence of ethanol producing microorganisms. The solids in the mash are separated from the liquid phase and ethanol and useful co-products such as distillers' grains are obtained.
[007] Improvements to the above fermentation processes have been accomplished by combining the saccharification step and fermentation step in a process referred to as
simultaneous saccharification and fermentation or simultaneous saccharification, yeast propagation and fermentation. These improved fermentation processes have advantages over the previously described dry or wet milling fermentation processes because significant sugar concentrations do not develop in the fermenter thereby avoiding sugar inhibition of yeast growth. In addition, bacterial growth is reduced due to lack of easily available glucose.
Increased ethanol production may result by use of the simultaneous saccharification and fermentation processes.
[008] The corn kernel has two kinds of endosperm portion: hard and soft endosperm. The soft endosperm contains spherical starch granule in protein matrix. The hard endosperm contains polygonal starch granules packed in a highly complex protein matrix. During drying on the cob and in the storage bins the protein matrix in hard endosperm are stretched and tightly aligned with starch granules which themselves change shapes from nice spherical shapes to polygonal shapes due to stretching during drying. Adding a protease to break the protein structure may result in release of more starch to be available for enzymes and yeast.
[009] Viscosity of corn slurry increase rapidly when milled corn, corn flour, corn starch, or other starch granular substrates are heated above 60°C at various dry solids level in water.
Typically alpha amylase is added to minimize the initial rise in the slurry viscosity (aka peak viscosity) as well as the viscosity of the final hot slurry produced (aka final viscosity).
Controlling both of these viscosity values is important in the corn cook process (gelatinization and pasting) for pumpability in the process pipes, slurry mixer as well as the steam pressured jet cooker. It is known in the literature that addition of protease aids the liquefaction process by producing high FAN (free amino nitrogen) resulting in higher ethanol yield. However, addition
of proteases to reduce slurry viscosity has not been observed in the past. Thus, there is a need in the field to develop processes that reduce viscosity during liquefaction of corn starch.
[0010] The present invention develops a new process, using proteases and/or other enzymes before or during the liquefaction process, solubolizing more starch and reducing the viscosity of the syrup, thus reducing the residual starch in the filtered cake. In addition, the protease produces more Free amino nitrogen (FAN), which is helpful to the fermentation organism, thus improving the fermentation process.
SUMMARY OF THE INVENTION
[0011] In one aspect, the invention comprises a method for producing a fermentation product from corn or similar grain, comprising: liquifying the corn-like grain slurry at a pH of about 4.0 to about 7.0 at a temperature in the range from about 25°C to about 65°C using: an alpha amylase, a protease; and optionally a beta-glucanase; saccharifying and fermenting the slurry using enzymes, including a glucoamylase and a fermenting organism to produce the
fermentation product.
[0012] In one aspect, the invention comprises a method for increasing the yield and/or rate of ethanol production from corn or similar grain, comprising: liquifying the corn-like grain slurry at a pH of about 4.0 to about 7.0 at a temperature in the range from about 25°C to about 65°C using: an alpha amylase, a protease; and optionally a beta-glucanase; saccharifying and fermenting the slurry using enzymes, including a glucoamylase and a fermenting organism to produce ethanol, wherein the yield and/or rate of ethanol production is greater than the rate observed witout the addition of protease.
[0013] In another aspect, the invention comprises a method for reducing the viscosity of the corn-like grain slurry during a fermentation, comprising: liquifying the corn-like grain slurry at a pH of about 4.0 to about 7.0 at a temperature in the range from about 25°C to about 65°C using: an alpha amylase, a protease; and optionally a beta-glucanase; saccharifying and fermenting the slurry using enzymes, including a glucoamylase and a fermenting organism to produce the fermentation product, wherein the viscosity of the slurry is reduced by at least 20% compared to a slurry not treated with a protease. In another aspect, the viscosity is reduced by 30%, 50% or 60%.
[0014] In another aspect, the invention comprises a method for reducing the viscosity of the corn- like grain slurry during a liquefaction process, comprising: liquifying the corn-like gain slurry at a pH of about 4.0 to about 7.0 at a temperature in the range from about 25°C to about 65°C using an alpha amylase, a protease; and optionally a beta-glucanase;
wherein the viscosity of the slurry is reduced by at least 20% compared to a slurry not treated with a protease. In another aspect, the viscosity is reduced by 30%, 50% or 60%.
[0015] In another aspect, the invention comprises a method for reducing the viscosity of the corn-like grain slurry during a liquefaction process, comprising: liquifying the corn-like gain slurry at a pH of about 4.0 to about 7.0 at a temperature in the range from about 25°C to about 95°C using an alpha amylase, a protease; and optionally a beta-glucanase;
wherein the viscosity of the slurry is reduced by at least 20% compared to a slurry not treated with a protease. In another aspect, the viscosity is reduced by 30%, 40%, 50% or 60%.
[0016] In another aspect of the invention, the invention comprises a method for reducing foam in a corn-like grain slurry during a liquefaction process, comprising: liquifying the corn-like gain slurry at a pH of about 4.0 to about 7.0 at a temperature in the range from about 25°C to about 90°C using an alpha amylase, a protease; and optionally a beta-glucanase; and wherein the foam in the slurry is reduced by at least 20%, 30%, 50% or 60% compared to a slurry not treated with a protease.
[0017] In another aspect of the invention, the invention comprises a method for reducing amount of residual starch after a liquefaction process of a corn-like grain slurry, comprising: liquifying the corn-like gain slurry at a pH of about 4.0 to about 7.0 at a temperature in the range from about 25°C to about 90°C using: an alpha amylase, a protease; and optionally a beta- glucanase; andwherein the amount of residual starch of the slurry is reduced by at least 20%, 30%, 50% or 60% compared to a slurry not treated with a protease.
[0018] In another aspect of the invention, the protease is a metallopro tease. In another aspect, the metalloprotease is a thermolysin or Proteinase T. In another aspect, the protease is a variant thermolysin with one or more substitutions. In another aspect, the protease is NprE. In another aspect, the protease is an NprE varaint with one or more substitutions. In another aspect, the protease is Fermgen, an acid fungal protease. These substitutions are disclosed in various patent applications, for example, WO 2002007/044993, WO 2009/058679, WO 2009/058661, WO 2009/058518, WO 2009/058303, and US provisional application 61/722,660 filed on 05 November 2012, all of which are herein incorporated by reference in their entirety.
[0019] In another aspect of the invention, the fermentation product is an alcohol, an organic acid, an amino acid, a sugar, an antibiotic, an enzyme, a vitamin or a hormone.
BRIEF DESCRIPTION OF THE DRAWINGS
[0020] Figure 1: Titration of Proteinase T with 15 μgrams of Cytophaga spp alpha amylase.
[0021] Figure 2: Addition of protease (lmg purified NprE) to 15 μgrams of Cytophaga spp
alpha amylase.
[0022] Figure 3 Dose dependent reduction of peak and final viscosity values.
[0023] Figure 4 The final ethanol yield at 48 hr for different liquefaction and SSF treatments.
[0024] Figure 5 The final ethanol yield at 48 hr for different liquefaction and SSF treatments.
[0025] Figure 6 The final ethanol yield at 48 hr for both Proteinase T and FAN used in SSF with Fermgen.
DETAILED DESCRIPTION
[0026] Described are compositions and methods relating to protease enzymes. Exemplary applications for the protease enzymes are for starch liquefaction, to reduce viscosity and increase the yield and/or rate of ethanol production. These and other aspects of the compositions and methods are described in detail, below.
[0027] Prior to describing the various aspects and embodiments of the present compositions and methods, the following definitions and abbreviations are described. 1. Definitions and Abbreviations
[0028] In accordance with this detailed description, the following abbreviations and definitions apply. Note that the singular forms "a," "an," and "the" include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to "an enzyme" includes a plurality of such enzymes, and reference to "the dosage" includes reference to one or more dosages and equivalents thereof known to those skilled in the art, and so forth.
[0029] The present document is organized into a number of sections for ease of reading;
however, the reader will appreciate that statements made in one section may apply to other sections. In this manner, the headings used for different sections of the disclosure should not be construed as limiting.
[0030] Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art. The following terms are provided below.
1.1. Abbreviations and Acronyms
[0031] The following abbreviations/acronyms have the following meanings unless otherwise specified: ABTS: 2,2-azino-bis-3-ethylbenzothiazoline-6-sulfonic acid ; AE or AEO: alcohol ethoxylate; AES or AEOS: alcohol ethoxysulfate; AkAA: Aspergillus kawachii a-amylase; AnGA : Aspergillus niger glucoamylase; AOS: a-olefinsulfonate; AS: alkyl sulfate; cDNA: complementary DNA; CMC: carboxymethylcellulose; DE: dextrose equivalent; DNA:
deoxyribonucleic acid; DPn: degree of saccharide polymerization having n subunits; ds or DS: dry solids; DTMPA: diethylenetriaminepentaacetic acid; EC: Enzyme Commission; EDTA: ethylenediaminetetraacetic acid; EO: ethylene oxide (polymer fragment); EOF: End of
Fermentation; GA: glucoamylase; GAU/g ds: glucoamylase activity unit/gram dry solids;
HFCS: high fructose corn syrup; HgGA: Humicola grisea glucoamylase; IPTG: isopropyl β-D- thiogalactoside; IRS: insoluble residual starch; kDa: kiloDalton; LAS: linear
alkylbenzenesulfonate; LAT, BLA: B. licheniformis amylase; MW: molecular weight; MWU:
modified Wohlgemuth unit; 1.6xl0~5 mg/MWU = unit of activity; NCBI: National Center for Biotechnology Information; NOBS: nonanoyloxybenzenesulfonate; NTA: nitriloacetic acid; OxAm: Purastar HP AM 5000L (Danisco US Inc.); PAHBAH : p-hydroxybenzoic acid hydrazide; PEG: polyethyleneglycol; pi: isoelectric point; PI: performance index; ppm: parts per million, e.g., μg protein per gram dry solid ; PVA: poly(vinyl alcohol); PVP:
poly(vinylpyrrolidone); RCF: relative centrifugal/centripetal force {i.e., x gravity); RNA:
ribonucleic acid; SAS: alkanesulfonate; SDS-PAGE: sodium dodecyl sulfate polyacrylamide gel electrophoresis; SSF: simultaneous saccharification and fermentation ; SSU/g solid : soluble starch unit/gram dry solids; sp.: species; TAED: tetraacetylethylenediamine; Tm: melting temperature; TrGA : Trichoderma reesei glucoamylase; w/v: weight/volume; w/w:
weight/weight; v/v: volume/volume; wt : weight percent; °C: degrees Centigrade; H20: water; dH20 or DI: deionized water; dIH20: deionized water, Milli-Q filtration; g or gm: grams; μg: micrograms; mg: milligrams; kg: kilograms;
and μΐ: microliters; mL and ml: milliliters; mm: millimeters; μιη: micrometer; M: molar; mM: millimolar; μΜ: micromolar; U: units; sec:
seconds; min(s): minute/minutes; hr(s): hour/hours; DO: dissolved oxygen; Ncm: Newton centimeter; ETOH: ethanol; eq.: equivalents; N: normal; MWCO: molecular weight cut-off; SSRL: Stanford Synchrotron Radiation Lightsource; PDB: Protein Database; CAZy:
Carbohydrate-Active Enzymes database; Tris-HCl: tris(hydroxymethyl)aminomethane hydrochloride; HEPES: 4-(2-hydroxyethyl)-l-piperazineethanesulfonic acid; mS/cm: milli- Siemens/cm; CV: column volumes.
1.2. Definitions
[0032] As used herein, the terms "protease" and "proteinase" refer to an enzyme protein that has the ability to break down proteins or peptides. A protease has the ability to conduct "proteolysis," which begins protein catabolism by hydrolysis of peptide bonds that link amino acids together in a peptide or polypeptide chain forming the protein. This activity of a protease as a protein-digesting enzyme is referred to as "proteolytic activity." Many procedures exist for measuring proteolytic activity {See e.g., Kalisz, "Microbial Proteinases," In: Fiechter (ed.), Advances in Biochemical Engineering/Biotechnology.
(1988)). For example, proteolytic activity may be ascertained by comparative assays which analyze the respective protease' s ability to hydrolyze a commercially available substrate. Exemplary substrates useful in the analysis of protease or proteolytic activity, include, but are not limited to, di-methyl casein (Sigma C-9801), bovine collagen (Sigma C-9879), bovine elastin (Sigma E-1625), and bovine keratin (ICN Biomedical 902111). Colorimetric assays utilizing these substrates are well known in the art (See e.g., WO 99/34011 and U.S. Pat. No. 6,376,450, both of which are incorporated herein by reference). The pNA assay (See e.g., Del Mar et al, Anal. Biochem. 99:316-320 [1979]) also finds use in determining the active enzyme concentration for fractions collected during gradient elution. This assay measures the rate at which p-nitroaniline is released as the enzyme hydrolyzes the soluble synthetic substrate, succinyl-alanine-alanine-proline-phenylalanine-p-nitroanilide (suc-AAPF-pNA). The rate of production of yellow color from the hydrolysis reaction is measured at 410 nm on a spectrophotometer and is proportional to the active enzyme concentration. In addition, absorbance measurements at 280 nanometers (nm) can be used to determine the total protein concentration. The active enzyme/total protein ratio gives the enzyme purity.
[0033] As used herein, the term "thermolysin" refers any member of the M4 protease family as described in MEROPS - The Peptidase Data base (See, Rawlings et al., MEROPS: the peptidase database, Nucl Acids Res, 34 Database issue, D270-272 [2006]), of which thermolysin (TLN; EC 3.4.24.27) is the prototype. The amino acid sequence of thermolysin, (EC 3.4.24.27) the neutral metallo endo-peptidase secreted from Bacillus thermoproteolyticus was first reported by Titani et al (Titani et al, (1972), Amino-acid sequence of thermolysin. Nature New Biol. 238:35-37). Subsequently, the gene for this enzyme was cloned by O'Donohue et al (0'Donohue,M.J (1994) Cloning and expression in Bacillus subtilis of the npr gene from Bacillus thermoproteolyticus Rokko coding for the thermostable metalloprotease thermolysin. Biochem. J. 300:599-603) and the sequence set forth as UniProtKB/Swiss- Prot Accession No. P00800. The only differences between the protein sequences reported by Titani et al and O'Donohue et al are the confirmation of Asn at position 37 (instead of Asp) and Gin at position 119 (instead of Glu). As such the terms "thermolysin," "stearolysin", "bacillolysin," "proteinase-T", "PrT", "Thermolysin-like protease", and "TLPs", are used interchangeably herein to refer to the neutral metalloprotease enzyme of Bacillus thermoproteolyticus.
[0034] The terms "amylase" or "amylolytic enzyme" refer to an enzyme that is, among other things, capable of catalyzing the degradation of starch, a-amylases are hydrolases that cleave the a-D-(l→4) O-glycosidic linkages in starch. Generally, a-amylases (EC 3.2.1.1 ; a-D-(l→4)- glucan glucanohydrolase) are defined as endo-acting enzymes cleaving a-D-(l→4) O-glycosidic linkages within the starch molecule in a random fashion yielding polysaccharides containing three or more (l-4)-a-linked D-glucose units. In contrast, the exo-acting amylolytic enzymes, such as β-amylases (EC 3.2.1.2; a-D-(l→4)-glucan maltohydrolase) and some product- specific amylases like maltogenic a-amylase (EC 3.2.1.133) cleave the polysaccharide molecule from the non-reducing end of the substrate, β-amylases, a-glucosidases (EC 3.2.1.20; a-D-glucoside
glucohydrolase), glucoamylase (EC 3.2.1.3; a-D-(l→4)-glucan glucohydrolase), and product- specific amylases like the maltotetraosidases (EC 3.2.1.60) and the maltohexaosidases (EC 3.2.1.98) can produce malto-oligosaccharides of a specific length or enriched syrups of specific maltooligosaccharides.
[0035] "Enzyme units" herein refer to the amount of product formed per time under the specified conditions of the assay. For example, a "glucoamylase activity unit" (GAU) is defined as the amount of enzyme that produces 1 g of glucose per hour from soluble starch substrate (4% DS) at 60°C, pH 4.2. A "soluble starch unit" (SSU) is the amount of enzyme that produces 1 mg of glucose per minute from soluble starch substrate (4% DS) at pH 4.5, 50°C. DS refers to "dry solids."
[0036] The term "starch" refers to any material comprised of the complex polysaccharide carbohydrates of plants, comprised of amylose and amylopectin with the formula (C6H1oOs)x, wherein X can be any number. The term includes plant-based materials such as grains, cereal, grasses, tubers and roots, and more specifically materials obtained from wheat, barley, corn, rye, rice, sorghum, brans, cassava, millet, milo, potato, sweet potato, and tapioca. The term "starch" includes granular starch. The term "granular starch" refers to raw, i.e., uncooked starch, e.g., starch that has not been subject to gelatinization.
[0037] The terms, "wild-type," "parental," or "reference," with respect to a polypeptide, refer to a naturally-occurring polypeptide that does not include a man-made substitution, insertion, or deletion at one or more amino acid positions. Similarly, the terms "wild-type," "parental," or "reference," with respect to a polynucleotide, refer to a naturally-occurring polynucleotide that does not include a man-made nucleoside change. However, note that a polynucleotide encoding a wild-type, parental, or reference polypeptide is not limited to a naturally-occurring
polynucleotide, and encompasses any polynucleotide encoding the wild- type, parental, or reference polypeptide.
[0038] Reference to the wild-type polypeptide is understood to include the mature form of the polypeptide. A "mature" polypeptide or variant, thereof, is one in which a signal sequence is absent, for example, cleaved from an immature form of the polypeptide during or following expression of the polypeptide.
[0039] The term "variant," with respect to a polypeptide, refers to a polypeptide that differs from a specified wild-type, parental, or reference polypeptide in that it includes one or more naturally-occurring or man-made substitutions, insertions, or deletions of an amino acid.
Similarly, the term "variant," with respect to a polynucleotide, refers to a polynucleotide that differs in nucleotide sequence from a specified wild-type, parental, or reference polynucleotide.
The identity of the wild-type, parental, or reference polypeptide or polynucleotide will be apparent from context.
[0040] In the case of the present a-amylases, "activity" refers to a-amylase activity, which can be measured as described, herein.
[0041] The term "recombinant," when used in reference to a subject cell, nucleic acid, protein or vector, indicates that the subject has been modified from its native state. Thus, for example, recombinant cells express genes that are not found within the native (non-recombinant) form of the cell, or express native genes at different levels or under different conditions than found in nature. Recombinant nucleic acids differ from a native sequence by one or more nucleotides and/or are operably linked to heterologous sequences, e.g. , a heterologous promoter in an expression vector. Recombinant proteins may differ from a native sequence by one or more amino acids and/or are fused with heterologous sequences. A vector comprising a nucleic acid encoding an amylase is a recombinant vector.
[0042] The terms "recovered," "isolated," and "separated," refer to a compound, protein
(polypeptides), cell, nucleic acid, amino acid, or other specified material or component that is removed from at least one other material or component with which it is naturally associated as found in nature. An "isolated" polypeptides, thereof, includes, but is not limited to, a culture broth containing secreted polypeptide expressed in a heterologous host cell.
[0043] The term "purified" refers to material (e.g. , an isolated polypeptide or polynucleotide) that is in a relatively pure state, e.g., at least about 90% pure, at least about 95% pure, at least about 98% pure, or even at least about 99% pure.
[0044] The term "enriched" refers to material (e.g., an isolated polypeptide or polynucleotide) that is in about 50% pure, at least about 60% pure, at least about 70% pure, or even at least about 70% pure.
[0045] The terms "thermostable" and "thermostability," with reference to an enzyme, refer to the ability of the enzyme to retain activity after exposure to an elevated temperature. The thermostability of an enzyme, such as an amylase enzyme, is measured by its half-life (t^) given in minutes, hours, or days, during which half the enzyme activity is lost under defined conditions. The half-life may be calculated by measuring residual a-amylase activity following exposure to (i.e. , challenge by) an elevated temperature.
[0046] A "pH range," with reference to an enzyme, refers to the range of pH values under which the enzyme exhibits catalytic activity.
[0047] The terms "pH stable" and "pH stability," with reference to an enzyme, relate to the ability of the enzyme to retain activity over a wide range of pH values for a predetermined period of time (e.g., 15 min., 30 min., 1 hour).
[0048] The term "amino acid sequence" is synonymous with the terms "polypeptide," "protein," and "peptide," and are used interchangeably. Where such amino acid sequences exhibit activity, they may be referred to as an "enzyme." The conventional one-letter or three-letter codes for amino acid residues are used, with amino acid sequences being presented in the standard amino- to-carboxy terminal orientation (i.e., N→C).
[0049] The term "nucleic acid" encompasses DNA, RNA, heteroduplexes, and synthetic molecules capable of encoding a polypeptide. Nucleic acids may be single stranded or double stranded, and may be chemical modifications. The terms "nucleic acid" and "polynucleotide" are used interchangeably. Because the genetic code is degenerate, more than one codon may be used to encode a particular amino acid, and the present compositions and methods encompass nucleotide sequences that encode a particular amino acid sequence. Unless otherwise indicated, nucleic acid sequences are presented in 5'-to-3' orientation.
[0050] "Hybridization" refers to the process by which one strand of nucleic acid forms a duplex with, i.e., base pairs with, a complementary strand, as occurs during blot hybridization techniques and PCR techniques. Stringent hybridization conditions are exemplified by hybridization under the following conditions: 65°C and 0.1X SSC (where IX SSC = 0.15 M NaCl, 0.015 M Na3 citrate, pH 7.0). Hybridized, duplex nucleic acids are characterized by a melting temperature (Tm), where one half of the hybridized nucleic acids are unpaired with the complementary strand. Mismatched nucleotides within the duplex lower the Tm.
[0051] A "synthetic" molecule is produced by in vitro chemical or enzymatic synthesis rather than by an organism.
[0052] The terms "transformed," "stably transformed," and "transgenic," used with reference to a cell means that the cell contains a non-native (e.g., heterologous) nucleic acid sequence integrated into its genome or carried as an episome that is maintained through multiple generations. The non-native sequence may be endogenous seqeunce.
[0053] The term "introduced" in the context of inserting a nucleic acid sequence into a cell, means "transfection", "transformation" or "transduction," as known in the art.
[0054] A "host strain" or "host cell" is an organism into which an expression vector, phage, virus, or other DNA construct, including a polynucleotide encoding a polypeptide of interest (e.g., an amylase) has been introduced. Exemplary host strains are microorganism cells (e.g.,
bacteria, filamentous fungi, and yeast) capable of expressing the polypeptide of interest and/or fermenting saccharides. The term "host cell" includes protoplasts created from cells.
[0055] The term "heterologous" with reference to a polynucleotide or protein refers to a polynucleotide or protein that does not naturally occur in a host cell.
[0056] The term "endogenous" with reference to a polynucleotide or protein refers to a polynucleotide or protein that occurs naturally in the host cell.
[0057] The term "expression" refers to the process by which a polypeptide is produced based on a nucleic acid sequence. The process includes both transcription and translation.
[0058] A "selective marker" or "selectable marker" refers to a gene capable of being expressed in a host to facilitate selection of host cells carrying the gene. Examples of selectable markers include but are not limited to antimicrobials (e.g. , hygromycin, bleomycin, or chloramphenicol) and/or genes that confer a metabolic advantage, such as a nutritional advantage on the host cell.
[0059] A "vector" refers to a polynucleotide sequence designed to introduce nucleic acids into one or more cell types. Vectors include cloning vectors, expression vectors, shuttle vectors, plasmids, phage particles, cassettes and the like.
[0060] An "expression vector" refers to a DNA construct comprising a DNA sequence encoding a polypeptide of interest, which coding sequence is operably linked to a suitable control sequence capable of effecting expression of the DNA in a suitable host. Such control sequences may include a promoter to effect transcription, an optional operator sequence to control transcription, a sequence encoding suitable ribosome binding sites on the mRNA, enhancers and sequences which control termination of transcription and translation.
[0061] The term "operably linked" means that specified components are in a relationship (including but not limited to juxtaposition) permitting them to function in an intended manner. For example, a regulatory sequence is operably linked to a coding sequence such that expression of the coding sequence is under control of the regulatory sequences.
[0062] A "signal sequence" is a sequence of amino acids attached to the N-terminal portion of a protein, which facilitates the secretion of the protein outside the cell. The mature form of an extracellular protein lacks the signal sequence, which is cleaved off during the secretion process.
[0063] "Biologically active" refer to a sequence having a specified biological activity, such an enzymatic activity.
[0064] The term "specific activity" refers to the number of moles of substrate that can be converted to product by an enzyme or enzyme preparation per unit time under specific conditions. Specific activity is generally expressed as units (U)/mg of protein.
[0065] As used herein, "water hardness" is a measure of the minerals (e.g. , calcium and magnesium) present in water.
[0066] As used herein, an "effective amount of amylase," or similar expressions, refers to an amount of amylase sufficient to produce a visible, or otherwise measurable amount of starch hydrolysis in an particular application. Starch hydrolysis may result in, e.g. , a visible cleaning of fabrics or dishware, reduced viscosity of a starch slurry or mash, and the like.
[0067] A "swatch" is a piece of material such as a fabric that has a stain applied thereto. The material can be, for example, fabrics made of cotton, polyester or mixtures of natural and synthetic fibers. The swatch can further be paper, such as filter paper or nitrocellulose, or a piece of a hard material such as ceramic, metal, or glass. For amylases, the stain is starch based, but can include blood, milk, ink, grass, tea, wine, spinach, gravy, chocolate, egg, cheese, clay, pigment, oil, or mixtures of these compounds.
[0068] A "smaller swatch" is a section of the swatch that has been cut with a single hole punch device, or has been cut with a custom manufactured 96-hole punch device, where the pattern of the multi-hole punch is matched to standard 96- well microtiter plates, or the section has been otherwise removed from the swatch. The swatch can be of textile, paper, metal, or other suitable material. The smaller swatch can have the stain affixed either before or after it is placed into the well of a 24-, 48- or 96-well microtiter plate. The smaller swatch can also be made by applying a stain to a small piece of material. For example, the smaller swatch can be a stained piece of fabric 5/8" or 0.25" in diameter. The custom manufactured punch is designed in such a manner that it delivers 96 swatches simultaneously to all wells of a 96-well plate. The device allows delivery of more than one swatch per well by simply loading the same 96-well plate multiple times. Multi-hole punch devices can be conceived of to deliver simultaneously swatches to any format plate, including but not limited to 24-well, 48-well, and 96-well plates. In another conceivable method, the soiled test platform can be a bead made of metal, plastic, glass, ceramic, or another suitable material that is coated with the soil substrate. The one or more coated beads are then placed into wells of 96-, 48-, or 24-well plates or larger formats, containing suitable buffer and enzyme.
[0069] "A cultured cell material comprising an amylase" or similar language, refers to a cell lysate or supernatant (including media) that includes an amylase as a component. The cell material may be from a heterologous host that is grown in culture for the purpose of producing the amylase.
[0070] "Percent sequence identity" means that a particular sequence has at least a certain percentage of amino acid residues identical to those in a specified reference sequence, when
aligned using the CLUSTAL W algorithm with default parameters. See Thompson et al. (1994) Nucleic Acids Res. 22:4673-4680. Default parameters for the CLUSTAL W algorithm are: Gap opening penalty: 10.0; Gap extension penalty: 0.05; Protein weight matrix: BLOSUM series; DNA weight matrix: IUB; Delay divergent sequences %:40; Gap separation distance: 8; DNA transitions weight: 0.50; List hydrophilic residues: G, P, S, N, D, Q, E, K, R; Use negative matrix: OFF; Toggle Residue specific penalties: ON; Toggle hydrophilic penalties: ON; Toggle end gap separation penalty OFF.
[0071] Deletions are counted as non-identical residues, compared to a reference sequence. Deletions occurring at either terminus are included. For example, a variant 500-amino acid residue polypeptide with a deletion of five amino acid residues from the C-terminus would have a percent sequence identity of 99% (495/500 identical residues x 100) relative to the parent polypeptide. Such a variant would be encompassed by the language, "a variant having at least 99% sequence identity to the parent."
[0072] "Fused" polypeptide sequences are connected, i.e., operably linked, via a peptide bond between two subject polypeptide sequences.
[0073] The term "filamentous fungi" refers to all filamentous forms of the subdivision
Eumycotina, particulary species within Pezizomycotina subdivision.
[0074] The term "degree of polymerization" (DP) refers to the number (n) of anhydro- glucopyranose units in a given saccharide. Examples of DPI are the monosaccharides glucose and fructose. Examples of DP2 are the disaccharides maltose and sucrose. The term "DE," or
"dextrose equivalent," is defined as the percentage of reducing sugar, i.e., D-glucose, as a fraction of total carbohydrate in a syrup.
[0075] The term "dry solids content" (ds) refers to the total solids of a slurry in a dry weight percent basis. The term "slurry" refers to an aqueous mixture containing insoluble solids.
[0076] The phrase "simultaneous saccharification and fermentation (SSF)" refers to a process in the production of biochemicals in which a microbial organism, such as an ethanologenic microorganism, and at least one enzyme, such as an amylase, are present during the same process step. SSF includes the contemporaneous hydrolysis of starch substrates (granular, liquefied, or solubilized) to saccharides, including glucose, and the fermentation of the saccharides into alcohol or other biochemical or biomaterial in the same reactor vessel.
[0077] An "ethanologenic or fermenting microorganism" refers to a microorganism with the ability to convert a sugar or oligosaccharide to ethanol.
[0078] The term "fermented beverage" refers to any beverage produced by a method comprising a fermentation process, such as a microbial fermentation, e.g., a bacterial and/or fungal
fermentation. "Beer" is an example of such a fermented beverage, and the term "beer" is meant to comprise any fermented wort produced by fermentation/brewing of a starch-containing plant material. Often, beer is produced exclusively from malt or adjunct, or any combination of malt and adjunct.
[0079] The term "malt" refers to any malted cereal grain, such as malted barley or wheat.
[0080] The term "adjunct" refers to any starch and/or sugar containing plant material that is not malt, such as barley or wheat malt. Examples of adjuncts include common corn grits, refined corn grits, brewer's milled yeast, rice, sorghum, refined corn starch, barley, barley starch, dehusked barley, wheat, wheat starch, torrified cereal, cereal flakes, rye, oats, potato, tapioca, cassava and syrups, such as corn syrup, sugar cane syrup, inverted sugar syrup, barley and/or wheat syrups, and the like.
[0081] The term "mash" refers to aqueous slurry of any starch and/or sugar containing plant material, such as grist, e.g., comprising crushed barley malt, crushed barley, and/or other adjunct or a combination thereof, mixed with water later to be separated into wort and spent grains.
[0082] The term "wort" refers to the unfermented liquor run-off following extracting the grist during mashing.
[0083] "Iodine-positive starch" or "IPS" refers to (1) amylose that is not hydrolyzed after liquefaction and saccharification, or (2) a retrograded starch polymer. When saccharified starch or saccharide liquor is tested with iodine, the high DPn amylose or the retrograded starch polymer binds iodine and produces a characteristic blue color. The saccharide liquor is thus termed "iodine-positive saccharide," "blue saccharide," or "blue sac."
[0084] The terms "retrograded starch" or "starch retro gradation" refer to changes that occur spontaneously in a starch paste or gel on ageing.
[0085] The term "about" refers to + 15% to the referenced value.
2. Enzymes of the Invention
Proteases
[0086] Proteases are currently classified into six broad groups: Serine proteases, Threonine proteases, Cysteine proteases, Aspartate proteases, Glutamic proteases, Metallopro teases. The mechanism used to cleave a peptide bond involves making an amino acid residue that has the cysteine and threonine (proteases) or a water molecule (aspartic acid, metallo- and glutamic acid proteases) nucleophilic so that it can attack the peptide carboxyl group. One way to make a nucleophile is by a catalytic triad, where a histidine residue is used to activate serine, cysteine, or threonine as a nucleophile.
[0087] Proteases of the invention may be wild type proteases or a variant thereof. Any suitable
protease may be adapted to perform in the methods of the invention.
[0088] In another aspect of the invention, the protease is a metallopro tease. In another aspect, the metalloprotease is a thermolysin or Proteinase T. In another aspect, the protease is a variant thermolysin with one or more substitutions. In another aspect, the protease is NprE. In another aspect, the protease is an NprE varaint with one or more substitutions. These substitutions of thermolysin and/or NprE are disclosed in various patent applications, for example, WO
2007/044993, WO 2009/058679, WO 2009/058661, WO 2009/058518, WO 2009/058303, and US provisional application 61/722,660 filed on 05 November 2012, all of which are herein incorporated by reference in their entirety.
[0089] In some embodiments, the present enzymes have a defined degree of amino acid sequence identity to other enzymes, for example, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or even at least 99%, amino acid sequence identity. In some embodiments, the present enzymes are derived from a parental enzyme having a defined degree of amino acid sequence identity, for example, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or even at least 99%, amino acid sequence identity.
[0090] In some embodiments, the present enzymes comprise conservative substitution of one or several amino acid residues relative to the amino acid sequence of a parent enzyme. Exemplary conservative amino acid substitutions are listed in the Table 1. Some conservative mutations can be produced by genetic manpulation, while others are produced by introducing synthetic amino acids into a polypeptide other means. Table 1. Conservative amino acid substitutions
[0091] In some embodiments, the present enzymes comprises a deletion, substitution, insertion, or addition of one or a few amino acid residues. In some embodiments, the present enzymes are derived from the amino acid sequence of the parent enzyme by conservative substitution of one or several amino acid residues. In some embodiments, the present enzymes are derived from the amino acid sequence of the parent enzyme by deletion, substitution, insertion, or addition of one or a few amino acid residues. In all cases, the expression "one or a few amino acid residues" refers to 10 or less, i.e., 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10, amino acid residues.
[0092] In some embodiments, the present enzymes are encoded by a nucleic acid that hybridizes under stringent conditions to a nucleic acid sequence that is complementary to a nucleic acid that encodes the parent enzyme.
[0093] The present enzymes may be "precursor," "immature," or "full-length," in which case they include a signal sequence, or "mature," in which case they lack a signal sequence. Mature forms of the polypeptides are generally the most useful. Unless otherwise noted, the amino acid residue numbering used herein refers to the mature forms of the respective amylase
polypeptides. The present amylase polypeptides may also be truncated to remove the N or C- termini, so long as the resulting polypeptides retain enzyme activity.
[0094] The present enzyme may be a "chimeric" or "hybrid" polypeptide, in that it includes at least a portion of a first enzyme polypeptide, and at least a portion of a second enzyme polypeptide (such chimeric enzymes have recently been "rediscovered" as domain-swap enzymes). The present enzymes may further include heterologous signal sequence, an epitope to allow tracking or purification, or the like. Exemplary heterologous signal sequences are from B. licheniformis amylase (LAT), B. subtilis (AmyE or AprE), and Streptomyces CelA.
[0095] In another aspect, nucleic acids encoding an enzyme polypeptide is provided. The nucleic acid may encode the enzyme having the amino acid sequence having a specified degree of amino acid sequence identity. In some embodiments, the nucleic acid encodes an enzyme having at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least
93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or even at least 99%, amino acid sequence identity to a parental enzyme. In some embodiments, the nucleic acid has at least 80%, at least 85%, at least 90%, at least 95%, or even at least 98% nucleotide sequence identity to parental enzyme.
[0096] In some embodiments, the present compositions and methods include nucleic acids that encode an enzyme having deletions, insertions, or substitutions, such as those mentioned, above. It will be appreciated that due to the degeneracy of the genetic code, a plurality of nucleic acids may encode the same polypeptide.
[0097] In another example, the nucleic acid hybridizes under stringent or very stringent conditions to a nucleic acid complementary to a nucleic acid encoding an enzyme having at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or even at least 99%, amino acid sequence identity to a parent enzyme. In some embodiments, the nucleic acid hybridizes under stringent or very stringent conditions to a nucleic acid complementary to a nucleic acid having the sequence of a parent enzyme. Such hybridization conditions are described herein but are also well known in the art.
[0098] Nucleic acids may encode a "full-length" ("fl" or "FL") amylase, which includes a signal sequence, only the mature form of an enzyme, which lacks the signal sequence, or a truncated form of an enzyme, which lacks the N or C-terminus of the mature form. Preferrably, the nucleic acids are of sufficient length to encode an active enzyme.
[0099] A nucleic acid that encodes an enzyme can be operably linked to various promoters and regulators in a vector suitable for expressing the enzyme in host cells. Exemplary promoters are from B. licheniformis amylase (LAT), B. subtilis (AmyE or AprE), and Streptomyces CelA. Such a nucleic acid can also be linked to other coding sequences, e.g., to encode a chimeric polypeptide.
3. Production of Enzymes of the Invention
[00100] The present enzymes can be produced in host cells, for example, by secretion or intracellular expression. A cultured cell material {e.g., a whole-cell broth) comprising an enzyme can be obtained following secretion of the enzyme into the cell medium. Optionally, the enzyme can be isolated from the host cells, or even isolated from the cell broth, depending on the desired purity of the final enzyme. A gene encoding an enzyme can be cloned and expressed according to methods well known in the art. Suitable host cells include bacterial, fungal (including yeast and filamentous fungi), and plant cells (including algae). Particularly useful
host cells include Aspergillus niger, Aspergillus oryzae or Trichoderma reesei. Other host cells include bacterial cells, e.g., Bacillus subtilis or B. licheniformis, as well as Streptomyces.
[00101] The host cell further may express a nucleic acid encoding a homologous or heterologous glucoamylase, i.e., a glucoamylase that is not the same species as the host cell, or one or more other enzymes. The glucoamylase may be a variant glucoamylase, such as one of the glucoamylase variants disclosed in U.S. Patent No. 8,058,033 (Danisco US Inc.), for example. Additionally, the host may express one or more accessory enzymes, proteins, peptides. These may benefit liquefaction, saccharification, fermentation, SSF, etc., processes. Furthermore, the host cell may produce biochemicals in addition to enzymes used to digest the various feedstock(s). Such host cells may be useful for fermentation or simultaneous saccharification and fermentation processes to reduce or eliminate the need to add enzymes.
3.1. Vectors
[00102] A DNA construct comprising a nucleic acid encoding an enzyme can be constructed to be expressed in a host cell. Because of the well-known degeneracy in the genetic code, different polynucleotides that encode an identical amino acid sequence can be designed and made with routine skill. It is also well-known in the art to optimize codon use for a particular host cell. Nucleic acids encoding enzymes can be incorporated into a vector. Vectors can be transferred to a host cell using well-known transformation techniques, such as those disclosed below.
[00103] The vector may be any vector that can be transformed into and replicated within a host cell. For example, a vector comprising a nucleic acid encoding an enzyme can be transformed and replicated in a bacterial host cell as a means of propagating and amplifying the vector. The vector also may be transformed into an expression host, so that the encoding nucleic acids can be expressed as a functional enzyme. Host cells that serve as expression hosts can include filamentous fungi, for example. The Fungal Genetics Stock Center (FGSC) Catalogue of Strains lists suitable vectors for expression in fungal host cells. See FGSC, Catalogue of Strains, University of Missouri, at www.fgsc.net (last modified January 17, 2007). A
representative vector is pJG153, a promoterless Cre expression vector that can be replicated in a bacterial host. See Harrison et al. (2011) Applied Environ. Microbiol. 77:3916-22. pJG153 can be modified with routine skill to comprise and express a nucleic acid encoding an enzyme variant.
[00104] A nucleic acid encoding an enzyme can be operably linked to a suitable promoter, which allows transcription in the host cell. The promoter may be any DNA sequence that shows transcriptional activity in the host cell of choice and may be derived from genes
encoding proteins either homologous or heterologous to the host cell. Exemplary promoters for directing the transcription of the DNA sequence encoding an enzyme, especially in a bacterial host, are the promoter of the lac operon of E. coli, the Streptomyces coelicolor agarase gene dag A or celA promoters, the promoters of the Bacillus licheniformis a-amylase gene (amyL), the promoters of the Bacillus stearothermophilus maltogenic amylase gene (amyM), the promoters of the Bacillus amyloliquefaciens α-amylase (amyQ), the promoters of the Bacillus subtilis xylA and xylB genes etc. For transcription in a fungal host, examples of useful promoters are those derived from the gene encoding Aspergillus oryzae TAKA amylase, Rhizomucor miehei aspartic proteinase, Aspergillus niger neutral a-amylase, A. niger acid stable a-amylase, A. niger glucoamylase, Rhizomucor miehei lipase, A. oryzae alkaline protease, A. oryzae triose phosphate isomerase, or A. nidulans acetamidase. When a gene encoding an enzyme is expressed in a bacterial species such as E. coli, a suitable promoter can be selected, for example, from a bacteriophage promoter including a T7 promoter and a phage lambda promoter. Examples of suitable promoters for the expression in a yeast species include but are not limited to the Gal 1 and Gal 10 promoters of Saccharomyces cerevisiae and the Pichia pastoris AOXl or AOX2 promoters, cbhl is an endogenous, inducible promoter from T. reesei. See Liu et al. (2008) "Improved heterologous gene expression in Trichoderma reesei by cellobiohydrolase I gene (cbhl) promoter optimization," Acta Biochim. Biophys. Sin (Shanghai) 40(2): 158-65.
[00105] The coding sequence can be operably linked to a signal sequence. The DNA encoding the signal sequence may be the DNA sequence naturally associated with the enzyme gene to be expressed or from a different Genus or species. A signal sequence and a promoter sequence comprising a DNA construct or vector can be introduced into a fungal host cell and can be derived from the same source. For example, the signal sequence is the cbhl signal sequence that is operably linked to a cbhl promoter.
[00106] An expression vector may also comprise a suitable transcription terminator and, in eukaryotes, polyadenylation sequences operably linked to the DNA sequence encoding an enzyme. Termination and polyadenylation sequences may suitably be derived from the same sources as the promoter.
[00107] The vector may further comprise a DNA sequence enabling the vector to replicate in the host cell. Examples of such sequences are the origins of replication of plasmids pUC19, pACYClW, pUBHO, pE194, pAMBl, and pIJ702.
[00108] The vector may also comprise a selectable marker, e.g., a gene the product of which complements a defect in the isolated host cell, such as the dal genes from B. subtilis or B.
licheniformis, or a gene that confers antibiotic resistance such as, e.g., ampicillin, kanamycin, chloramphenicol or tetracycline resistance. Furthermore, the vector may comprise Aspergillus selection markers such as amdS, argB, niaD and xxsC, a marker giving rise to hygromycin resistance, or the selection may be accomplished by co-transformation, such as known in the art. See e.g., International PCT Application WO 91/17243.
[00109] Intracellular expression may be advantageous in some respects, e.g., when using certain bacteria or fungi as host cells to produce large amounts of enzyme for subsequent enrichment or purification. Extracellular secretion of enzyme into the culture medium can also be used to make a cultured cell material comprising the isolated enzyme.
[00110] The expression vector typically includes the components of a cloning vector, such as, for example, an element that permits autonomous replication of the vector in the selected host organism and one or more phenotypically detectable markers for selection purposes. The expression vector normally comprises control nucleotide sequences such as a promoter, operator, ribosome binding site, translation initiation signal and optionally, a repressor gene or one or more activator genes. Additionally, the expression vector may comprise a sequence coding for an amino acid sequence capable of targeting the enzyme to a host cell organelle such as a peroxisome, or to a particular host cell compartment. Such a targeting sequence includes but is not limited to the sequence, SKL. For expression under the direction of control sequences, the nucleic acid sequence of the enzyme is operably linked to the control sequences in proper manner with respect to expression.
[00111] The procedures used to ligate the DNA construct encoding an enzyme, the promoter, terminator and other elements, respectively, and to insert them into suitable vectors containing the information necessary for replication, are well known to persons skilled in the art (see, e.g., Sambrook et al, MOLECULAR CLONING: A LABORATORY MANUAL, 2nd ed., Cold Spring Harbor, 1989, and 3rd ed., 2001).
3.2. Transformation and Culture of Host Cells
[00112] An isolated cell, either comprising a DNA construct or an expression vector, is advantageously used as a host cell in the recombinant production of an enzyme. The cell may be transformed with the DNA construct encoding the enzyme, conveniently by integrating the DNA construct (in one or more copies) in the host chromosome. This integration is generally considered to be an advantage, as the DNA sequence is more likely to be stably maintained in the cell. Integration of the DNA constructs into the host chromosome may be performed according to conventional methods, e.g., by homologous or heterologous recombination.
Alternatively, the cell may be transformed with an expression vector as described above in connection with the different types of host cells.
[00113] Examples of suitable bacterial host organisms are Gram positive bacterial species such as Bacillaceae including Bacillus subtilis, Bacillus licheniformis, Bacillus lentus, Bacillus brevis, Geobacillus (formerly Bacillus) stearothermophilus, Bacillus alkalophilus, Bacillus amyloliquefaciens, Bacillus coagulans, Bacillus lautus, Bacillus megaterium, and Bacillus thuringiensis; Streptomyces species such as Streptomyces murinus; lactic acid bacterial species including Lactococcus sp. such as Lactococcus lactis; Lactobacillus sp. including Lactobacillus reuteri; Leuconostoc sp.; Pediococcus sp.; and Streptococcus sp. Alternatively, strains of a Gram negative bacterial species belonging to Enterobacteriaceae including E. coli, or to Pseudomonadaceae can be selected as the host organism.
[00114] A suitable yeast host organism can be selected from the biotechnologically relevant yeasts species such as but not limited to yeast species such as Pichia sp., Hansenula sp., or Kluyveromyces, Yarrowinia, Schizosaccharomyces species or a species of Saccharomyces, including Saccharomyces cerevisiae or a species belonging to Schizosaccharomyces such as, for example, S. pombe species. A strain of the methylotrophic yeast species, Pichia pastoris, can be used as the host organism. Alternatively, the host organism can be a Hansenula species.
Suitable host organisms among filamentous fungi include species of Aspergillus, e.g.,
Aspergillus niger, Aspergillus oryzae, Aspergillus tubigensis, Aspergillus awamori, or
Aspergillus nidulans. Alternatively, strains of a Fusarium species, e.g., Fusarium oxysporum or of a Rhizomucor species such as Rhizomucor miehei can be used as the host organism. Other suitable strains include Thermomyces and Mucor species. In addition, Trichoderma sp., such as T. reesei can be used as a host. A suitable procedure for transformation of Aspergillus host cells includes, for example, that described in EP 238023. An enzyme expressed by a fungal host cell can be glycosylated, i.e., will comprise a glycosyl moiety. The glycosylation pattern can be the same or different as present in the wild-type enzyme. The type and/or degree of glycosylation may impart changes in enzymatic and/or biochemical properties.
[00115] It may be advantageous to delete genes from expression hosts, where the gene deficiency may be cured by the transformed expression vector. Known methods may be used to obtain a fungal host cell having one or more inactivated genes. Gene inactivation may be accomplished by complete or partial deletion, by insertional inactivation or by any other means that renders a gene nonfunctional for its intended purpose, such that the gene is prevented from expression of a functional protein. Any gene from a Trichoderma sp. or other filamentous fungal host that has been cloned can be deleted, for example, cbhl, cbh2, egll, and egl2 genes.
Gene deletion may be accomplished by inserting a form of the desired gene to be inactivated into a plasmid by methods known in the art.
[00116] Introduction of a DNA construct or vector into a host cell includes techniques such as transformation; electroporation; nuclear microinjection; transduction; transfection, e.g., lipofection mediated and DEAE-Dextrin mediated transfection; incubation with calcium phosphate DNA precipitate; high velocity bombardment with DNA-coated microprojectiles; and protoplast fusion. General transformation techniques are known in the art. See, e.g., Sambrook et al. (2001), supra. The expression of heterologous protein in Trichoderma is described, for example, in U.S. Patent No. 6,022,725. Reference is also made to Cao et al. (2000) Science 9:991-1001 for transformation of Aspergillus strains. Genetically stable transformants can be constructed with vector systems whereby the nucleic acid encoding an enzyme is stably integrated into a host cell chromosome. Transformants are then selected and purified by known techniques.
[00117] The preparation of Trichoderma sp. for transformation, for example, may involve the preparation of protoplasts from fungal mycelia. See Campbell et al. (1989) Curr. Genet. 16: 53-56. The mycelia can be obtained from germinated vegetative spores. The mycelia are treated with an enzyme that digests the cell wall, resulting in protoplasts. The protoplasts are protected by the presence of an osmotic stabilizer in the suspending medium. These stabilizers include sorbitol, mannitol, potassium chloride, magnesium sulfate, and the like. Usually the concentration of these stabilizers varies between 0.8 M and 1.2 M, e.g., a 1.2 M solution of sorbitol can be used in the suspension medium.
[00118] Uptake of DNA into the host Trichoderma sp. strain depends upon the calcium ion concentration. Generally, between about 10-50 mM CaCl2 is used in an uptake solution. Additional suitable compounds include a buffering system, such as TE buffer (10 mM Tris, pH 7.4; 1 mM EDTA) or 10 mM MOPS, pH 6.0 and polyethylene glycol. The polyethylene glycol is believed to fuse the cell membranes, thus permitting the contents of the medium to be delivered into the cytoplasm of the Trichoderma sp. strain. This fusion frequently leaves multiple copies of the plasmid DNA integrated into the host chromosome.
[00119] Usually transformation of Trichoderma sp. uses protoplasts or cells that have been subjected to a permeability treatment, typically at a density of 10 5 to 107 /mL, particularly 2xl06/mL. A volume of 100
of these protoplasts or cells in an appropriate solution {e.g., 1.2 M sorbitol and 50 mM CaCl2) may be mixed with the desired DNA. Generally, a high concentration of PEG is added to the uptake solution. From 0.1 to 1 volume of 25% PEG 4000 can be added to the protoplast suspension; however, it is useful to add about 0.25 volumes to the
protoplast suspension. Additives, such as dimethyl sulfoxide, heparin, spermidine, potassium chloride and the like, may also be added to the uptake solution to facilitate transformation.
Similar procedures are available for other fungal host cells. See, e.g., U.S. Patent No. 6,022,725.
3.3. Expression [00120] A method of producing an enzyme may comprise cultivating a host cell as described above under conditions conducive to the production of the enzyme and recovering the enzyme from the cells and/or culture medium.
[00121] The medium used to cultivate the cells may be any conventional medium suitable for growing the host cell in question and obtaining expression of an enzyme. Suitable media and media components are available from commercial suppliers or may be prepared according to published recipes (e.g., as described in catalogues of the American Type Culture Collection).
[00122] An enzyme secreted from the host cells can be used in a whole broth preparation.
In the present methods, the preparation of a spent whole fermentation broth of a recombinant microorganism can be achieved using any cultivation method known in the art resulting in the expression of an enzyme. Fermentation may, therefore, be understood as comprising shake flask cultivation, small- or large-scale fermentation (including continuous, batch, fed-batch, or solid state fermentations) in laboratory or industrial fermenters performed in a suitable medium and under conditions allowing the enzyme to be expressed or isolated. The term "spent whole fermentation broth" is defined herein as unfractionated contents of fermentation material that includes culture medium, extracellular proteins (e.g., enzymes), and cellular biomass. It is understood that the term "spent whole fermentation broth" also encompasses cellular biomass that has been lysed or permeabilized using methods well known in the art.
[00123] An enzyme secreted from the host cells may conveniently be recovered from the culture medium by well-known procedures, including separating the cells from the medium by centrifugation or filtration, and precipitating proteinaceous components of the medium by means of a salt such as ammonium sulfate, followed by the use of chromatographic procedures such as ion exchange chromatography, affinity chromatography, or the like.
[00124] The polynucleotide encoding an enzyme in a vector can be operably linked to a control sequence that is capable of providing for the expression of the coding sequence by the host cell, i.e. the vector is an expression vector. The control sequences may be modified, for example by the addition of further transcriptional regulatory elements to make the level of transcription directed by the control sequences more responsive to transcriptional modulators. The control sequences may in particular comprise promoters.
[00125] Host cells may be cultured under suitable conditions that allow expression of an enzyme. Expression of the enzymes may be constitutive such that they are continually produced, or inducible, requiring a stimulus to initiate expression. In the case of inducible expression, protein production can be initiated when required by, for example, addition of an inducer substance to the culture medium, for example dexamethasone or IPTG or Sophorose. Polypeptides can also be produced recombinantly in an in vitro cell-free system, such as the TNT™ (Promega) rabbit reticulocyte system.
[00126] An expression host also can be cultured in the appropriate medium for the host, under aerobic conditions. Shaking or a combination of agitation and aeration can be provided, with production occurring at the appropriate temperature for that host, e.g., from about 25°C to about 75°C (e.g., 30°C to 45°C), depending on the needs of the host and production of the desired enzyme. Culturing can occur from about 12 to about 100 hours or greater (and any hour value there between, e.g., from 24 to 72 hours). Typically, the culture broth is at a pH of about 4.0 to about 8.0, again depending on the culture conditions needed for the host relative to production of an enzyme.
3.4. Identification of Enzyme Activity
[00127] To evaluate the expression of an enzyme in a host cell, assays can measure the expressed protein, corresponding mRNA, or enzyme activity. For example, suitable assays include Northern blotting, reverse transcriptase polymerase chain reaction, and in situ hybridization, using an appropriately labeled hybridizing probe. Suitable assays also include measuring enzyme activity in a sample, for example, by assays directly measuring products in the culture media. For example, glucose concentration may be determined using glucose reagent kit No. 15-UV (Sigma Chemical Co.) or an instrument, such as Technicon Autoanalyzer.
a- Amylase activity also may be measured by any known method, such as the PAHBAH or ABTS assays, described below. Assays are also known in the art to measure other enzyme activities.
3.5. Methods for Enriching and Purifying Enzymes of the Invention
[00128] Fermentation, separation, and concentration techniques are well known in the art and conventional methods can be used in order to prepare a concentrated enzyme polypeptide- containing solution.
[00129] After fermentation, a fermentation broth is obtained, the microbial cells and various suspended solids, including residual raw fermentation materials, are removed by conventional separation techniques in order to obtain an enzyme solution. Filtration,
centrifugation, microfiltration, rotary vacuum drum filtration, ultrafiltration, centrifugation followed by ultra-filtration, extraction, or chromatography, or the like, are generally used.
[00130] It is desirable to concentrate an enzyme polypeptide-containing solution in order to optimize recovery. Use of unconcentrated solutions requires increased incubation time in order to collect the enriched or purified enzyme precipitate.
[00131] The enzyme containing solution is concentrated using conventional concentration techniques until the desired enzyme level is obtained. Concentration of the enzyme containing solution may be achieved by any of the techniques discussed herein. Exemplary methods of enrichment and purification include but are not limited to rotary vacuum filtration and/or ultrafiltration.
[00132] The enzyme solution is concentrated into a concentrated enzyme solution until the enzyme activity of the concentrated enzyme polypeptide-containing solution is at a desired level.
[00133] During fermentation, an enzyme polypeptide accumulates in the culture broth. For the isolation, enrichment, or purification of the desired enzyme, the culture broth is centrifuged or filtered to eliminate cells, and the resulting cell-free liquid is used for enzyme enrichment or purification. In one embodiment, the cell-free broth is subjected to salting out using ammonium sulfate at about 70% saturation; the 70% saturation-precipitation fraction is then dissolved in a buffer and applied to a column such as a Sephadex G-100 column, and eluted to recover the enzyme-active fraction. For further enrichment or purification, a conventional procedure such as ion exchange or affinity chromatography may be used.
[00134] For production scale recovery, enzyme polypeptides can be enriched or partially purified as generally described above by removing cells via flocculation with polymers.
Alternatively, the enzyme can be enriched or purified by microfiltration followed by
concentration by ultrafiltration using available membranes and equipment. However, for some applications, the enzyme does not need to be enriched or purified, and whole broth culture can be lysed and used without further treatment. The enzyme can then be processed, for example, into granules.
4. Compositions and Uses of Proteases
[00135] The present proteases are useful for a variety of industrial applications. For example, proteases are useful in a starch conversion process, particularly in a saccharification process of a starch that has undergone liquefaction. The desired end-product may be any product that may be produced by the enzymatic conversion of the starch substrate. For example, the desired product may be a syrup rich in glucose and maltose, which can be used in other
processes, such as the preparation of HFCS, or which can be converted into a number of other useful products, such as ascorbic acid intermediates (e.g. , gluconate; 2-keto-L-gulonic acid; 5- keto-gluconate; and 2,5-diketogluconate); ethanol, butanol, 1,3-propanediol; aromatic amino acids (e.g. , tyrosine, phenylalanine and tryptophan); organic acids (e.g. , lactate, pyruvate, succinate, citrate, isocitrate, gluconic acid, and oxaloacetate); amino acids (e.g. , serine, lysine, glutamic acid, and glycine); antibiotics; antimicrobials; enzymes; vitamins; and hormones.
[00136] The starch conversion process may be a precursor to, or simultaneous with, a fermentation process designed to produce alcohol for fuel or drinking (i.e. , potable alcohol). One skilled in the art is aware of various fermentation conditions that may be used in the production of these end-products. Proteases are also useful in compositions and methods of food preparation. These various uses of proteases are described in more detail below.
4.1. Preparation of Starch Substrates
[00137] Those of general skill in the art are well aware of available methods that may be used to prepare starch substrates for use in the processes disclosed herein. For example, a useful starch substrate may be obtained from tubers, roots, stems, legumes, cereals or whole grain. More specifically, the granular starch may be obtained from corn, cobs, wheat, barley, rye, triticale, milo, sago, millet, cassava, tapioca, sorghum, rice, peas, bean, banana, or potatoes. Corn contains about 60-68% starch; barley contains about 55-65% starch; millet contains about 75-80% starch; wheat contains about 60-65% starch; and polished rice contains 70-72% starch. Specifically contemplated starch substrates are corn starch and wheat starch. The starch from a grain may be ground or whole and includes corn solids, such as kernels, bran and/or cobs. The starch may also be highly refined raw starch or feedstock from starch refinery processes.
Various starches also are commercially available. For example, corn starch is available from Cerestar, Sigma, and Katayama Chemical Industry Co. (Japan); wheat starch is available from Sigma; sweet potato starch is available from Wako Pure Chemical Industry Co. (Japan); and potato starch is available from Nakaari Chemical Pharmaceutical Co. (Japan).
[00138] The starch substrate can be a crude starch from milled whole grain, which contains non-starch fractions, e.g., germ residues and fibers. Milling may comprise either wet milling or dry milling or grinding. In wet milling, whole grain is soaked in water or dilute acid to separate the grain into its component parts, e.g., starch, protein, germ, oil, kernel fibers. Wet milling efficiently separates the germ and meal (i.e., starch granules and protein) and is especially suitable for production of syrups. In dry milling or grinding, whole kernels are ground into a fine powder and often processed without fractionating the grain into its component parts. In some cases, oils from the kernels are recovered. Dry ground grain thus will comprise
significant amounts of non-starch carbohydrate compounds, in addition to starch. Dry grinding of the starch substrate can be used for production of ethanol and other biochemicals. The starch to be processed may be a highly refined starch quality, for example, at least 90%, at least 95%, at least 97%, or at least 99.5% pure. 4.2. Gelatinization and Liquefaction of Starch
[00139] As used herein, the term "liquefaction" or "liquefy" means a process by which starch is converted to less viscous and shorter chain dextrins. Generally, this process involves gelatinization of starch simultaneously with or followed by the addition of an a-amylase, although additional liquefaction-inducing enzymes optionally may be added. In some embodiments, the starch substrate prepared as described above is slurried with water. The starch slurry may contain starch as a weight percent of dry solids of about 10-55%, about 20-45%, about 30-45%, about 30-40%, or about 30-35%. a-Amylase (EC 3.2.1.1) may be added to the slurry, with a metering pump, for example. The a-amylase typically used for this application is a thermally stable, bacterial a-amylase, such as a Geobacillus stearothermophilus a-amylase. The α-amylase is usually supplied, for example, at about 1500 units per kg dry matter of starch. To optimize α-amylase stability and activity, the pH of the slurry typically is adjusted to about pH 5.5-6.5 and about 1 mM of calcium (about 40 ppm free calcium ions) can also be added. Geobacillus stearothermophilus variants or other cc-amylases may require different conditions. Bacterial α-amylase remaining in the slurry following liquefaction may be deactivated via a number of methods, including lowering the pH in a subsequent reaction step or by removing calcium from the slurry in cases where the enzyme is dependent upon calcium.
[00140] The slurry of starch plus the α-amylase may be pumped continuously through a jet cooker, which is steam heated to 105°C. Gelatinization occurs rapidly under these conditions, and the enzymatic activity, combined with the significant shear forces, begins the hydrolysis of the starch substrate. The residence time in the jet cooker is brief. The partly gelatinized starch may be passed into a series of holding tubes maintained at 105-110°C and held for 5-8 min. to complete the gelatinization process ("primary liquefaction"). Hydrolysis to the required DE is completed in holding tanks at 85-95°C or higher temperatures for about 1 to 2 hours ("secondary liquefaction"). These tanks may contain baffles to discourage back mixing. As used herein, the term "minutes of secondary liquefaction" refers to the time that has elapsed from the start of secondary liquefaction to the time that the Dextrose Equivalent (DE) is measured. The slurry is then allowed to cool to room temperature. This cooling step can be 30 minutes to 180 minutes, or more. The liquefied starch typically is in the form of a slurry having
a dry solids content (w/w) of about 10-50%; about 10-45%; about 15-40%; about 20-40%; about 25-40%; or about 25-35%.
[00141] Liquefaction with amylases advantageously can be conducted at low pH, eliminating the requirement to adjust the pH to about pH 5.5-6.5. Proteases can be used for liquefaction at a pH range of 2 to 7, e.g., pH 3.0 - 7.5, pH 4.0 - 6.0, or pH 4.5 - 5.8. Amylases can maintain liquefying activity at a temperature range of about 85°C - 95°C, e.g., 85°C, 90°C, or 95°C. For example, liquefaction can be conducted with an amylase in a solution of 25% DS corn starch for 10 min at pH 5.8 and 85°C, or pH 4.5 and 95°C, for example. Liquefying activity can be assayed using any of a number of known viscosity assays in the art.
[00142] In particular embodiments, starch liquefaction is performed at a temperature range of 90-115°C, for the purpose of producing high-purity glucose syrups, HFCS,
maltodextrins, etc.
4.3. Saccharification
[00143] The liquefied starch can be saccharified into a syrup rich in lower DP (e.g., DPI + DP2) saccharides, using a-amylases, optionally in the presence of other enzyme(s). The exact composition of the products of saccharification depends on the combination of enzymes used, as well as the type of granular starch processed. Advantageously, the syrup may contain a weight percent of DP2 of the total oligosaccharides in the saccharified starch exceeding 30%, e.g., 45% - 65% or 55% - 65%. The weight percent of (DPI + DP2) in the saccharified starch may exceed about 70%, e.g., 75% - 85% or 80% - 85%. The present amylases also produce a relatively high yield of glucose, e.g., DPI > 20%, in the syrup product.
[00144] Whereas liquefaction is generally run as a continuous process, saccharification is often conducted as a batch process. Saccharification typically is most effective at temperatures of about 60-65°C and a pH of about 4.0-4.5, e.g., pH 4.3, necessitating cooling and adjusting the pH of the liquefied starch. Saccharification may be performed, for example, at a temperature between about 40°C, about 50°C, or about 55°C to about 60°C or about 65°C. Saccharification is normally conducted in stirred tanks, which may take several hours to fill or empty. Enzymes typically are added either at a fixed ratio to dried solids as the tanks are filled or added as a single dose at the commencement of the filling stage. A saccharification reaction to make a syrup typically is run over about 24-72 hours, for example, 24-48 hours. When a maximum or desired DE has been attained, the reaction is stopped by heating to 85°C for 5 min., for example. Further incubation will result in a lower DE, eventually to about 90 DE, as accumulated glucose re-polymerizes to isomaltose and/or other reversion products via an enzymatic reversion reaction and/or with the approach of thermodynamic equilibrium. When using an amylase,
saccharification optimally is conducted at a temperature range of about 30°C to about 75°C, e.g., 45°C - 75°C or 47°C - 74°C. The saccharifying may be conducted over a pH range of about pH 3 to about pH 7, e.g., pH 3.0 - pH 7.5, pH 3.5 - pH 5.5, pH 3.5, pH 3.8, or pH 4.5.
[00145] An amylase may be added to the slurry in the form of a composition. Amylase can be added to a slurry of a granular starch substrate in an amount of about 0.6 - 10 ppm ds, e.g., 2 ppm ds. An amylase can be added as a whole broth, clarified, enriched, partially purified, or purified enzyme. The specific activity of the amylase may be about 300 U/mg of enzyme, for example, measured with the PAHBAH assay. The amylase also can be added as a whole broth product.
[00146] An amylase may be added to the slurry as an isolated enzyme solution. For example, an amylase can be added in the form of a cultured cell material produced by host cells expressing an amylase. An amylase may also be secreted by a host cell into the reaction medium during the fermentation or SSF process, such that the enzyme is provided continuously into the reaction. The host cell producing and secreting amylase may also express an additional enzyme, such as a glucoamylase. For example, U.S. Patent No. 5,422,267 discloses the use of a glucoamylase in yeast for production of alcoholic beverages. For example, a host cell, e.g., Trichoderma reesei ox Aspergillus niger, may be engineered to co-express an amylase and a glucoamylase, e.g., HgGA, TrGA, or a TrGA variant, during saccharification. The host cell can be genetically modified so as not to express its endogenous glucoamylase and/or other enzymes, proteins or other materials. The host cell can be engineered to express a broad spectrum of various saccharolytic enzymes. For example, the recombinant yeast host cell can comprise nucleic acids encoding a glucoamylase, an alpha-glucosidase, an enzyme that utilizes pentose sugar, an a-amylase, a pullulanse, an isoamylase, and/or an isopullulanase. See, e.g., WO 2011/153516 A2. 4.4. Fermentation
[00147] The soluble starch hydrolysate, particularly a glucose rich syrup, can be fermented by contacting the starch hydrolysate with a fermenting organism typically at a temperature around 32°C, such as from 30°C to 35°C for alcohol-producing yeast. The temperature and pH of the fermentation will depend upon the fermenting organism. EOF products include metabolites, such as citric acid, lactic acid, succinic acid, monosodium glutamate, gluconic acid, sodium gluconate, calcium gluconate, potassium gluconate, itaconic acid and other carboxylic acids, glucono delta-lactone, sodium erythorbate, lysine and other amino acids, omega 3 fatty acid, butanol, isoprene, 1,3-propanediol and other biomaterials.
[00148] Ethanologenic microorganisms include yeast, such as Saccharomyces cerevisiae and bacteria, e.g., Zymomonas moblis, expressing alcohol dehydrogenase and pyruvate decarboxylase. The ethanologenic microorganism can express xylose reductase and xylitol dehydrogenase, which convert xylose to xylulose. Improved strains of ethanologenic
microorganisms, which can withstand higher temperatures, for example, are known in the art and can be used. See Liu et al. (2011) Sheng Wu Gong Cheng Xue Bao 27: 1049-56.
Commercial sources of yeast include ETHANOL RED® (LeSaffre); THERMOSACC®
(Lallemand); RED STAR® (Red Star); FERMIOL® (DSM Specialties); and SUPERSTART® (Alltech). Microorganisms that produce other metabolites, such as citric acid and lactic acid, by fermentation are also known in the art. See, e.g., Papagianni (2007) Biotechnol. Adv. 25:244-63; John et al. (2009) Biotechnol. Adv. 27: 145-52.
[00149] The saccharification and fermentation processes may be carried out as an SSF process. Fermentation may comprise subsequent enrichment, purification, and recovery of ethanol, for example. During the fermentation, the ethanol content of the broth or "beer" may reach about 8-18% v/v, e.g., 14-15% v/v. The broth may be distilled to produce enriched, e.g., 96% pure, solutions of ethanol. Further, C02 generated by fermentation may be collected with a C02 scrubber, compressed, and marketed for other uses, e.g., carbonating beverage or dry ice production. Solid waste from the fermentation process may be used as protein-rich products, e.g., livestock feed.
[00150] As mentioned above, an SSF process can be conducted with fungal cells that express and secrete amylase continuously throughout SSF. The fungal cells expressing amylase also can be the fermenting microorganism, e.g., an ethanologenic microorganism. Ethanol production thus can be carried out using a fungal cell that expresses sufficient amylase so that less or no enzyme has to be added exogenously. The fungal host cell can be from an
appropriately engineered fungal strain. Fungal host cells that express and secrete other enzymes, in addition to amylase, also can be used. Such cells may express one or more glucoamylase and/or a pullulanase, phytase, ί /ια-glucosidase, isoamylase, beta-amylase cellulase, xylanase, other hemicellulases, protease, beto-glucosidase, pectinase, esterase, redox enzymes, transferase, or other enzyme.
[00151] A variation on this process is a "fed-batch fermentation" system, where the substrate is added in increments as the fermentation progresses. Fed-batch systems are useful when catabolite repression may inhibit the metabolism of the cells and where it is desirable to have limited amounts of substrate in the medium. The actual substrate concentration in fed- batch systems is estimated by the changes of measurable factors such as pH, dissolved oxygen
and the partial pressure of waste gases, such as C02. Batch and fed-batch fermentations are common and well known in the art.
[00152] Continuous fermentation is an open system where a defined fermentation medium is added continuously to a bioreactor, and an equal amount of conditioned medium is removed simultaneously for processing. Continuous fermentation generally maintains the cultures at a constant high density where cells are primarily in log phase growth. Continuous fermentation permits modulation of cell growth and/or product concentration. For example, a limiting nutrient such as the carbon source or nitrogen source is maintained at a fixed rate and all other parameters are allowed to moderate. Because growth is maintained at a steady state, cell loss due to medium being drawn off should be balanced against the cell growth rate in the fermentation. Methods of optimizing continuous fermentation processes and maximizing the rate of product formation are well known in the art of industrial microbiology.
4.6. Compositions
[00153] Proteases may be combined with a glucoamylase (EC 3.2.1.3), e.g., a
Trichoderma glucoamylase or variant thereof. An exemplary glucoamylase is Trichoderma reesei glucoamylase (TrGA) and variants thereof that possess superior specific activity and thermal stability. See U.S. Published Applications Nos. 2006/0094080, 2007/0004018, and 2007/0015266 (Danisco US Inc.). Suitable variants of TrGA include those with glucoamylase activity and at least 80%, at least 90%, or at least 95% sequence identity to wild-type TrGA. a- amylases advantageously increase the yield of glucose produced in a saccharification process catalyzed by TrGA.
[00154] Alternatively, the glucoamylase may be another glucoamylase derived from plants (including algae), fungi, or bacteria. For example, the glucoamylases may be Aspergillus niger Gl or G2 glucoamylase or its variants (e.g., Boel et al. (1984) EMBO J. 3: 1097-1102; WO 92/00381 ; WO 00/04136 (Novo Nordisk A/S)); and A. awamori glucoamylase (e.g. , WO
84/02921 (Cetus Corp.)). Other contemplated Aspergillus glucoamylase include variants with enhanced thermal stability, e.g., G137A and G139A (Chen et al. (1996) Prot. Eng. 9:499-505); D257E and D293E/Q (Chen et al. (1995) Prot. Eng. 8:575-582); N182 (Chen et al. (1994) Biochem. J. 301:275-281); A246C (Fierobe et al. (1996) Biochemistry, 35: 8698-8704); and variants with Pro residues in positions A435 and S436 (Li et al. (1997) Protein Eng. 10: 1199- 1204). Other contemplated glucoamylases include Talaromyces glucoamylases, in particular derived from T. emersonii (e.g., WO 99/28448 (Novo Nordisk A/S), T. leycettanus (e.g., U.S. Patent No. RE 32,153 (CPC International, Inc.)), T. duponti, or T. thermophilus (e.g., U.S.
Patent No. 4,587,215). Contemplated bacterial glucoamylases include glucoamylases from the
genus Clostridium, in particular C. thermoamylolyticum {e.g., EP 135138 (CPC International, Inc.) and C. thermohydrosulfuricum {e.g., WO 86/01831 (Michigan Biotechnology Institute)). Suitable glucoamylases include the glucoamylases derived from Aspergillus oryzae, such as a glucoamylase shown in WO 00/04136 (Novo Nordisk A/S). Also suitable are commercial glucoamylases, such as AMG 200L; AMG 300 L; SAN™ SUPER and AMG™ E (Novozymes); OPTIDEX® 300 and OPTIDEX L-400 (Danisco US Inc.); AMIGASE™ and AMIGASE™ PLUS (DSM); G-ZYME® G900 (Enzyme Bio-Systems); and G-ZYME® G990 ZR (A. niger glucoamylase with a low protease content). Still other suitable glucoamylases include
Aspergillus fumigatus glucoamylase, Talaromyces glucoamylase, Thielavia glucoamylase, Trametes glucoamylase, Thermomyces glucoamylase, Athelia glucoamylase, or Humicola glucoamylase {e.g., HgGA). Glucoamylases typically are added in an amount of about 0.1 - 2 glucoamylase units (GAU)/g ds, e.g., about 0.16 GAU/g ds, 0.23 GAU/g ds, or 0.33 GAU/g ds.
[00155] Optionally, OPTIMASH™ BG may be used which is an enzyme preparation intended for the fuel alcohol industry. This product is capable of reducing viscosity of barley and wheat mashes. OPTIMASH™ BG enzyme contains a combination of enzymes, including but not limited to, a beta glucanase and a xylanase, which effectively modify and digest non- starch carbohydrates, the structural material of plant ceils. OPTIMASH™ BG is produced by subraergedfermentation of a genetically modified strain of Trichoderma reesei. Alternately, or in combination, OPTIMASH™ TBG may be used, which is an enzyme blend that is heat stable, food grade preparation of the enzyme cellulase, EC 3.2.1.4. The product has been specifically formulated for use in the fermentation ethanol and starch processing industries for the breakdown of the non-starch polysaccharides of barley and wheat. It is produced by the fermentation of a non-genetically modified strain of Geosmithia emersonii, also known as Talaromyces emersonii. The major enzyme activity of OPTIMASH™ TBG enzyme is a component, endo- 1,3(4)- B-glucanase (systematic name: (l ,3-l ,3;L4)~a-D~glucan 3(4)- glucanohydrolase), which catalyses the endohydrolysis of 1,3- or 1,4-!inkages in β-D-glucans.
[00156] Other suitable enzymes that can be used include a phytase, protease, pullulanase, β-amylase, isoamylase, a different a-amylase, alpha-glucosidase, cellulase, xylanase, other hemicellulases, beta-glucosidase, transferase, pectinase, lipase, cutinase, esterase, redox enzymes, or a combination thereof. For example, a debranching enzyme, such as an isoamylase (EC 3.2.1.68), may be added in effective amounts well known to the person skilled in the art. A pullulanase (EC 3.2.1.41), e.g., PROMOZYME®, is also suitable. Pullulanase typically is added at 100 U/kg ds. Further suitable enzymes include proteases, such as fungal and bacterial
proteases. Fungal proteases include those obtained from Aspergillus, such as A. niger, A.
awamori, A. oryzae; Mucor (e.g., M. miehei); Rhizopus; and Trichoderma.
[00157] β-Amylases (EC 3.2.1.2) are exo-acting maltogenic amylases, which catalyze the hydrolysis of 1,4-a-glucosidic linkages into amylopectin and related glucose polymers, thereby releasing maltose. β-Amylases have been isolated from various plants and microorganisms. See Fogarty et al. (1979) in PROGRESS IN INDUSTRIAL MICROBIOLOGY, Vol. 15, pp. 112-115. These β-Amylases have optimum temperatures in the range from 40°C to 65°C and optimum pH in the range from about 4.5 to about 7.0. Contemplated β-amylases include, but are not limited to, β-amylases from barley SPEZYME® BBA 1500, SPEZYME® DBA, OPTIMALT™ ME, OPTIMALT™ BBA (Danisco US Inc.); and NOVOZYM™ WBA (Novozymes A/S).
[00158] Compositions comprising the present proteases may be aqueous or non-aqueous formulations, granules, powders, gels, slurries, pastes, etc., which may further comprise any one or more of the additional enzymes listed, herein, along with buffers, salts, preservatives, water, co-solvents, surfactants, and the like. Such compositions may work in combination with endogenous enzymes or other ingredients already present in a slurry, water bath, washing machine, food or drink product, etc, for example, endogenous plant (including algal) enzymes, residual enzymes from a prior processing step, and the like.
EXPERIMENTAL
Example 1
Study the effect on ethanol production for Proteinase T, NprE and FNA protease addition during liquefaction step of the dry grind ethanol process for corn as a substrate
[00159] This experiment was performed to study the effect of the proteases addition during the liquefaction unit operation in the dry grind process on the ethanol yield for the corn as substrate. The corn flour was mixed with DI water to prepare 25% ds slurry. The unadjusted pH of the slurry was at ~pH 6.0 and was left unchanged. Enzyme solutions containing SPEZYME® CL alpha amylase at 2.5 AAUs/g ds was dispensed in the slurry. This slurry was mixed at room temperature to blend the added enzymes. A 35 g aliquot with 4 replications for each treatment was weighed into LABOMAT steel beakers. Following the weighing process the proteases were added as such 1) no protease 2) Proteinase T at 0.05mg/g ds, 3) FNA at 0.05mg/g ds and 4)
NprE at 0.05mg/g ds. The metal beakers were fitted back into the LABOMAT for liquefaction unit operation at 60°C for 45 min followed by 85°C for 90 min with clockwise and counterclockwise constant mixing at 60rpm.
[00160] After the liquefaction the liquefied mash for each treatment was mixed together
for pH adjustment and fermentation preparation. The pH was adjusted to pH 4.5 using 4N sulfuric acid. ADY at 3.57 mg/g ds, urea at 600 ppm and GA at 0.325 GAUs /g ds were added to each flask. A 50 g of slurry was thereafter transferred to 125 ml flask for fermentation. The flasks were incubated at 32°C for 54 hrs. The samples were drawn at regular intervals for ethanol measurements.
[00161] The ethanol data from the table below shows that for the corn fermentation the protease addition during liquefaction helped the ethanol production rate and the final ethanol concentration for the corn slurry treated with Proteinase T, NprE and FNA compared to the control.
Table 2. Effect of protease addition during liquefaction on the ethanol yield during fermentation of corn substrate
Example 2
[00162] The objective of this experiment is to determine effects of protease addition on viscosity changes during corn liquefaction by alpha amylases.
Methods:
[00163] In a Rapid Visco Analyzer (RVA) sample cup, 9.1 grams of ground corn flour was mixed with 23.6 grams of water and pH was adjusted to 5.8 with IN H2S04. Then, 15 μgrams of amylase (e.g., Cytophaga spp. Amylase 1777dRG) was added with and without Proteinase T (Product: 4.9 mg/mL, specific protein) or NprE (purified: 22.3 mg/mL, specific protein). Changes in viscosity were monitored using RVA at constant temperature set at 85 °C.
[00164] Titration of Proteinase T with 15 μgrams of Cytophaga spp alpha amylase (1777 dRG) shows progressive reduction of the peak and final viscosities during CF slurry
gelatinization and pasting steps. The liquefaction reactions were carried out with corn flour (25% DS) at pH 5.8 with the rapid temperature ramp and held at 85 °C. Without protease addition, the viscosity rises above a point at which the instrument torques out and stops collecting data.
[00165] Addition of protease (lmg purified NprE) to 15 μgrams of Cytophaga spp alpha
amylase (1777 dRG) reduces the peak viscosity by -30% while addition of buffer control does not significantly change. Reactions were carried out in RVA with corn flour (25% DS) at pH 5.8 with the rapid temperature ramp and held at 85 °C. Without protease addition, the viscosity rises above a point at which the instrument torques out and stops collecting data.
[00166] Dose dependent reduction of peak and final viscosity values. Percent reduction shown list changes in viscosity relative to no protease addition control. The final viscosity value for no protease addition was estimated from previous experiments. The data are presented as Figures 1 to 3. Example 3
[00167] Study the addition of Proteinase T and SPEZYME FAN during liquefaction on ethanol production in SSF.
[00168] Materials:
32% ds ground corn from ADM in Cedar Rapids, IA
Thin stillage from Lincolnway, IA (used at 30% of dilutant)
Big River Dyersville liquefact
Urea from JT Baker, USP grade (Lot number G05583)
Yeast from Lincolnway Ethanol Red (Sticker # 2011-0365)
6N HC1, 25 % v/v NH4OH, IN H2S04
GPA 502
[00169] Enzymes used in liquefaction and/or fermentation are shown in Table 3
Enzymes used in liquefaction and/or fermentation.
Table 3
[00170] Liquefaction process - Addition of Proteases. Whole corn ground slurry of 800 g at 32% ds containing 30% thin stillage was used. The slurry was then mixed well and the pH was adjusted to 5.8 using 25 % v/v NH4OH. The slurry was placed in a 70°C (158.0°F) water
bath and continuously mixed for 90 seconds. SPEZYME CL was added into the slurry with the dosage of 0.75 AAUs/g ds. After the 30 minute mark, the corn slurry was taken to a 99°C water bath and continuously mixed for 10 minutes to imitate a jet cooker. In addition, approximately 1 gram sample of the slurry was taken at 30 minutes for DE determination as described in GPA 502. The slurry was then brought back to an 85°C (185.0°F) water bath and continuously mixed for the remainder of the experiment (160 minutes total). The secondary dosage of SPEZYME CL at 1.0 AAUs/g ds was added at the 45 minute mark. Samples of ~1 gram were taken for DE determination at 50 and 160 minutes. This liquefaction procedure was repeated two more times under the same conditions but with proteases added in the slurry in addition to the SPEZYME CL dose: 1) 0.75 AAUs/g ds CL + 1.0 kg/MT ds SPEZYME FAN in the slurry ++ 1.0 AAUs/g ds CL in secondary liquefaction, and 2) 0.75 AAUs/g ds CL + 1.0 kg/MT ds Proteinase T in the slurry ++ 1.0 AAUs/g ds CL in the secondary liquefaction. The moisture content was determined at the end of liquefaction by using a Mettler Toledo HR83 moisture balance and the amount of moisture lost for each of these cooks was calculated. The amount of water lost during liquefaction was added back in at the end using DI water and the pH was then brought back down to 4.5 using 6 N HC1.
[00171] Fermentation process - Proteases used in liquefaction. The three separate liquefacts were thawed at 60°C and then cooled to room temperature, at which point 400 ppm of urea was added to each liquefact. The pH was then adjusted to 4.5 using 6N sulfuric acid.
Samples of the initial liquefacts were measured into separate 2.0 mL centrifuge tubes and centrifuged for approximately 3 minutes at 13.2k rpm. After centrifugation, the samples were prepared for HPLC analysis, where 0.5 mL of supernatant was acidified with 50 μΐ^ of IN sulfuric acid for 5 minutes, diluted with 4.45 mL of RO water, and then filtered through a 3 mL syringe with a 0.45 μιη GHP membrane. The samples were placed in HPLC vials and went through the organic acid column. For each of the three separate liquefacts, a sample of 100.00 grams (+0.05g) was weighed into 4 separate 250 mL wide-mouthed Erlenmeyer flasks. Thus, a total of 12 flasks were used.The dose used for TrGA (GC 321), AkAA (GC 626), and Fermgen are shown in Table 4. As shown, the enzymes were added in duplicate.
Dosing of fermentation enzymes
Table 4
Liquefact Enzymes and dosages
SPEZYME CL TrGA+AkAA
SPEZYME CL TrGA + AkAA + 0.02 kg/MT ds Fermgen
SPEZYME CL + SPEZYME FAN TrGA+AkAA
SPEZYME CL + SPEZYME FAN TrGA+AkAA + 0.02 kg/MT ds Fermgen
SPEZYME CL + Proteinase T TrGA+AkAA
SPEZYME CL + Proteinase T TrGA+AkAA + 0.02 kg/MT ds Fermgen
[00172] A 20% w/v yeast solution was prepared by adding 5 grams of Ethanol Red yeast in a 50 mL conical centrifuge tube with the addition of DI water up to 25 mL mark. The yeast solution was mixed for 10 minutes at 150 rpm and each fermentation flask was dosed with 500 μΐ^ of yeast, which yielded a concentration of 0.1% w/w. Each flask was then covered with a rubber stopper with a hole to vent C02. The 12 flasks were incubated at 32°C at 150 rpm for 72 hours. Samples were taken at 5, 18, 24, 42, 48, 66, and 72 hours for ethanol concentrations. A sample was measured into a 2.0 mL centrifuge tube and centrifuged for approximately 3 minutes at 13.2k rpm and prepared for HPLC analysis, where 0.5 mL of supernatant was acidified with 50 μΐ^ of IN sulfuric acid for 5 minutes, diluted with 4.45 mL of RO water, and then filtered through a 3 mL syringe with a 0.45 μιη GHP membrane. The samples were placed in HPLC vials and went through the organic acid column.
[00173] As Proteinase T and FAN are thermostable at 70°C, liquefaction was performed with slurry at 70°C for 30 min followed by jet simulation (boil step) which was followed with secondary liquefaction at 85°C for 120 min. In liquefactions Proteinase T and FAN were added in slurry and not in secondary liquefaction. So the liquefacts were incubated with Proteinase T and FAN only for 30 min at 70°C.
[00174] Increase in ethanol by 0.5 to 0.8% v/v when seen using Proteinase T with
SPEZYME CL in liquefaction compared to control when only SPEZYME CL was used. The fermentation with liquefact from SPEZYME CL and Proteinase T and TRGA+AKAA+
Fermgen almost reached 17.5% v/v whereas the fermentation with liquefact from only
SPEZYME CL and TRGA+AKAA+ Fermgen reached 16.47% w/w. Ethanol increase was also seen with use of SPEZYME FAN and Fermgen in liquefaction.
[00175] During the replication, the fermentation was allowed for 72 hrs and the ethanol started decreasing as the yeast started to metabolize the ethanol. This data indicates that adding the Proteinase T and FAN during liquefaction increased starch availability and ethanol fermentation rate. The differentiation in ethanol production rate is seen as early as 16-18 hr.
[00176] Higher Proteinase T and FAN dosages were added as they are neutral pH proteases and their activity may be reduced during SSF at pH 4.5. No difference in % ethanol was detected (Figures 4, 5 and 6). The IRS (insoluble residual starch) tests were negative for all the treatment as AKAA was included in the SSF.
Example 4
[00177] Analysis of Residual Starch, Free Amino Nitrogen (FAN) and Citric Acid
Production in Fermentation on Application of FERMGEN in Low Temperature Liquefaction
[00178] In citric acid industry, after filtration, high residual starch in filtrate cake was the big waste for the corn consumption. A new process was developed using the FERMGEN protease addition in the slurry tank before liquefaction, in order to get better liquefaction and filtration performance.
[00179] The benchmark was conducted with Liquezyme Supra at 95°C.
[00180] Materials: Corn flour, Liquezyme Supra, FERMGEN, 95°C, 55°C water bath, 60°C Oven, Muller, pH6.0 PB buffer, pH4.2 Acetic acid buffer, Spezyme Fred, AnGA.
[00181] Prepare DS=20 of corn flour slurry, and adjust pH to 5.7. Record the total weight of baker and mash for evaporation adjustment after liquefaction. For FERMGEN process, add FERMGEN at 0.2kg/tds into the slurry and put it in 55°C water bath for 0.5hr to do pretreatment process, then add Supra at 0.7kg/tds and transferred to 95°C water bath for 1.5hr to do liquefaction process. For blank group, add Supra at 0.7kg/tds and put it into 95°C water bath for 1.5hr to do liquefaction process. After the liquefaction process, the slurry was filtrated and collected the cake, which was then dried in 60°C oven overnight. The cake was crashed to fine powder and check residual starch in it.
[00182] In another set of experiemtns, , after the liquefaction process, the slurry was filtrated and collected the filtrate, which was then analyzed for the FAN concentration with ninhydrin method.
[00183] In another set of experiments, after the liquefaction process, the slurry was filtrated and the filtrate was collected. Liquefaction slurry and filtrate were mixed together according to the C/N. A strain of Aspergillus niger was grown on potato dextrose agar (PDA) slant at 35°C for 5-7d, then the spores were washed with sterilized water, and spores suspension was inoculated into fermentation medium to keep every bottle at the same conditions. The fermentation was performed in the shaker with 300rpm/min, 35 °C, 96hr. Ending the
fermentation, the broth was filtrated through filter paper, and the filtrate was used for analysis. The citric acid concentration and DPI, DP2, DP3, DP4+ concentration was analyzed by HPLC.
[00184] In another set of experiments, Proteinase T was used to increase citric acid fermentation (Table 4.4).
Table 4.1 The effect of FERMGEN on residual starch in the filtration cake
Table 4.3 The effect of FERMGEN on citric acid production
Table 4.4 The effect of Proteinase T on citric acid production and residual Sugars
[00185] The data showed that FERMGEN addition before liquefaction gave a reduction of residual starch (Table 4.1), increased FAN (Table 4.2) and increased citric acid production (Table 4.3, and Table 4.4 for Proteinase T). FERMGEN and Proteinase T application may have increased the small peptides, amino acids and other nitrogen species, which can be directly used for the fermentation. The proteases may make the starch granules bound with protein to increased dissolution. Additionally, it could reduce the viscosity of the fermentation broth and improve oxygen transfer efficiency.
Example 5
[00186] Analysis of Residual Starch, Free Amino Nitrogen and Effect of Calcium on
Application of Proteinase T in Low Temperature Liquefaction
[00187] In this set of experiments, for low temperature liquefaction using Spezyme Alpha as S-type AA, we explored Proteinase T process, which was conducted at 85°C along with Alpha liquefaction process.
[00188] Materials: Corn flour, Spezyme Alpha, Proteinase T, 90°C, 85°C water bath,
60°C Oven, Muller pH6.0 PB buffer, pH4.2 Acetic acid buffer, Spezyme Fred AnGA.
[00189] Prepare DS=20 of corn flour slurry, and adjust pH to 5.7. Record the total weight of baker and mash for evaporation adjustment after liquefaction. For Proteinase T process, add Proteinase T at 0.2kg/tds and Spezyme Alpha at 0.3kg/tds into the slurry and put it in 85°C water bath for 1.5hr to do liquefaction process. In some experiemnts, Ca2+ is added at 200 ppm. For blank group, add Alpha at 0.3kg/tds (and Proteinase T for Ca2+ experiements) and put it into 90°C water bath for 1.5hr to do liquefaction process. In one set of experiemtns, after the liquefaction process, the slurry was filtrated and collected the cake, which was then dried in 60°C oven overnight. The cake was crashed to fine powder and check residual starch in it. Analysis conditions: Agilent 1260 HPLC, RID Detector, Rezex-ROA-Organic acid
(Phenomenex), Mobile Phase: 5mM H2S04, Column: 60°C, Pump: 0.6ml/min, njection: 20μL·.
[00190] In another set of experiments, after the liquefaction process, the slurry was filtrated and collected the filtrate, which was then analyzed for the FAN concentration with ninhydrin method.
Table 5.1 The effect on residual starch in the filtration cake
Table 5.2 The effect on FAN concentration in the filtrate
[00191] The data showed that Proteinase T process gave a reduction of residual starch, which could make the starch granules bound with protein to dissolution due to its dominant thermostability.
[00192] The Ninhydrin analysis showed that Proteinase T process could increase the FAN concentration.
[00193] Addition of 200 ppm Ca2+ increased FAN concentrations as compared to controls with no added Ca2+.
Example 6
[00194] Use of FERMGEN in Lactic Acid Fermentation
[00195] Materials and Methods: Strain of Bacillus coagulans 20138 was obtained from
CICC (China Center of Industrial Culture Collection).
[00196] Seed media : Casein 10.0 g, Beef extract 10.0 g, Yeast extract 5.0 g, Glucose 5.0 g, Sodium acetate 5.0 g, Diammonium citrate 2.0 g, Tween 80 1.0 g, K2HP04 2.0 g,
MgS04-7H20 0.2 g, MnS04 H20 0.05 g. Distilled water 1.0L, pH6.8; for inoculum media additional 20g agar were added, Sterilization® 121°C,20min.
[00197] Fermentation medium: whole ground Corn liquefact, one treated with additional Protease like FERMGEN, another run as control without protease.
[00198] Casein, Beef extract, Yeast extract, Glucose, Sodium acetate, diammonium hydrogen citrate, Tween 80, K2HP04, MgS04.7H20, MnS04.H20, Agar powder, NH40H, calcium hydroxide were analytical grade from local supplier. Whole ground corn was from Yixin Xielian Citric acid factory. FERMGEN, SPEZYME ALPHA, TrGA was from
Genencor/DuPont.
[00199] Prepare DS=16 of whole ground corn slurry, and adjust pH to 5.6. Record the total weight of baker and mash for evaporation adjustment after liquefaction, for "pretreatment using protease", add FERMGEN at 0.5kg/tds and SPEZYME ALPHA at 0.3kg/tds into the slurry and put it in 60°C water bath holding 30min, and then transferred to 87°C water bath for 1.5hr for liquefaction, for control group "without protease pretreatment", add only SPEZYME ALPHA at 0.3kg/tds and put it in 60°C water bath holding 30min, and then transferred to 87°C
water bath for 1.5hr for liquefaction, After the liquefaction, the slurry was filtrated and collected the filtrated as fermentation medium.
[00200] Lactic acid fermentation was carried out using Bacillus coagulans strain. The inoculums of Bacillus coagulans was transferred to each lOOmL seed culture and cultivated at 50°C, 12~24hrs, 200rpm. The cultivation was controlled based on OD6oo value around 0.5. 500 mL filtrate was used as fermentation medium, Treesei GlucoAmylase (TrGA) was dosed at 0.75 GAU/g for SSF process, then 50mL seed culture was added to each fermentor to start fermentation. Fermentation pH was maintained at pH 6.5 using 15% Ca(OH)2 and the temperature was set at 55°C, and the agitation was 300rpm. Samples were taken at 18h, 25h, 44h, 50h. Lactic acid concentration of the fermentation broth was given in Table 6.1.
Table 6.1
[00201] While preferred embodiments of the present invention have been shown and described herein, it will be obvious to those skilled in the art that such embodiments are provided by way of example only. Numerous variations, changes, and substitutions will now occur to those skilled in the art without departing from the invention. It should be understood that various alternatives to the embodiments of the invention described herein can be employed in practicing the invention. It is intended that the following claims define the scope of the invention and that methods and structures within the scope of these claims and their equivalents be covered thereby.
Claims
1. A method for producing a fermentation product from corn-like grain, comprising:
a) liquifying the corn-like grain slurry at a pH of about 4.0 to about 7.0 at a temperature in the range from about 25°C to about 65°C using:
an alpha amylase, a protease; and optionally a beta-glucanase;
b) saccharifying and fermenting the slurry using enzymes, including a glucoamylase and a fermenting organism to produce the fermentation product.
2. A method for increasing yield and/or rate of ethanol production from corn-like grain, comprising:
a) liquifying the corn-like grain slurry at a pH of about 4.0 to about 7.0 at a temperature in the range from about 25 °C to about 65 °C using:
an alpha amylase, a protease; and optionally a beta-glucanase;
b) saccharifying and fermenting the slurry using enzymes, including a glucoamylase and a fermenting organism to produce ethanol, wherein the yield and/or rate of ethanol production is greater than the rate observed witout the addition of protease.
3. A method for increasing yield and/or rate of an organic acid production from corn-like grain, comprising:
a) liquifying the corn-like grain slurry at a pH of about 4.0 to about 7.0 at a temperature in the range from about 25 °C to about 65 °C using:
an alpha amylase, a protease; and optionally a beta-glucanase;
b) saccharifying and fermenting the slurry using enzymes, including a glucoamylase and a fermenting organism to produce the organic acid, wherein the yield and/or rate of the organic acid production is greater than the rate observed witout the addition of protease.
4. A method for reducing viscosity of a corn-like grain slurry during a fermentation, comprising: a) liquifying the corn-like grain slurry at a pH of about 4.0 to about 7.0 at a temperature in the range from about 25°C to about 65°C using an alpha amylase, a protease; and optionally a beta-glucanase;
b) saccharifying and fermenting the slurry using enzymes, including a glucoamylase and a fermenting organism to produce the fermentation product, wherein the viscosity of the slurry is reduced by at least 20% compared to a slurry not treated with a protease.
5. The method of claim 4, wherein the viscosity is reduced by about 30%.
6. The method of any one of claim 4 or 5, wherein the viscosity is reduced by about 50%.
7. The method of any one of claim 4 to 6, wherein the viscosity is reduced by about 60%.
8. Amethod for reducing viscosity of a corn-like grain slurry during a liquefaction process,
comprising:
a) liquifying the corn-like gain slurry at a pH of about 4.0 to about 7.0 at a temperature in the range from about 25°C to about 65°C using an alpha amylase, a protease; and optionally a beta-glucanase; and
wherein the viscosity of the slurry is reduced by at least 20% compared to a slurry not treated with a protease.
9. The method of claim 8, wherein the viscosity is reduced by about 30%.
10. The method of any one of claim 8 or 9, wherein the viscosity is reduced by about 50%.
11. The method of any one of claim 8 to 10, wherein the viscosity is reduced by about 60%.
12. A method for reducing viscosity of a corn-like grain slurry during a liquefaction process, comprising:
liquifying the corn-like gain slurry at a pH of about 4.0 to about 7.0 at a temperature in the range from about 25°C to about 90°C using:
an alpha amylase, a protease; and optionally a beta-glucanase; and
wherein the viscosity of the slurry is reduced by at least 20% compared to a slurry not treated with a protease.
13. The method of claim 12, wherein the viscosity is reduced by about 30%.
14. The method of any one of claim 12 or 13, wherein the viscosity is reduced by about 50%.
15. The method of any one of claim 12 to 14, wherein the viscosity is reduced by about 60%.
16. A method for reducing foam in a corn-like grain slurry during a liquefaction process, comprising:
liquifying the corn-like gain slurry at a pH of about 4.0 to about 7.0 at a temperature in the range from about 25°C to about 90°C using:
an alpha amylase, a protease; and optionally a beta-glucanase; and
wherein the foam in the slurry is reduced by at least 20% compared to a slurry not treated with a protease.
17. The method of claim 16, wherein the foam is reduced by about 30%.
18. The method of any one of claim 16 or 17, wherein the foam is reduced by about 50%.
19. The method of any one of claim 16 to 18, wherein the foam is reduced by about 60%.
20. A method for reducing amount of residual starch after a liquefaction process of a corn-like grain slurry, comprising:
liquifying the corn-like gain slurry at a pH of about 4.0 to about 7.0 at a temperature in the range from about 25°C to about 90°C using:
an alpha amylase, a protease; and optionally a beta-glucanase; and
wherein the amount of residual starch of the slurry is reduced by at least 20% compared to a slurry not treated with a protease.
21. The method of claim 20, wherein the amount of residual starch is reduced by about 30%.
22. The method of any one of claim 20 or 21, wherein the amount of residual starch is reduced by about 50%.
23. The method of any one of claim 20 to 22, wherein the amount of residual starch is reduced by about 60%.
24. The method of any one of claims above, wherein the protease is proteinase T.
25. The method of any one of claims above, wherein the protease is NprE.
26. The method of any one of claims above, wherein the protease is proteinase T variant.
27. The method of any one of claims above, wherein the protease is proteinase T variant Q17I.
28. The method of any one of claims above, wherein the protease is proteinase T variant Q17V.
29. The method of any one of claims above, wherein the protease is FNA.
30. The method of any one of claims above, wherein the protease is FERMGEN.
31. The method of claim 1, wherein the fermentation product is an alcohol, an organic acid, an amino acid, a sugar, an antibiotic, an enzyme, a vitamin or a hormone.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361899755P | 2013-11-04 | 2013-11-04 | |
US61/899,755 | 2013-11-04 | ||
CNPCT/CN2014/089754 | 2014-10-29 | ||
CN2014089754 | 2014-10-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2015066669A1 true WO2015066669A1 (en) | 2015-05-07 |
Family
ID=51871337
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2014/063798 WO2015066669A1 (en) | 2013-11-04 | 2014-11-04 | Proteases in corn processing |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2015066669A1 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020247582A1 (en) | 2019-06-06 | 2020-12-10 | Danisco Us Inc | Methods and compositions for cleaning |
WO2021142057A1 (en) * | 2020-01-07 | 2021-07-15 | Danisco Us Inc | Methods and compositions for enhanced ethanol production |
CN113373133A (en) * | 2021-07-02 | 2021-09-10 | 广西乐酵生物科技有限公司 | Novel liquefaction process for producing alcohol from colloidal corn |
US20230277956A1 (en) * | 2022-03-01 | 2023-09-07 | Lee Tech Llc | Methods of and systems for a dry milling process with two steps liquefications |
WO2023250301A1 (en) | 2022-06-21 | 2023-12-28 | Danisco Us Inc. | Methods and compositions for cleaning comprising a polypeptide having thermolysin activity |
US12065513B2 (en) | 2022-06-17 | 2024-08-20 | Lee Tech Llc | System for and method of producing pure starch slurry and alcohol by using a process combining wet corn milling and a dry corn milling processes |
US12084707B2 (en) | 2014-08-29 | 2024-09-10 | Lee Tech Llc | Yeast stage tank incorporated fermentation system and method |
WO2024258941A3 (en) * | 2023-06-12 | 2025-02-06 | Icm, Inc. | Advanced processing methods to produce high protein feeds and/or low-fat fiber products from dry grind cereal grains |
Citations (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1984002921A2 (en) | 1983-01-28 | 1984-08-02 | Cetus Corp | Glucoamylase cdna |
EP0135138A2 (en) | 1983-08-17 | 1985-03-27 | Cpc International Inc. | A novel thermostable glucoamylase and method for its production |
WO1986001831A1 (en) | 1984-09-18 | 1986-03-27 | Michigan Biotechnology Institute | Thermostable starch converting enzymes |
US4587215A (en) | 1984-06-25 | 1986-05-06 | Uop Inc. | Highly thermostable amyloglucosidase |
USRE32153E (en) | 1978-09-01 | 1986-05-20 | Cpc International Inc. | Highly thermostable glucoamylaseand process for its production |
EP0238023A2 (en) | 1986-03-17 | 1987-09-23 | Novo Nordisk A/S | Process for the production of protein products in Aspergillus oryzae and a promoter for use in Aspergillus |
WO1991017243A1 (en) | 1990-05-09 | 1991-11-14 | Novo Nordisk A/S | A cellulase preparation comprising an endoglucanase enzyme |
WO1992000381A1 (en) | 1990-06-29 | 1992-01-09 | Novo Nordisk A/S | Enzymatic hydrolysis of starch to glucose, using a genetically engineered enzyme |
US5422267A (en) | 1984-05-22 | 1995-06-06 | Robert R. Yocum | Industrial yeast comprising an integrated glucoamylase gene |
WO1999028448A1 (en) | 1997-11-26 | 1999-06-10 | Novo Nordisk A/S | Thermostable glucoamylase |
WO1999034011A2 (en) | 1997-12-24 | 1999-07-08 | Genencor International, Inc. | Method of assaying for a preferred enzyme and/or detergent |
WO2000004136A1 (en) | 1998-07-15 | 2000-01-27 | Novozymes A/S | Glucoamylase variants |
US6022725A (en) | 1990-12-10 | 2000-02-08 | Genencor International, Inc. | Cloning and amplification of the β-glucosidase gene of Trichoderma reesei |
US6376450B1 (en) | 1998-10-23 | 2002-04-23 | Chanchal Kumar Ghosh | Cleaning compositions containing multiply-substituted protease variants |
WO2002038787A2 (en) * | 2000-11-10 | 2002-05-16 | Novozymes A/S | Secondary liquefaction of starch in ethanol production |
US20060094080A1 (en) | 2004-05-27 | 2006-05-04 | Nigel Dunn-Coleman | Trichoderma reesei glucoamylase and homologs thereof |
WO2006086792A2 (en) * | 2005-02-07 | 2006-08-17 | Novozymes North America, Inc. | Fermentation product production processes |
WO2007044993A2 (en) | 2005-10-12 | 2007-04-19 | Genencor International, Inc. | Use and production of storage-stable neutral metalloprotease |
WO2009052101A1 (en) * | 2007-10-18 | 2009-04-23 | Danisco Us, Inc. | Enzyme blends for fermentation |
WO2009058518A1 (en) | 2007-10-31 | 2009-05-07 | Danisco Us Inc., Genencor Division | Use and production of neutral metallproteases in a serine protease-free background |
WO2009058661A1 (en) | 2007-10-31 | 2009-05-07 | Danisco Us Inc., Genencor Division | Use and production of citrate-stable neutral metalloproteases |
WO2009058679A1 (en) | 2007-10-30 | 2009-05-07 | Danisco Us Inc., Genencor Division | Streptomyces protease |
WO2009058303A2 (en) | 2007-11-01 | 2009-05-07 | Danisco Us Inc., Genencor Division | Production of thermolysin and variants thereof and use in liquid detergents |
US20110014671A1 (en) * | 2007-12-14 | 2011-01-20 | Instituto Tecnologico Y De Estudios Superiores De | Method for obtaining bioethanol from sorghum grain (sorghum bicolor l. moench), comprising steps involving decortication and hydrolysis with proteases |
US8058033B2 (en) | 2007-11-20 | 2011-11-15 | Danisco Us Inc. | Glucoamylase variants with altered properties |
WO2011153516A2 (en) | 2010-06-03 | 2011-12-08 | Mascoma Corporation | Yeast expressing saccharolytic enzymes for consolidated bioprocessing using starch and cellulose |
WO2012012297A1 (en) * | 2010-07-19 | 2012-01-26 | Xyleco, Inc. | Processing biomass |
WO2012088303A2 (en) * | 2010-12-22 | 2012-06-28 | Novozymes North America, Inc. | Processes for producing fermentation products |
-
2014
- 2014-11-04 WO PCT/US2014/063798 patent/WO2015066669A1/en active Application Filing
Patent Citations (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE32153E (en) | 1978-09-01 | 1986-05-20 | Cpc International Inc. | Highly thermostable glucoamylaseand process for its production |
WO1984002921A2 (en) | 1983-01-28 | 1984-08-02 | Cetus Corp | Glucoamylase cdna |
EP0135138A2 (en) | 1983-08-17 | 1985-03-27 | Cpc International Inc. | A novel thermostable glucoamylase and method for its production |
US5422267A (en) | 1984-05-22 | 1995-06-06 | Robert R. Yocum | Industrial yeast comprising an integrated glucoamylase gene |
US4587215A (en) | 1984-06-25 | 1986-05-06 | Uop Inc. | Highly thermostable amyloglucosidase |
WO1986001831A1 (en) | 1984-09-18 | 1986-03-27 | Michigan Biotechnology Institute | Thermostable starch converting enzymes |
EP0238023A2 (en) | 1986-03-17 | 1987-09-23 | Novo Nordisk A/S | Process for the production of protein products in Aspergillus oryzae and a promoter for use in Aspergillus |
WO1991017243A1 (en) | 1990-05-09 | 1991-11-14 | Novo Nordisk A/S | A cellulase preparation comprising an endoglucanase enzyme |
WO1992000381A1 (en) | 1990-06-29 | 1992-01-09 | Novo Nordisk A/S | Enzymatic hydrolysis of starch to glucose, using a genetically engineered enzyme |
US6022725A (en) | 1990-12-10 | 2000-02-08 | Genencor International, Inc. | Cloning and amplification of the β-glucosidase gene of Trichoderma reesei |
WO1999028448A1 (en) | 1997-11-26 | 1999-06-10 | Novo Nordisk A/S | Thermostable glucoamylase |
WO1999034011A2 (en) | 1997-12-24 | 1999-07-08 | Genencor International, Inc. | Method of assaying for a preferred enzyme and/or detergent |
WO2000004136A1 (en) | 1998-07-15 | 2000-01-27 | Novozymes A/S | Glucoamylase variants |
US6376450B1 (en) | 1998-10-23 | 2002-04-23 | Chanchal Kumar Ghosh | Cleaning compositions containing multiply-substituted protease variants |
WO2002038787A2 (en) * | 2000-11-10 | 2002-05-16 | Novozymes A/S | Secondary liquefaction of starch in ethanol production |
US20070004018A1 (en) | 2004-05-27 | 2007-01-04 | Nigel Dunn-Coleman | Trichoderma reesei glucoamylase and homologs thereof |
US20070015266A1 (en) | 2004-05-27 | 2007-01-18 | Nigel Dunn-Coleman | Trichoderma reesei glucoamylase and homologs thereof |
US20060094080A1 (en) | 2004-05-27 | 2006-05-04 | Nigel Dunn-Coleman | Trichoderma reesei glucoamylase and homologs thereof |
WO2006086792A2 (en) * | 2005-02-07 | 2006-08-17 | Novozymes North America, Inc. | Fermentation product production processes |
WO2007044993A2 (en) | 2005-10-12 | 2007-04-19 | Genencor International, Inc. | Use and production of storage-stable neutral metalloprotease |
WO2009052101A1 (en) * | 2007-10-18 | 2009-04-23 | Danisco Us, Inc. | Enzyme blends for fermentation |
WO2009058679A1 (en) | 2007-10-30 | 2009-05-07 | Danisco Us Inc., Genencor Division | Streptomyces protease |
WO2009058518A1 (en) | 2007-10-31 | 2009-05-07 | Danisco Us Inc., Genencor Division | Use and production of neutral metallproteases in a serine protease-free background |
WO2009058661A1 (en) | 2007-10-31 | 2009-05-07 | Danisco Us Inc., Genencor Division | Use and production of citrate-stable neutral metalloproteases |
WO2009058303A2 (en) | 2007-11-01 | 2009-05-07 | Danisco Us Inc., Genencor Division | Production of thermolysin and variants thereof and use in liquid detergents |
US8058033B2 (en) | 2007-11-20 | 2011-11-15 | Danisco Us Inc. | Glucoamylase variants with altered properties |
US20110014671A1 (en) * | 2007-12-14 | 2011-01-20 | Instituto Tecnologico Y De Estudios Superiores De | Method for obtaining bioethanol from sorghum grain (sorghum bicolor l. moench), comprising steps involving decortication and hydrolysis with proteases |
WO2011153516A2 (en) | 2010-06-03 | 2011-12-08 | Mascoma Corporation | Yeast expressing saccharolytic enzymes for consolidated bioprocessing using starch and cellulose |
WO2012012297A1 (en) * | 2010-07-19 | 2012-01-26 | Xyleco, Inc. | Processing biomass |
WO2012088303A2 (en) * | 2010-12-22 | 2012-06-28 | Novozymes North America, Inc. | Processes for producing fermentation products |
Non-Patent Citations (25)
Title |
---|
"MOLECULAR CLONING: A LABORATORY MANUAL", 2001 |
"THE ALCOHOL TEXTBOOK", 2009, NOTTINGHAM UNIVERSITY PRESS |
BOEL ET AL., EMBO J., vol. 3, 1984, pages 1097 - 1102 |
BOTHAST ET AL., APPL. MICROBIOL. BIOTECHNOL., vol. 67, 2005, pages 19 - 25 |
CAMPBELL ET AL., CURR. GENET., vol. 16, 1989, pages 53 - 56 |
CAO ET AL., SCIENCE, vol. 9, 2000, pages 991 - 1001 |
CHEN ET AL., BIOCHEM. J., vol. 301, 1994, pages 275 - 281 |
CHEN ET AL., PROTO ENG., vol. 8, 1995, pages 575 - 582 |
CHEN ET AL., PROTO ENG., vol. 9, 1996, pages 499 - 505 |
DEL MAR, ANAL. BIOCHEM., vol. 99, 1979, pages 316 - 320 |
FGSC, CATALOGUE OF STRAINS, UNIVERSITY OF MISSOURI, 17 January 2007 (2007-01-17), Retrieved from the Internet <URL:www.fgsc.net> |
FIEROBE ET AL., BIOCHEMISTRY, vol. 35, 1996, pages 8698 - 8704 |
FOGARTY ET AL., PROGRESS IN INDUSTRIAL MICROBIOLOGY, vol. 15, 1979, pages 112 - 115 |
HARRISON ET AL., APPLIED ENVIRON. MICROBIOL., vol. 77, 2011, pages 3916 - 22 |
JOHN ET AL., BIOTECHNOL. ADV., vol. 27, 2009, pages 145 - 52 |
KALISZ: "Advances in Biochemical Engineering/Biotechnology", 1988, article "Microbial Proteinases" |
LI ET AL., PROTEIN ENG., vol. 10, 1997, pages 1199 - 1204 |
LIU ET AL., SHENG WU GONG CHENG XUE BAO, vol. 27, 2011, pages 1049 - 56 |
LIU ET AL.: "Improved heterologous gene expression in Trichoderma reesei by cellobiohydrolase I gene (cbhl) promoter optimization", ACTA BIOCHIM. BIOPHYS. SIN (SHANGHAI), vol. 40, no. 2, 2008, pages 158 - 65 |
O'DONOHUE,M.J: "Cloning and expression in Bacillus subtilis of the npr gene from Bacillus thermoproteolyticus Rokko coding for the thermostable metalloprotease thermolysin", BIOCHEM. J., vol. 300, 1994, pages 599 - 603 |
PAPAGIANNI, BIOTECHNOL. ADV., vol. 25, 2007, pages 244 - 63 |
RAWLINGS ET AL.: "MEROPS: the peptidase database", NUCL ACIDS RES, vol. 34, 2006, pages D270 - 272 |
SAMBROOK ET AL.: "MOLECULAR CLONING: A LABORATORY MANUAL", 1989, COLD SPRING HARBOR |
THOMPSON ET AL., NUCLEIC ACIDS RES., vol. 22, 1994, pages 4673 - 4680 |
TITANI: "Amino-acid sequence of thermolysin", NATURE NEW BIOL., vol. 238, 1972, pages 35 - 37 |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US12084707B2 (en) | 2014-08-29 | 2024-09-10 | Lee Tech Llc | Yeast stage tank incorporated fermentation system and method |
WO2020247582A1 (en) | 2019-06-06 | 2020-12-10 | Danisco Us Inc | Methods and compositions for cleaning |
WO2021142057A1 (en) * | 2020-01-07 | 2021-07-15 | Danisco Us Inc | Methods and compositions for enhanced ethanol production |
CN113373133A (en) * | 2021-07-02 | 2021-09-10 | 广西乐酵生物科技有限公司 | Novel liquefaction process for producing alcohol from colloidal corn |
CN113373133B (en) * | 2021-07-02 | 2023-10-20 | 广西乐酵生物科技有限公司 | Novel liquefying process for producing alcohol from colloid corn |
US20230277956A1 (en) * | 2022-03-01 | 2023-09-07 | Lee Tech Llc | Methods of and systems for a dry milling process with two steps liquefications |
WO2023167874A1 (en) * | 2022-03-01 | 2023-09-07 | Lee Tech Llc | Methods of and systems for a dry milling process with two steps liquefications |
US12065513B2 (en) | 2022-06-17 | 2024-08-20 | Lee Tech Llc | System for and method of producing pure starch slurry and alcohol by using a process combining wet corn milling and a dry corn milling processes |
WO2023250301A1 (en) | 2022-06-21 | 2023-12-28 | Danisco Us Inc. | Methods and compositions for cleaning comprising a polypeptide having thermolysin activity |
WO2024258941A3 (en) * | 2023-06-12 | 2025-02-06 | Icm, Inc. | Advanced processing methods to produce high protein feeds and/or low-fat fiber products from dry grind cereal grains |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2297313B1 (en) | Variant alpha-amylases from bacillus subtilis and methods of use, thereof | |
CN105722989B (en) | Trehalase in Fermentation | |
US9365871B2 (en) | Method of using α-amylase from Aspergillus clavatus for saccharification | |
EP2291526B1 (en) | Saccharification enzyme composition with Bacillus subtilis alpha-amylase | |
CN102647918B (en) | Alpha-amylase blend for starch processing and method of use thereof | |
JP5419303B2 (en) | Alpha amylase mixture and method of using the mixture | |
WO2015066669A1 (en) | Proteases in corn processing | |
US20160010128A1 (en) | Method of using alpha-amylase from aspergillus terreus and pullulanase for saccharification | |
US20150218606A1 (en) | Method of using alpha-amylase from aspergillus clavatus and pullulanase for saccharification | |
US20150240223A1 (en) | Method of using alpha-amylase from talaromyces emersonii for saccharification | |
US20150232901A1 (en) | Method of using alpha-amylase from aspergillus clavatus and isoamylase for saccharification | |
US20160040202A1 (en) | Method of using alpha-amylase from aspergillus fumigatus and pullulanase for saccharification | |
WO2015021601A1 (en) | Simultanenous liquifaction and malto-saccharification | |
AU2022202136A1 (en) | Trehalase in fermentations | |
WO2015094714A1 (en) | Proteases in grain processing | |
US20160032338A1 (en) | Method of using alpha-amylase from aspergillus fumigatus and isoamylase for saccharification | |
EP2935606A1 (en) | Method of using alpha-amylase from aspergillus terreus and isoamylase for saccharification | |
CN111989400B (en) | Alpha-amylase, compositions and methods | |
WO2015066667A1 (en) | Proteases in wheat processing | |
AU2014342553A1 (en) | Trehalase in fermentations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14796385 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 14796385 Country of ref document: EP Kind code of ref document: A1 |